Are toxins from harmful algae a factor involved in the decline of harbour seal populations in Scotland? by Jensen, Silje-Kristin
->1 @<C5;? 2><9 4->92A8 -83-1 - 2-/@<>
5;B<8B10 5; @41 01/85;1 <2 4->.<A> ?1-8
=<=A8-@5<;? 5; ?/<@8-;0+
?LOMH!7TLUVLQ 6HQUHQ
- @KHULU ?WEPLVVHG IRT VKH 0HJTHH RI =K0
DV VKH
AQLXHTULV[ RI ?V -QGTHYU
&$%(
2WOO PHVDGDVD IRT VKLU LVHP LU DXDLODEOH LQ
>HUHDTFK,?V-QGTHYU*2WOO@HZ V
DV*
KVVS*##THUHDTFK!THSRULVRT[ "UV!DQGTHYU"DF"WN#
=OHDUH WUH VKLU LGHQVLILHT VR FLVH RT OLQN VR VKLU LVHP*
KVVS*##KGO"KDQGOH"QHV#%$$&'#)$'(
@KLU LVHP LU STRVHFVHG E[ RTLJLQDO FRS[ TLJKV
  
 
 
 
Are toxins from harmful algae a factor involved in 
the decline of harbour seal populations in Scotland? 
 
 
 
Silje-Kristin Jensen 
 
 
 
 
 
 
 
 
 
A thesis submitted for the Degree of Doctor of Philosophy, 
at the  
University of St Andrews 
 
 
 
November 2014 
 
i 
iii 
Declarations: 
 
I Silje-Kristin Jensen, hereby certify that this thesis, which is approximately 
50,000 words in length, has been written by me, and that it is the record of 
work carried out by me, or principally by myself in collaboration with others as 
acknowledged, and that it has not been submitted in any previous application 
for a higher degree.  
 
I was admitted as a research student in October 2011 and as a candidate for 
the degree of Doctor of Philosophy in October 2011; the higher study for 
which this is a record was carried out in the University of St Andrews between 
2011 and 2014.  
 
Date  10.04.15 Signature of candidate  
 
I hereby certify that the candidate has fulfilled the conditions of the Resolution 
and Regulations appropriate for the degree of Doctor of Philosophy in the 
University of St Andrews and that the candidate is qualified to submit this 
thesis in application for that degree. 
 
 
Date  10.04.15 Signature of supervisor 
 
Permission for electronic publication: In submitting this thesis to the University 
of St Andrews I understand that I am giving permission for it to be made 
available for use in accordance with the regulations of the University Library 
for the time being in force, subject to any copyright vested in the work not 
being affected thereby. I also understand that the title and the abstract will be 
published, and that a copy of the work may be made and supplied to any 
bona fide library or research worker, that my thesis will be electronically 
accessible for personal or research use unless exempt by award of an 
embargo as requested below, and that the library has the right to migrate my 
thesis into new electronic forms as required to ensure continued access to the 
thesis. I have obtained any third-party copyright permissions that may be 
required in order to allow such access and migration, or have requested the 
appropriate embargo below. 
 
The following is an agreed request by candidate and supervisor regarding the 
electronic publication of this thesis: Access to printed copy and electronic 
publication of thesis through the University of St Andrews. 
 
Date 10.04.15 
 
Signature of candidate  
 
Signature of supervisor 
iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
 
 
 
 
 
 
 
 
"... all the water that were in the 
river were turned into blood. And the fish 
that was in the river died; and the river 
stank, and the Egyptians could not drink of 
the water of the river" (Exodus 7: 20-21).
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Thesis abstract 
 
Firstly this study builds on the investigation initiated by Hall and Frame (2010), 
which found that Scottish harbour seals were exposed to domoic acid (DA), a 
potent natural neurotoxin produced by phytoplankton. Using the same sample 
collection technique to gather urine and faecal material from various 
populations around Scotland with differing population trajectories (Lonergan et 
al., 2007), the objective was to investigate not only exposure to DA, but also 
other groups of toxins such as paralytic shellfish poisoning (PSP) toxins and 
the lipophilic toxins okadaic acid (OA) and dinophysis toxins (DTXs). Toxins 
from harmful algae are thought to be potential causative factors in the on-
going harbour seal decline in some regions of Scotland (Hall and Frame, 
2010).  
 
This investigation was initiated because Pseudo-nitzschia (which produces 
DA) in particular was found to be highly prevalent in the phytoplankton 
communities in Scotland (Fehling et al., 2004; Stobo et al., 2008) and indeed 
was first observed at increased concentrations at around the time the harbour 
seal populations were observed as declining (Lonergan et al., 2007; Stobo et 
al., 2008). Prior to 2000 harbour seal populations in Scotland were largely 
stable or increasing. In addition DA exposure has had a devastating effect on 
the California sea lions (CSL) from the US west coast, where morbidity and 
mass mortality has occurred as a result of exposure (Goldstein et al., 2008; 
Gulland et al., 2002; Lefebvre et al., 1999; Scholin et al., 2000). In addition to 
the toxin analysis in urine and faecal samples, blood samples were collected 
and health parameters such as white blood cell and differential cell counts 
were investigated. Plasma cortisol concentrations and parasite faecal egg 
counts were additionally investigated as parameters indicative of adrenal 
function and parasite burden. CSL exposed to DA have significantly lower 
blood cortisol levels and higher eosinophil counts (Gulland et al., 2012) so it 
was possible that these indicators of effects might also be seen in the harbour 
seals. High parasite loads are often associated with high eosinophil levels 
(Klion and Nutman, 2004) so these data were needed to ensure any positive 
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relationships found were linked to DA and were not a consequence of parasite 
burdens. 
 
The work presented in this thesis highlights the effect of exposure to the 
neurotoxin DA and documents that Scottish harbour seals are exposed to 
multiple toxins such as PSP toxins, OA and DTX-2 (Chapter 2, Chapter 4). 
Immunomodulatory effects of DA exposure such as lymphocytopenia and 
monocytosis are also reported. In general, harbour seals from the east coast 
and Northern Isles, where the decline in abundance has been greatest, had 
higher levels of DA in their excreta than animals from the west coast. The 
concentrations in the faeces and urine samples were generally low but time 
since exposure was unknown. Uptake of DA, PSP toxins, OA and DTXs in 
randomly selected fish from the east coast of Scotland in the Firth of Forth 
was investigated (Chapter 3), where benthic, flat and pelagic fish are shown 
to be vectors of toxin transfer and emphasis is drawn to flatfish as they seem 
to accumulate higher levels of toxins than the other species analysed. This 
indicates that harbour seals foraging off the east coast are likely to regularly 
encounter toxic prey that could impair their health. 
 
In addition to live captured harbour seals, samples from dead stranded marine 
mammals (including cetaceans and in particular harbour porpoise) found a 
range of species in Scottish waters were exposed to both DA and PSP toxins 
(Chapter 4). A monitoring tool to rapidly determine chronic DA exposure in 
blood samples was published recently for DA exposed CSLs and in Chapter 5 
this monitoring technique was attempted in phocid seals, and where it failed to 
be replicated or validated which questions its function as a DA monitoring tool. 
Questions regarding how quickly a marine mammal excretes DA from the 
body have been discussed in the literature and in Chapter 6 an experiment 
was set up to measure the clearance of DA by using a biomarker (Iohexol). 
Iohexol was successfully measured in plasma samples from captive harbour 
seals following oral intake, where concentration and time of the iohexol peak 
was identified together with the calculation of its half-life. These results 
indicate the approximate elimination rate of DA (and potentially other 
hydrophilic toxins) and can be used to better interpret urine levels of DA 
 3 
measured in wild caught harbour seals. Collectively the results of this 
research will enable the risk posed by the ingestion of various toxins present 
in the Scottish marine food chain to marine mammals (particularly harbour 
seals but also harbour porpoise and grey seals) to be assessed. 
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Chapter 1 
 
 
1. General Introduction 
 
1.1 Decline in the abundance of harbour seals in Scotland 
 
Harbour (also called common) seals (Phoca vitulina) have the most 
widespread distribution of any phocid seal. There are four subspecies of 
harbour seals worldwide (Burg et al., 1999; Stanley et al., 1996; Westlake and 
O'Corry-Crowe, 2002) with the European subspecies (Phoca vitulina vitulina) 
ranging from northern France in the south, to Iceland in the west, Svalbard in 
the north and the Baltic Sea in the east. 
 
The harbour seal is the smaller of the two seal species found in the UK; the 
other one is the larger grey seal (Halichoerus grypus). Harbour seals can live 
up to 30 years, and an adult harbour seal weighs around 80-100 kg. They 
have a diet that varies seasonally and differs among regions, with sandeels, 
gadoids, flatfish and cephalopods making up their main prey (Hall et al., 1998; 
Thompson et al., 1996; Wilson, 2014). The Sea Mammal Research Unit 
(SMRU) monitors the trends in abundance of UK harbour seal populations 
during their annual moult in August using aerial photography and thermal 
imagery to count the numbers hauled out on land. This gives a minimum 
population size and an index from which to determine trends. Amalgamated 
counts from 2007 to 2012 give a minimum estimation of 26 836 harbour seals 
around the British Isles (SCOS, 2013). Around 30% of the European harbour 
seal population is found in the UK (SCOS, 2013). In 2005 almost 50% of the 
British harbour seal population was found in Scotland. Today, nearly 80% of 
the Scottish population inhabit the islands of Orkney and Shetland, as well as 
the west coast of Scotland. Since 1999 the harbour seal population in eastern 
coastal waters around Scotland has declined significantly, especially around 
Orkney and Shetland. Although the Moray Firth population has been 
continually stable in the last few years, other harbour seal populations on the 
east coast are declining (Lonergan et al., 2007; SCOS, 2013). For example, 
 18 
harbour seal populations on the east coast in the Tay and Eden estuaries and 
in the Northern Isles (Orkney and Shetland) in particular have decreased by 
up to 85% between 2000 and 2010, representing an average rate of decline of 
up to 18% per annum (SCOS, 2013). Whilst many factors have been 
considered as causes for these declines, one that remains of particular 
interest is the effect of harmful algal bloom toxins on harbour seal health and 
survival (Hall and Frame, 2010). This potential causal factor is therefore the 
focus of this thesis. 
 
1.2 Harmful algal blooms 
 
Phytoplankton are single-celled plants that form the base of the marine food 
chain. A rapid increase in phytoplankton growth is called an ‘algal bloom’, 
which consists of dinoflagellates or cyanobacteria (a blue-green algae), but 
other algae like diatoms may, under the right environmental conditions (light, 
nutrient, temperature, etc.), also proliferate to form blooms. There are two 
different seasonal blooms, the spring and autumn bloom. After winter nutrient 
supplies are mixed up to the surface layer, and when the spring begins, 
increased sea temperature and longer daylight hours become excellent 
conditions for phytoplankton to grow. Diatoms often dominate spring blooms. 
 
The term Harmful Algal Blooms (HABs, also called red tides) refers to 
phytoplankton species that produce toxins. Around 40 species of 
phytoplankton are known to produce a toxin, although as many as 200 
species are thought to be harmful or toxic (Hallegraeff, 1993). There are two 
distinct aspects to HABs: firstly, they cause hypoxia-like oxygen depletion due 
to either excess organic matter, which reduces oxygen dissolved in the water 
(Hallegraeff, 1993), that in return can cause mortality of benthic animals and 
fishes (Glibert et al., 2002; Granéli et al., 1989) or secondly blocking of light 
for subsurface communities (Landsberg, 2002). But the other main aspect of 
HABs is the production of toxins. Hypoxia, although potentially resulting in 
major fish kills, which could affect marine mammals through the mortality of 
their prey, will not be considered in the context of this thesis. 
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In certain regions in the North-East Atlantic and North Sea, there has been a 
noticeable increase in phytoplankton biomass (Bresnan et al., 2013), although  
the occurrence of phytoplankton in the water that can produce toxins does not 
necessarily mean that toxins are continually present, and when HABs do 
occur, nutrients are required for the bloom to be sustained. Eutrophication 
(especially caused by increased nitrogen and phosphorus) and degraded 
water quality is thought to be a main factor triggering such blooms (Anderson, 
1989; Anderson et al., 2008; Anderson et al., 2002; Glibert and Burkholder, 
2006; Heisler et al., 2008). Most of these HABs do not harm people wildlife or 
the environment, but some of them do. Marine algal toxins are accountable for 
between 50 000 - 60 000 toxic events per year. It is unclear why toxins are 
produced by phytoplankton, but it has been suggested that they prevent 
grazers from feeding on them (Bergkvist et al., 2008). With only 2 % of the 
world’s phytoplankton taxa are known to be toxic (Smayda, 1997), HABs are 
reported from every part of the world and are increasing in frequency and 
intensity (Hallegraeff, 1993; Landsberg, 2002; Van Dolah, 2000). In Scottish 
waters closures due to HAB have increased since the mid 1990’s (Stobo et 
al., 2008; Whyte et al., 2014), along with increased toxin monitoring. Today 
there are no clear trends regarding an increase or a decrease in toxin 
distribution, but there is a lot of variability between years with some groups 
decreasing and other toxins showing high concentration for the first time 
(Bresnan et al., 2013). 
 
1.3 Routes of exposure to HAB toxins 
 
Filter-feeding marine organisms such as shellfish and plankton-eating fish 
ingest these algae and act as vectors for transferring the toxin up the food 
chain. This can lead to mortality, throughout the food chain and pose a threat 
to the balance of the ecosystem. Toxic events are usually recognised by 
large-scale mortalities of benthic animals, fish, marine mammals and sea 
birds, sometimes together with human illness or death following ingestion of 
toxic phytoplankton either directly or via prey (Anderson and White, 1992; 
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Bargu et al., 2011; Bates et al., 1989; Bossart et al., 1998; DeGange and 
Vacca, 1989; Finucane, 1964; Fire et al., 2010b; Geraci et al., 1989; Glibert et 
al., 2002; Granéli et al., 1989; Gulland et al., 1998; Hernández et al., 1998; 
Konovalova, 1993; Konovalova, 1989; Landsberg, 2002; Lefebvre et al., 
1999; O'Shea et al., 1991; Scholin et al., 2000; Sierra-Beltràn et al., 1997; 
Silvagni et al., 2005; Steidinger, 1983; Work et al., 1993). Although most 
shellfish are not affected even though they filter toxic phytoplankton, humans 
or marine animals consuming the shellfish may become ill. 
 
HABs produce toxins that can cause various human illnesses depending on 
the nature of the toxin and cooking of the shellfish does not usually eliminate 
many of these toxins as they are heat stable (Isbister and Kiernan, 2005). In 
general they are neurotoxins but may also cause additional effects on other 
systems such as the respiratory system and heart.  Diseases known as 
Paralytic Shellfish Poisoning (PSP), Diarrheic Shellfish Poisoning (DSP), 
Ciguatera Fish Poisoning, Amnesic Shellfish Poisoning (ASP) or Neurotoxic 
shellfish poisoning (NSP) are the most common outcomes in humans. 
Generally toxic algae are present in low concentrations having little effect on 
human health; toxicity therefore depends on their presence in high cell 
concentrations (Van Dolah, 2000). 
 
1.4 Occurrence of HABs in Scotland 
 
In spring and autumn, algae in the sea give rise to blooms around Scotland. 
Some of these result in toxins produced by harmful algae. In the European 
Union (EU) there are three major toxin groups that can cause significant 
health effects in mammalian systems (including marine mammals and 
humans): ASP, PSP and DSP toxins including Okadaic acid and Dinophysis 
Toxins. 
 
As an EU member state, the UK is obliged to monitor the presence of marine 
toxins in shellfish as well as toxin-producing phytoplankton. In England and 
Wales, the Food Standards Agency (FSA) is the authority that enforces the 
legislation, and in Scotland the Food Standard Agency Scotland (FSAS) is the 
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national competent authority. The Official Control Biotoxin Monitoring 
Programme for Scotland is carried out by The Centre for Environment, 
Fisheries and Aquaculture Science (Cefas), and the Scottish Association for 
Marine Science (SAMS) are in charge of the delivery and reports on the 
phytoplankton aspect of the Scottish biotoxin monitoring programme (Centre 
for Environment, 2011; Swan and Davidson, 2011). 
 
The most harmful toxins arise from the PSP toxin group and ever since an 
outbreak in the North east of England in 1968 where 78 people were admitted 
to the hospital displaying PSP symptoms, toxins from this group have been 
monitored (Ayres and Cullum, 1978). Toxins from the ASP and DSP group 
have also been monitored in more recent years (Gallacher et al., 2000; Turrell 
et al., 2007). However, toxins from the PSP group remain the most important 
toxin to monitor due to their potential to harm wildlife and humans and in 
Scottish waters almost every year shellfish farms are closed due to high 
concentrations of PSP toxins (exceeding the European Community regulatory 
limit of 80 µg STX equivalents (eq) 100 g−1 of shellfish flesh) (Stobo et al., 
2008). Since the monitoring of DSP started in 1992 there has been an annual 
recording of this toxin in Scottish waters (Stobo et al., 2008). It has been 
known that toxins from the ASP group could have existed prior to the 
monitoring, that first commenced in 1998. Shellfish with DA concentrations 
above the regulatory limit (20 µg ASP toxins g−1 shellfish flesh) occurred since 
1999 with a peak around year 2000 (Stobo et al., 2008). Interestingly, this is 
around the time when the Scottish harbour seal population in some regions 
also started declining (Lonergan et al., 2007) 
 
 
1.5 Pseudo-nitzschia blooms, Domoic Acid and Amnesic Shellfish 
Poisoning 
 
Pseudo-nitzschia is a cosmopolitan marine diatom that exhibits a range of 
physiological tolerances. Diatoms are microalgae encased with a siliceous cell 
wall (SiO2) called the frustule. Diatoms often dominate spring blooms, and 
due to their immobility they require turbulence to keep them in a well-mixed 
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water column. Under certain conditions, when the bloom has reached its peak 
and nutrients become limited, toxin can be produced. Pseudo-nitzschia is now 
a common phytoplankton in Scotland (Stobo et al., 2008). Pseudo-nitzschia 
seems to bloom when it can out-compete other algae in conditions when silica 
is available or the temperature is falling, while other algae need warmer 
temperatures, low salinity and calmer sea to bloom (Bates et al., 1998; Mos, 
2001). Diatoms from the P. nitzschia group are considered to be one of the 
most harmful algae to marine mammal health. Not all species of P. nitzschia 
produce toxin, but those that do, produce the marine neurotoxin Domoic Acid 
(DA). 
 
DA is a water-soluble compound produced by at least eight species of the 
genus P. nitzschia spp. and the microalgae Chondria armata. Symptoms such 
as memory loss caused by DA intoxication gave the associated illness the 
name ASP. DA causes neuronal degeneration and necrosis in specific 
sections of the hippocampus. DA has been found all around the world in the 
last decade and there have been several reports of human intoxication where 
P. nitzschia was involved (Bates et al., 1989; Cendes et al., 1995; Todd, 
1993). The first DA intoxication was in 1987 when three people died and over 
100 became sick from eating mussels from Prince Edward Island, Canada 
(Bates et al., 1989; Bates et al., 1998). Domoic acid is also one of the biggest 
health threats to California sea lions (Zalophus californianus) on the US west 
coast, and the effect it has depends on the amount of toxic prey the sea lions 
eat (Lefebvre et al., 1999). Vectors such as krill, crab, shellfish and finfish are 
known to filter and accumulate the toxic algae and transfer it to top predators 
(Landsberg, 2002). 
 
1.6 Alexandrium blooms, Paralytic Shellfish Toxins and Paralytic 
Shellfish Poisoning 
 
The microscopic marine dinoflagellate genus Alexandrium poses the greatest 
concern for top predators due to its toxicity and it is the only toxic 
dinoflagellate known to cause PSP found in Scottish waters. A bloom from 
this genus has been known to occur for several decades on the southeast 
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coast of Scotland (Stobo et al., 2008). There are 30 recognized species of the 
genus and at least eight species produce PSP toxins; (A. acatenella, A. 
catenella, A. cohorticula, A. fundyense, A. ostenfeldii, A. minutum, A. 
tamarense (= A. excavatum) and A. tamiyavanichi) (Anderson, 1998), where 
four species have been recorded in Scottish waters (A. tamarense, A. 
minutum, A. ostenfeldii and A. tamutum) (Collins et al., 2009). The life cycle of 
Alexandrium is important in understanding its toxicity, and consists of nine 
stages, which include both motile, and cyst phases. One aspect that 
increases its success to bloom is the cyst phase, and its ability to reside on 
the bottom sediment when growth conditions are unfavourable as seen in Fig. 
1.1 from Anderson et al., (1996). 
 
 
Figure 1.1: Life cycle diagram of Alexandrium tamarense. Stages are identified as follows: (1) 
vegetative, motile cell; (2) temporary or pellicle cyst; (3) anisogamous "female" and "male" 
gametes; (4) fusing gametes; (5) swimming zygote or planozygote; (6) resting cyst or 
hypnozygote; (7 & 8) motile, germinated cell or planomeiocyte; and (9) pair of vegetative cells 
following division. Adapted from Anderson et al.,(Anderson et al., 1996). 
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The motile stage of the cells develops by binary fission and blooms occur 
when conditions are favourable. If conditions are poor (e.g. low temperature 
or changes in salinity) the motile species can go into a ‘’temporary cyst’’ which 
allows them to avoid unfavourable short-term fluctuations in the ocean 
(Anderson, 1998). Higher levels of toxicity have been associated with a 
limitation of phosphorous or other nutrients (John and Flynn, 2000). In 
Scotland Alexandrium produces toxins whilst in the planktonic phase of the 
life cycle (Wyatt and Jenkinson, 1997). 
 
PSP toxins are neurotoxins that block sodium channels in nerve axons 
interfering with signal transmission, causing paralysis or death. Toxic 
Alexandrium species normally produce more than one PSP toxin derivative 
that can cause the devastating PSP. Blue mussels (Mytilus edulis) are 
normally used as a sentinel for monitoring these toxins as they are relatively 
insensitive to PSP toxins and will keep grazing when other shellfish stop 
(Bricelj et al., 1990). However in Scotland King Scallops (Pecten maximus) 
are used for this monitoring. Historically there have only been a few cases of 
PSP events in Scottish waters (Table 1.1) where shellfish production had to 
be closed due to the presence of PSP toxins, but in Orkney there have been 
several events of PSP over the years (Töbe et al., 2001). In 1968, 80 % of the 
Shags (Phalacrocorax aristotelis) on the Farne Islands on the northeast coast 
of England, were killed (Coulson et al., 1968). Fish are reported to also carry 
STX and therefore cause sickness when ingested, where the fish gut is 
usually the toxic part (Adnan, 1984; Nakamura et al., 1984). 
 
1.7 Dinophysis spp. blooms, lipophilic toxins and Diarrhetic Shellfish 
Poisoning 
 
Dinophysis spp. are normally a temperate genus with over 200 species, six of 
which can be found in Scottish waters (Hart et al., 2007; Larsen and 
Moestrup, 1992). Dinophysis spp. seems to puzzle taxonomists since they 
form morphotypes, which compromise taxonomic identification. Dinophysis 
spp. appear throughout Scottish coastal waters in relatively low numbers and 
are indigenous to offshore waters and sea lochs. 
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Dinophysis spp. are known to produce several derivatives of toxins known as 
dinophysistoxin (DTX1-4) together with okadaic acid (OA) (James et al., 1999; 
Landsberg, 2002). Okadaic acid is a lipophilic toxin that causes DSP 
associated with the algae genera from the planktonic dinoflagellate 
Dinophysis and the epibenthic dinoflagellate Prorocentrum. Shellfish (primarily 
bivalve filter-feeding molluscs) consumption of toxins in northern Europe and 
subsequent DSP illness has been recorded from 10 countries. Monitoring 
programs try to minimize the impact of DSP, mostly to protect public health 
and although there are no known mortalities recorded due to DSP, monitoring 
the toxin has increased because it is becoming a threat in Scottish waters 
(Table 1.1). In laboratory animals, these toxins cause epithelial damage and 
fluid accumulation in the gastrointestinal tract. These substances have also 
been shown to be tumour promoters (Fujiki et al., 1988; Suganuma et al., 
1988b). OA and some of its derivatives are potent inhibitors of protein 
phosphatases, which play many roles in cellular function. The effect that DSP 
has on marine organisms is, however, poorly understood. 
 
Table 1.1: Overview over the main Harmful algal bloom (HAB) species in Scotland, the toxic 
syndrome, effect of toxic ingestion, location of outbreaks, intensity of the outbreak and the 
pharmacologic target. 
Organism Syndrome Effect Where 
(effect) 
Intensity of 
problem 
Pharma-
cologic 
target 
Pseudo-
nitzschia 
spp. 
ASP DA 
intoxication 
of shellfish 
and ASP 
danger to 
humans 
Islay to east 
of Aberdeen 
 
Endemic, 
causing 
long-
duration 
shell-fishery 
closure 
 
Glutamate 
receptors 
Alexandrium 
spp. 
PSP STX 
intoxication 
of shellfish 
and PSP 
danger to 
humans 
Mostly east 
coast to 
Northern 
Isles 
 
Endemic; a 
common 
cause of 
shell-fishery 
closure 
 
Voltage 
dependent 
sodium 
channel Site 
1 
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Dinophysis 
spp. 
DSP OA 
intoxication 
of shellfish 
and DSP 
danger to 
humans 
Widespread Occasional 
cause of 
shell- fishery 
closure 
 
Serine/threo
nine protein 
phosphatas
es 
 
 
1.8 Effect of toxins on marine mammals 
 
Marine mammals feed on prey, often shared with humans including various 
species of fish, cephalopods and shellfish which makes marine mammals 
good sentinels for likely effect of toxins in seafood (Goldstein et al., 2008).  
1.8.1 Domoic acid 
 
In laboratory studies mice, rats and monkeys have been reported with 
symptomatic responses after exposure to DA, where the more common 
symptoms were scratching, tremors and seizures (Iverson et al., 1989; Scallet 
et al., 1993; Tryphonas et al., 1990). For birds and mammals natural exposure 
to DA causes symptoms such as, seizures, vomiting, amnesia, behavioural 
abnormalities and in the worst cases coma and death follows (Fehling et al., 
2004; Goldstein et al., 2008; Gulland et al., 1998; Scholin et al., 2000; 
Tryphonas et al., 1990). 
 
1.8.2 Paralytic Shellfish Poisoning toxins 
 
Ingesting contaminated mussels or fish containing toxins (PSP toxins) can 
cause a potentially lethal disease, PSP. Clinically this is characterized by 
symptoms such as ataxia, tingling, numbness, drowsiness, incoherence, 
gastrointestinal malfunction and muscular weakness (Andrinolo et al., 1999). 
Respiratory depression is the most severe symptom where death can rapidly 
occur (Clark, 1968; Coulson et al., 1968). 
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1.8.3 Lipophilic and other toxins 
 
DSP is the most common intoxication caused by contaminated shellfish in 
Europe, where OA and DTX are common lipophilic toxins causing gastro 
abdominal disturbances (Gerssen et al., 2009). After ingestion, OA binds to 
protein phosphatase receptors which build up phosphorylated proteins which 
can then lead to clinical symptoms of DSP like fatigue, weakness, cramps, 
vomiting, abdominal pain and diarrhoea (Larsen and Moestrup; Yasumoto et 
al., 1984). 
 
Brevetoxin (PbTxs) are neurotoxins produced by the dinoflagellate Karenia 
brevis. Toxic blooms from this genus are known to cause fish mortalities and 
death of marine mammals (Flewelling et al., 2005). PbTxs have not been 
detected in Scottish waters and will not be tested for in this thesis (Cook et al., 
2010). 
 
1.8.4 Acute effects of toxin exposure 
 
Acute effects, defined as when an organism is suddenly exposed to a 
substance, are characterised by the onset of severe symptoms that develop 
quickly and can lead to a health crisis. Symptoms usually subside when 
exposure stops. Acute toxic exposures are known to have dramatic effects in 
humans as was evidenced on Prince Edward Island after humans consumed 
toxic mussels (Perl et al., 1990). Behaviour, pathological or physiological 
changes often occur when animals are exposed to high concentrations of 
toxin, exposure can also lead to mortality (Landsberg, 2002). In the US 
following a HAB event California sea lions may be found stranded alive, 
showing neurological signs like ataxia, head weaving, seizures or coma 
indicating DA toxicosis (Gulland et al., 2002). During a mass stranding in 
1998, and an even larger stranding event in 2002 together with strandings in 
2000, 2001 and 2005 almost a third of the females experienced prenatal 
reproductive failure (Goldstein et al., 2008; Gulland et al., 1998). Foetuses are 
in danger of repeated direct exposure through the amniotic fluid from pregnant 
females that have ingested DA. Experimental exposure to DA in laboratory 
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animals has shown abnormal development of brain neurons which is likely to 
occur at the completion of neurodevelopment of the foetus (Ramsdell and 
Zabka, 2008). In a study in mice by Ryan et al., (2005), gene expression was 
shown to be affected following acute DA exposure. Experimental studies in 
monkeys confirms that clinical signs together with brain lesions occur which 
may also inflict excitotoxic central nervous system damage (Tryphonas et al., 
1990).  
 
In a Finnish lake, a cyanobacterial (Anabaena lemmermannii) bloom occurred 
between 2002 and 2003, where symptoms such as eye irritation, fever, skin 
rash and abdominal pain were reported in children after they had been 
swimming in the lake and had been exposed to the bloom. These symptoms 
do not represent typical PSP symptoms, but rather acute effect due to a toxic 
bloom (Rapala et al., 2005). There have been no reported mortalities in 
humans caused by drinking contaminated water with PSP toxins. However, in 
Australia 14 sheep died after drinking contaminated water with the neurotoxic 
Anabaena circinalis which produces saxitoxin (Negri et al., 1995). Acute 
cases of PSP can be hard to track because of the lack of post mortem 
indications of organ injury due to the respiratory failure effect PSP can have. 
In Scotland, there have been six cases of poisoning of the neurotoxin 
anatoxin-a in dogs where they had either swum in a contaminated loch, or 
walked along the shore. All the dogs showed nervous symptoms of acute 
PSP. The neurotoxin was isolated from the dogs’ stomach (Gunn et al., 1992). 
In 1990 a PSP epidemic occurred in Guatemala where 26 people died from 
eating clams contaminated with saxitoxin (Rodrigue et al., 1990).  
 
Diarrhetic Shellfish Poisoning is a milder seafood poisoning where the main 
acute symptoms are gastrointestinal signs like diarrhoea and vomiting. 
Generally the symptoms resolve within two to three days (Dawson and 
Holmes, 1999; Lange et al., 1989). Stranded manatees (Trichechus manatus 
latirostris) and green sea turtles (Chelonia mydas) were found exposed to OA 
in Florida, US between 2003 and 2006 (Capper et al., 2013), although the 
exposure was not the cause of death, questions regarding if these toxins can 
compromise their health did arise from these findings. To date OA and DTXs 
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have not been shown to have any negative effect on marine mammal health, 
but OA was detected in an unusual mortality event affecting bottlenose 
dolphins (Tursiops truncatus) in Texas (Fire et al., 2010b).  
 
1.8.5 Chronic effects of toxin exposure 
 
Chronic effects are often characterized by continuous or repeated exposure 
(days, months or years) to a low concentration of a substance. Symptoms will 
not always be obvious and recent observations have outlined a chronic 
disease in California sea lions where epilepsy and unusual behaviours are 
seen (Goldstein et al., 2008; Ramsdell and Gulland, 2014). This chronic 
disease may be a result of acute exposure but is diagnosed in animals 
outside a large HAB event.  Animals strand individually rather than as part of 
a mass mortality event and show hippocampal atrophy with necrosis in the 
amygdala and sometimes the olfactory bulb (Ramsdell and Gulland, 2014). 
The lack of information about low dose exposure to toxins from harmful algae 
is of concern. However, a recent long term, low level DA exposure study in 
zebra fish (Hiolski et al., 2014) found that gene transcription involved in 
neurological function and development was altered.  Although the gene 
transcription changes were not consistent across all exposure levels, the most 
notable finding was that central nervous system mitochondrial function, based 
on respiration rates and protein content, was affected. The authors concluded 
that this might indicate fundamental cellular level impacts from repeated low 
exposure (at levels below those that induce seizures or behavioural changes) 
that could have chronic health implications. Existing monitoring programs 
prevent acute toxin poisoning in humans, but due to very limited knowledge 
about the chronic effects, little is being done to monitor toxins on a wider 
temporal or spatial scale.  The recent study by Hiolski et al., (2014) does 
suggest that there may be harmful impacts caused by long-term and low-level 
exposure and as the frequency of harmful algal blooms increases, the 
likelihood of marine mammals being indirectly exposed (e.g. via low toxic level 
prey) to toxins increases. When organisms are exposed to lower level, 
repeated toxin contact, the toxin may not be excreted completely and 
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repeated exposures without total depuration may, over time, exceed the 
threshold of toxicity and cause chronic effects (Goldstein et al., 2008; 
Landsberg, 2002).  
 
These low dose, or repeated exposure levels are not well described and 
experimental results are varied, but effects have been found to be more 
common in adult animals (Scallet et al., 1993; Sobotka et al., 1996). Recent 
observations have described chronic disease in juvenile California sea lions 
linked to DA ingestion possibly through milk (Goldstein et al., 2008; Maucher 
and Ramsdell, 2005). The numbers of stranded California sea lions are 
increasing, and especially the proportion suffering from chronic effects. 
California sea lions have shown neurological signs after DA exposure such as 
sporadic seizures, and unusual behaviours and pathological changes have 
been documented (Goldstein et al., 2008). Low doses by systemic injection of 
DA (in rats) have been shown to produce clinical signs like seizures, fatigue, 
lack of appetite, muscular twitching and behavioural changes together with 
mild lesions and brain gliosis (Goldstein et al., 2008; Scallet et al., 1993; 
Sobotka et al., 1996). How relevant these findings are for low level oral 
exposure is difficult to assess. 
 
Although saxitoxins have only shown acute effects in mammals, it seems that 
prior exposure to non-lethal doses of PSP toxins can lower the susceptibility 
of rats to lethal doses as noted by Parkas et. al. (1971)  . However no other 
information on sub chronic or chronic effects of PSP toxins exists for animals. 
 
As mentioned earlier DSP is known to be a short-term acute disease, but 
interestingly, there is increasing evidence suggesting the role of OA-like 
polyether toxins as tumour promoters in skin and stomach in both humans 
and wildlife (Landsberg, 2002; Suganuma et al., 1988b). Thus again, low-level 
chronic exposure should induce cellular changes that have long-term effects 
on individual fitness. 
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1.9 Aims of this study 
 
Exposure to toxins from harmful algae has caused devastating health effects 
and mortality in marine mammals in several places around the world 
(Doucette et al., 2006; Doucette et al., 2012; Gulland, 2000; Gulland et al., 
2012; Hernández et al., 1998; Scholin et al., 2000). Because of these 
observed effects, there has been an interest in studying these toxins and their 
involvement in the decline of the harbour seal populations in Scotland.  
Currently it is not known why the population is declining so rapidly (SCOS, 
2013), particularly after a period of stability in many regions, but after 2000 a 
change may have occurred which led to the populations in Orkney, Shetland 
and on the east coast in particular, to decline. Interestingly, the timing fits 
when DA in Scottish waters reached its peak and have also occurred over the 
regulatory limit on an annual basis since then in Scotland (Stobo et al., 2008). 
 
If the Scottish harbour seals are exposed to a range of toxins this study will 
provide information on the effect this may have on their health and what type 
of prey are likely to be the most important vectors, how quickly the toxins are 
cleared by the seals (i.e. the depuration rate or half-life) and how any 
exposure in harbour seals compares to other top predators such as cetaceans 
and grey seals. The results from this thesis will help with the conservation and 
management of this now vulnerable population. 
 
1.10 Thesis structure 
 
The main goal of this thesis was to investigate the exposure of harbour seals 
to toxins from harmful algae in Scotland and investigate their transfer through 
the marine food chain to these and other top predators.  
 
The first objective was to investigate multiple algal toxin exposure to harbour 
seals (Chapter 2). Chapter 2 measures toxins in various matrices (largely 
faeces and urine) for the major groups of toxins currently identified in Scottish 
waters (mainly DA, PSP toxins and lipophilic toxins) to determine the types 
and quantities of toxins the harbour seals are exposed to and relate the levels 
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found in the excreta to health parameters in individuals, particularly immune 
and endocrine endpoints. Anonymous faecal samples collected from harbour 
seal haul-out locations were gathered on a regular basis during spring, 
summer and autumn to better understand the temporal and spatial variation in 
the toxin exposure. 
 
The second objective was to investigate randomly selected fish from the east 
coast of Scotland to determine the concentration of toxins accumulated by the 
fish and what prey species are likely to be of most importance as vectors 
(Chapter 3). The results will then be compared to the diet of harbour seals 
from the same region, recently studied in a PhD project by Wilson (2014).  
 
The third objective was to examine toxin exposure in stranded marine 
mammals in collaboration with the Scottish Marine Animal Stranding Scheme 
(Chapter 4). Faecal material, urine and other body fluids (such as thoracic and 
amniotic fluid) are collected during the post mortem examination of dead 
marine mammals. This enabled me to compare the levels found in harbour 
seals with other top predators foraging in the same region but perhaps in 
different locations and feeding on different prey. 
 
The fourth objective was to assess a method to study the historic exposure of 
Scottish harbour seals to DA by using archived harbour seal blood samples 
(Chapter 5). This method ostensibly detects a naturally occurring, DA specific 
antibody produced when an animal is chronically exposed to DA. The 
objective of Chapter 5 was firstly to verity the method published for California 
sea lions to see if this could also be detected in harbour and grey seal 
samples and to study chronic DA exposure and to determine whether 
exposure rates have increased over the same time frame as the decline in 
abundance. 
 
The fifth objective was to assess how quickly DA clears from the harbour 
seals by measuring a substrate (iohexol) that has been shown to clear out of 
the body at the same rate as DA (Chapter 6). The results of this study will 
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then allow me to more readily interpret, particularly the urinary results, from 
the live captured harbour seals. 
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Chapter 2 
 
2. Exposure of Harbour Seals to multiple Algal Toxins 
in Scotland 
 
 
2.1 Introduction 
 
2.1.1 Domoic acid in marine mammals 
 
Pseudo-nitzschia diatoms are a common part of the phytoplankton community 
in Scotland, but only some Pseudo-nitzschia species produce DA (Fehling et 
al., 2006). Monitoring for DA in shellfish production areas in Scotland started 
in 1998 and it has since been detected in Scottish shellfish above the 
regulatory limit (20 mg DA/kg of shellfish meat) (Stobo et al., 2008; Tett and 
Edwards, 2002). Exposure to DA by top predators such as seals can occur in 
two ways; acute and chronic exposure. Acute exposure can happen when a 
rapid absorption of large amounts of DA is involved. Such acute exposure can 
cause severe impacts such as seizures, coma reproductive failure and death 
(Geraci et al., 1989; Goldstein et al., 2008; Goldstein et al., 2009; Scholin et 
al., 2000), while heart disease, chronic epilepsy and reproductive failure can 
come from repeated more long-term (chronic) exposure to DA (Brodie et al., 
2006; Goldstein et al., 2008; Goldstein et al., 2009; Gulland et al., 2002; 
Lefebvre et al., 1999; Scholin et al., 2000; Silvagni et al., 2005). In humans 
DA triggers the condition ASP and can cause neuronal degeneration and 
necrosis in specific parts of the brain. After the outbreak of illness in humans 
caused by the consumption of DA toxic blue mussels in Canada in 1987 the 
regulatory level was established for human consumption (Bates et al., 1989). 
In the US, acutely DA exposed California sea lions may show neurological 
signs such as ataxia, head weaving, seizures or coma which together indicate 
DA toxicosis (Gulland et al., 2002). Haematological parameter changes have 
also been documented in CSLs following DA toxicosis, but the physiological 
mechanism underlying this is not well understood (Gulland et al., 2002). For 
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example, Gulland et al., (2012) found that eosinophil counts were significantly 
higher in CSLs showing clinical signs of DA toxicity, and this was also 
reported for bottlenose dolphins in the northern Gulf of Mexico (Schwacke et 
al., 2010). Studies have suggested that pregnant CSL females may have 
higher exposure due to sequestration of the toxins in the amniotic fluid and 
that DA causes reproductive failure (Brodie et al., 2006; Goldstein et al., 2008; 
Goldstein et al., 2009). In addition, endocrinological changes have also been 
documented when CSLs are exposed to DA as it also affects the adrenal 
gland, lowering the production of cortisol (Gulland et al., 2012; Gulland et al., 
2002). 
 
2.1.2 PSP toxins in marine mammals 
 
PSP toxins and its derivatives produced by the dinoflagellate Alexandrium 
pose the greatest potential concern for seals in Scotland due to their highly 
lethal effects. With a lack of chronic toxicity data on PSP toxins the European 
Food and Standards Authority derived an oral acute reference dose (ARfD) of 
0.5 µg STX equivalents/kg b.w. in humans (Alexander et al., 2009). Canids, 
considered to be evolutionarily and physiologically similar to seals, have a 
lethal dose of 180 – 200 µg STX/kg b.w. (McFarren et al., 1961). Mice have 
an acute oral LD50 dose of 263 µg STX/kg, humans have a minimum oral dose 
of 7–16 µg of STX/kg body weight (Levin, 1992; Schantz et al., 1975), but 
mortal cases in humans linked to PSP poisoning have been observed in 
humans with oral doses of between 500 – 12400 µg STX/kg body weight 
(Meyer, 1953). Since the outbreak of PSP in the UK in 1968 where 80 % of 
the Shags on the Farne Islands on the northeast coast of England, were killed 
(Coulson et al., 1968), a programme has been set up to monitor the Scottish 
coast for the presence of Alexandrium in the vicinity of shellfish aquaculture 
sites. Concurrently, shellfish were also checked for the presence of PSP 
toxins using the mouse bioassay (MBA). Although toxic events have been 
very sporadic in Scottish waters, no known human cases of PSP have been 
reported (Swan and Davidson, 2011). PSP toxins has also been found in a 
range of organisms such as fish and benthic invertebrates (Landsberg, 2002) 
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even though Alexandrium were absent (Sakamoto et al., 1992). Toxic 
Alexandrium normally produce more than one PSP toxin derivative including 
STX, gonyautoxin I~VIII, neosaxitoxin (NEO) and decarbamoyl toxins, all of 
which can cause PSP. The biochemical production of the neurotoxins from 
the PSP toxin family is complex. PSP toxins bind to the voltage-gated sodium 
channels in the brain, blocking the flow of ions across the cell membrane. This 
process inhibits nerve and muscle cells to send electrical signals, which 
prevents normal cellular function, and this causes paralysis. PSP toxins can 
also bind to the potassium channel where it modifies the channel gating and 
reduces the potassium conductance (Cusick and Sayler, 2013; Narahashi et 
al., 1967). Respiratory depression is the most severe symptom of PSP, 
following which death can rapidly occur. Evidence of STX exposure in the 
endangered North Atlantic right whale (Eubalaena glacialis) (Doucette et al., 
2006) occurred in 2001 where STX was considered to be a contributing factor 
in the failure of the population to recover from decline. Saxitoxin was also 
considered to be involved in the sudden unusual mortality event of the 
Mediterranean monk seals (Monachus monachus) off western Sahara in 1997 
(Hernández et al., 1998) and humpback whales (Megaptera novaeangliae) off 
Cape Cod Bay, USA in 2001 (Geraci et al., 1989).  
 
2.1.3 Lipophilic toxins in marine mammals 
 
Another group of toxins that causes illness are the lipophilic toxins such as 
Okadaic acid and its derivatives, the Dinophysis toxins (DTXs). These 
lipophilic toxins cause the human illness known as DSP and the toxins are 
produced by the dinoflagellate Dinophysis spp. (Larsen and Moestrup, 1992; 
Yasumoto et al., 1984). Okadaic acid and DTXs are two lipophilic toxins 
groups that inhibit the serine/theorine protein phosphatases PP1 and PP2A 
and builds up phosphorylated proteins, the protein phosphatases are 
essential in regulating the physiological functions such as growth and division 
in a cell. Chronic exposure to OA and DTXs can result in skin and stomach 
tumour development and when injected into the brains of rodents it induces 
neuronal damage reminiscent of that seen in Alzheimer’s disease (Fujiki and 
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Suganuma, 2009; Suganuma et al., 1988a). In laboratory animals, these 
toxins cause epithelial damage and fluid accumulation in the gastrointestinal 
tract and can in extreme cases cause death. A maximum tolerated level of 
these toxins have been set at 160 µg OA equivalents /kg shellfish meat 
(European Commission (2002)). Regular monitoring of these toxins in 
shellfish started in 1997 and occasional shellfish closures occur (Tett and 
Edwards, 2002). To date OA and DTXs have not shown to have any negative 
effect on marine mammal health, but OA was detected in an unusual mortality 
event among bottlenose dolphin in Texas (Fire et al., 2010b). Low levels of 
OA was also detected in stranded manatees in Florida between 2003 and 
2006 (Capper et al., 2013). 
 
2.1.4 Multiple toxin exposure in marine mammals 
 
In Sarasota Bay, Florida, USA bottlenose dolphins have been exposed to 
multiple toxins (brevetoxin and/or DA) on an annual basis since 2000 (Twiner 
et al., 2011). North Atlantic right whales have been found to be exposed to 
both DA and STX via consumption of contaminated copepods (Calanus 
finmarchicus) (Leandro et al., 2010) which is thought to have had an effect on 
their reproduction. However, information on exposure of marine mammals to 
multiple toxins is sparse. Acute and chronic exposure to individual toxins from 
harmful algae thus have the potential to compromise an animals’ fitness but 
the potential synergistic effects of multiple toxin exposure, particularly over a 
long period of time has not been assessed which thus raises questions about 
the combined health effects. Immunosuppression is thought to be one of the 
effects that can come from multiple toxin exposure (Twiner et al., 2011).  
Dragunow et al., (2005) discovered that OA toxicity increases (in vitro) in the 
presence of a toxin produced by the dinoflagellate Karenia called 
gymnodimine. This demonstrates that being exposed to multiple toxins could 
potentially have a synergetic effect. 
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2.1.5 Objectives of this chapter 
 
Thus this study (a) builds on the earlier work by Hall and Frame (2010) to 
investigate the temporal and spatial exposure of harbour seals in Scotland to 
DA (b) investigates exposure to other potentially lethal toxins including the 
PSP toxins as well as those that could cause serious health effects (OA and 
the DTXs) in urine and faecal material from live-captured harbour seals. In 
addition scat collected from haul out sites provides an indication on the spatial 
scale of the toxin exposure (c) determines the occurrence of combined 
exposure to multiple toxins in these populations to a level that might affect 
their health, population dynamics and therefore cause a decline in abundance 
(d) investigates the response of the harbour seals to the toxins by examining 
several health parameters, and (e) examines the levels of the main toxins in 
potential prey vectors to determine any link between the concentrations and 
differing degrees of exposure in declining compared to stable harbour seal 
populations. 
 
2.2 Methods 
 
2.2.1 Sample collection 
 
2.2.1.1 Live captured harbour seals 
 
Urine, faeces and blood samples were collected from live-captured harbour 
seals (Table 2.1, n =111) between 2008 and 2013, from west Scotland central 
and south hereby named ‘west coast’. Samples were also collected from the 
North coast, Orkney and Shetland are hereby named ‘Northern Isles’ and 
samples from Moray Firth and southern east coast are hereby named ‘east 
coast’ (Fig. 2.1, West, North and East) with the aim of detecting and 
quantifying a range of harmful algal toxins (DA, STX and lipophilic toxins, Fig. 
2.1, Table 2.1). The harbour seals populations have different abundance 
trends where the west coast population is stable or increasing in certain 
areas, while in the Northern Isles and the east coast the population of harbour 
seals are declining. The harbour seal samples were collected in relation to 
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capture-release studies carried out by the SMRU under the UK Animal 
(Scientific Procedures) Act 1986, Project and Personal Licenses. Once 
captured, all the seals were weighed and anaesthetised using 0.05 mg kg -1 
Zoletil100 (Virbac, France) intravenously using the extradural vein. Blood 
samples were collected from the same vein and stored in plain and 
heparinised blood vacuum tubes (Vacutainers, Becton Dickinson Ltd, UK). A 
subsample was taken out from the heparinised tube for further haematology 
work. Each sample was then centrifuged (3,000 x g, 10 min) and serum or 
plasma was extracted and subsequently stored at -20°C for health analysis. 
For DA analysis urine was identified as one of the major routes of DA 
excretion (Suzuki and Hierlihy, 1993), hence urine samples were collected 
using a catheter. Furthermore faecal samples were also collected manually 
using a modified plastic pipette when possible. 
 
Table 2.1: Number of live captured harbour seals by region, season (spring = Mar, Apr, May; 
summer = Jun, Jul, Aug; autumn = Sept, Oct) and matrix (faeces, urine or serum). 
Region Season Faeces (Sex) Urine (Sex) Serum 
East coast Spring 
Summer 
Autumn 
7 (2 F, 5 M) 
4 (1 F, 3 M) 
9 (5 F, 4 M) 
6 (1 F, 5 M) 
10 (4 F, 6 M) 
19 (11 F, 8 M) 
7 
10 
19 
Northern Isles Spring 
Summer 
Autumn 
n.a 
10 (9 F, 1 M) 
15 (8 F, 7 M) 
n.a 
21 (16 F, 5 M) 
17 (7 F, 10 M) 
n.a 
21 
17 
West coast Spring 
Summer 
Autumn 
16 (9 F, 7 M) 
4 (4 F, 0 M)  
n.a 
23 (10 F, 13 M) 
14 (10 F, 4 M)  
n.a 
23 
14 
n.a 
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Figure 2.1: The collection sites of harbour seal faecal and/or urine samples. The size of the 
circles reflects the sample size, green circles indicate samples from live captured and 
stranded harbour seals, and brown circles indicate anonymous faecal samples collected at 
haul-out sites. The purple boundaries and labels represent the regions used for the analysis. 
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2.2.1.2 Haulout collection of anonymous faecal samples 
 
Faecal samples were collected from selected sites around Scotland (Fig. 2.1) 
in spring and autumn between 2010 and 2013 (with a few samples in 2003 
and 2008) at harbour seal haul-out sites. Samples were collected at low tide 
into individual plastic bags and stored at -20 °C until extraction and analysis. 
Grey seals also sometimes use some of these haul-out sites, therefore sub-
samples of the faeces from the mixed sites were stored for DNA extraction 
and species identification (carried out in collaboration with Xelect, St. 
Andrews. UK). 
 
2.2.2 Otolith identification 
 
Any remaining faecal material was sieved and the fish otoliths were removed 
and identified to fish species using a reference collection and other available 
guides (this identification was carried out in collaboration with Mr. John 
Watkins) (Breiby, 1985; Brodeur and Center, 1979; Härkönen, 1986). 
 
2.2.3 Domoic acid analysis 
 
2.2.3.1 Domoic acid extraction 
 
Faecal samples were extracted and analysed based on the method published 
by Lefebvre (1999). The samples were defrosted and a 4 g subsample was 
homogenized and extracted using 50 % methanol in a 1:4 ratio. Samples 
were then centrifuged at 3000 x g for 30 min, the supernatant was filtered 
through a 0.45 µm syringe filter (Millipore Corp., Bedford, MA) and collected 
for Solid Phase Extraction (SPE), using Strong Anion Exchange (SAX) 
columns (Supelco, UK). Between 2-3 ml of filtrate were passed through the 3 
ml SPE column that was pre-conditioned with 6 ml of methanol followed by 3 
ml of water then by 3 ml of methanol:water (1:1). The cartridge was not 
allowed to get dry at any point during the procedure. Two ml of the sample 
supernatant was loaded into the cartridge slowly (ca. 1 drop/s). The column 
was then washed with 5 ml 10 % acetonitrile. Finally 5 ml of 0.5 N sodium 
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chloride in 10 % acetonitrile was used to elute the DA into a 15 ml Falcon 
tube. The sample was stored in a fridge and analysed within a month of 
extraction (Lefebvre et al., 1999). Urine samples were used directly for the 
Amnesic Shellfish Poisoning Enzyme-Linked Immunosorbent Assay (ASP 
ELISA assay kits, Biosense, Norway) method. 
 
2.2.3.2 ASP ELISA analysis 
 
For DA confirmation the Amnestic Shellfish Poisoning Enzyme-Linked 
Immunosorbent Assay (ASP ELISA assay kits, Biosense, Norway), has been 
found to be a reliable, sensitive and rapid method for detecting DA in various 
matrices in the marine environment (Garthwaite et al., 2001). The ELISA 
assay has no cross-reactivity to non-toxic, structural analogues like kainic 
acid. This direct competitive ELISA was used to measure DA concentrations 
in urine and toxin extracted and SPE filtered faecal samples. The assay is 
based on detection of DA by polyclonal anti-DA antibodies, where free DA in 
the sample (e.g. urine or faeces) competes for binding to the polyclonal 
antibodies with DA-conjugated protein coated on the plastic wells. A colour-
producing enzyme is added and the bound (antibody) proportion is measured 
through the colour intensity using a microplate reader at wavelength of 450 
nm. The limit of quantification (LOQ) for the ASP ELISA was set to 0.004 µl/ml 
(urine) and 0.020 µg/g (faeces). The intra-assay CV was 0.04 (n = 10) and an 
inter-assay CV was 0.12 (n = 6). 
 
2.2.3.3 Instrumentation for DA analysis using UHPLC-MS/MS 
 
For confirmation of the results obtained using the ASP ELISA a method based 
on the use of ultra high performance liquid chromatography-tandem mass 
spectrometry (UHPLC-MS/MS) was used to quantify DA and was carried out 
at Marine Scotland Science, Aberdeen (Fig. 2.2). A hybrid triple quadruple 
linear ion trap mass spectrometer (3200 QTRAP, ABSciex) fitted with a 
TurboIonSpay® Ion source was coupled to a 1290 Infinity UHPLC system 
(Agilent) comprising a 1290 Infinity binary pump, a 1290 Infinity thermostated 
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column compartment and a 1290 Infinity auto-sampler. Elution of DA was 
achieved using a kinetex C18 column (100 mm × 2.1 mm, 1.7 µm – 
Phenomenex) using an isocratic elution (12 % B). Mobile phase A was 100% 
aqueous and mobile phase B was 95% acetonitrile, both containing 2 mM 
ammonium formate and 50 mM formic acid. With a flow rate set up at 0.3 
ml/min and a column oven maintained at 20º C throughout the analysis, the 
run time per sample was six minutes. The injection volume for both standards 
and sample extracts was 5 µl. The mass spectrometer was used in multiple 
reaction-monitoring (MRM) mode and three specific transitions, one for 
quantitation and the other two for confirmation, were monitored for DA. The 
monitored transitions and source parameters are detailed in Table 2.2 and 
2.3. LOQ was selected using the lowest standard that had a peak, and the 
noise and the signal intensity was visually quantified. The signal to noise ratio 
(S/N) was then calculated. At the end the LOQ was proportionally calculated. 
The limit of detection for DA (LOD) was set to 0.004 µg/g and limit of 
quantification (LOQ) to 0.025 µg/g. 
 
Table 2.2: Mass spectrometer optimised parameters for the considered DA transitions 
 
Transit
ion 
Q1 
(m/z) 
Q3 
(m/z) DP (V) EP (V) CEP (V) CE (V) CXP (V) 
DA 
T1 310 266.3 -50 -3 -10 -20 -3 
T2 310 222.3 -50 -3 -10 -25 -2 
T3 310 160.2 -40 -4 -10 -30 -1 
Q: quadrupole  
m/z: mass/charge 
DP: declustering potential 
V: voltage 
 EP: entrance potential  
 CEP: collision cell entrance potential 
 CE: collision energy potential 
 CXP collision cell exit potential 
 
 
Table 2.3: Source/Gas optimised parameters 
 
CUR IS TEM GS1 GS2 CAD 
Source 
/Gas 10 -4500 450 55 50 Medium 
 CUR:  Curtain gas voltage 
 IS:  electro spray voltage 
 TEM:  source temperature 
 GS1:  nebuliser gas pressure 
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 GS2:  heater gas pressure 
 CAD: collisional activated dissociation voltage 
 
 
 
Figure 2.2: Relationship between DA concentrations (ng/g) in faecal samples from the ASP 
ELISA kit and the analysis using the UHPLC-MS/MS. 
 
2.2.4 PSP toxin analysis 
 
2.2.4.1 PSP toxin extraction 
 
For faecal extraction a 4 g subsample was homogenized and then mixed with 
in a 1:1 ratio of 0.1 M hydrochloric acid and boiled between 2-5 min while 
stirring. The mixture was allowed to cool and then centrifuged for 10 min at 
3500 x g. The supernatant was passed through a 0.45 µm filter and stored at 
4° C until protein precipitation. 
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2.2.4.2 Protein precipitation for PSP toxin analysis 
 
An aliquot of 500 µl sample extract was pipetted into a 2.5 ml eppendorf tube 
where 2.5 µl of 30 % tricarboxylic acid (TCA) was added. The sample was 
briefly vortexed before it was centrifuged for 5 min at 14 000 x g. To bring the 
pH in between 2-4, 35 µl and 1.0 M NaOH was added to the sample. The 
sample was then briefly vortexed and centrifuged for 5 min at 14000 x g. The 
supernatant was filtered through a 0.2 µm filter at 10 000 x g for 3 min. The 
filtered sample was transferred into a vial ready for HPLC analysis. 
 
2.2.4.3 Urine sample preparation 
 
PSP toxin was analysed in urine samples based on the method by Garcia et 
al., (2005) where 2 ml urine was mixed with 200 µl of 0.5M acetic acid and 
stored in a 2-5 ml eppendorf tube at 4° C until analysis. The sample was 
transferred into vials before analysis with the HPLC. 
 
2.2.4.4 Instrumentation for PSP toxin analysis using HPLC 
 
High Performance Liquid Chromatography (HPLC) with fluorescence 
detection (FLD), which is designed to separate compounds that are dissolved 
in solution with the purpose of identifying, quantifying and purifying the 
individual components, was used for evaluating PSP toxin levels. This method 
is very specific and selective, and can separate substances that fluoresce 
(PSP toxins wavelength: excitation: 330 nm, emission: 390 nm) it has been 
used for detecting individual concentration and total PSP toxicity of shellfish 
samples (Van de Riet et al., 2009). The instrument components (a-d) used in 
this analysis were different to those described by Van de Riet et al., (2009) as 
follows: 
a) LC system - A Shimadzu (Tokyo, Japan) Prominence UFLCXR liquid 
chromatographic system equipped with a CBM-20A communication bus 
module, a LC-20AD XR binary pump, a DGU-20A5R degassing unit, a SIL-
20AC XR auto-sampler, and a CTO-20AC column oven. 
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b) Post-column reaction system. An Eppendorf (Stevenage, UK) post-
column reaction module comprising a FH-40 reactor heater and a TC-50 
temperature controller capable of maintaining temperature at 85ºC with 
reagents delivered by two LC-20AD pumps and a DGU-20A3R degassing 
unit. 
c) Reaction coil. - Supelco teflon tube (Sigma-Aldrich, Gillingham, UK) 
with a total volume of 2.4 ml. 
d) Fluorescence detector. - Jasco FP-2020 Plus fluorescence detector 
e) LC columns. – 1. Agilent Zorbax BonusRP, 3.5 µm, 4.6 x 150 mm 
(Agilent Technologies). 2. Thermo BetaBasic 8, 5 µm, 4.6 x 250 mm (Fisher 
Scientific, Nepean, ON, Canada). To confirm some of the results obtained 
with the PCOx method, extracts, which were found to contain PSP toxins, 
were investigated further. A pre-column oxidation HPLC-FLD method (AOAC, 
2005) refined and validated for UK shellfish samples (Turner et al., 2008) was 
used to validate the results obtained from the first method of analysis. 
Samples were analysed following reverse-phase SPE clean up and both 
periodate and peroxide oxidation, with additional analysis of unoxidised 
extracts being used to compensate for the presence of naturally fluorescent 
matrix co-extractives. The results from the validation can be seen in Fig. 2.3. 
Only results from the Marine Scotland Science analysis will be used in this 
chapter. The LOD and LOQ for the PSP toxins are described in Table 2.4 and 
for this study a calculation of total toxicity was calculated according to Quilliam 
(2007) and these numbers are used in all the figures and models. 
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Table 2.4: Table showing the limit of detection (LOD) and the limit of quantification (LOQ) for 
the different PSP toxins, the units are expressed in µg STX diHCl eq/kg 
PSP toxin LOD LOQ 
Saxitoxin (STX) 0.67 2.00 
decarbamoyl saxitoxin 
(dcSTX) 
4.33 13.00 
Neosaxitoxin (NEO) 15.30 46.00 
Gonyautoxins (GTX) -2 0.67 2.00 
GTX-3 0.67 2.00 
dcGTX-2 0.33 1.00 
dcGTX-3 0.67 2.00 
GTX-5 0.33 1.00 
GTX-1 5.67 17.00 
GTX-4 6.00 18.00 
 
 
 
 
Figure 2.3: Validation of PSP toxins using the method HPLC-FLD analysed at Marine 
Scotland Science (MSS) compared with pre-column oxidation HPLC-FLD analysed at The 
Centre for Environment, Fisheries and Aquaculture Science (CEFAS). 
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2.2.5 Lipophilic toxin analysis  
 
2.2.5.1 Sample extraction 
 
For the lipophilic toxins a 2 g faecal sample was placed in a 50 mL disposable 
centrifuge tube. The extraction solvent (8 ml, 80% v/v methanol-water) was 
added using a calibrated pipette and the sample and solvent were blended 
using a homogenizer. The sample was then centrifuged (3000 x g for 12 min) 
and a 2 ml proportion of the supernatant extract was filtered (0.2 µm cellulose 
acetate syringe filter, Nalgene syringe filter, Thermo Scientific, Weltham, MA, 
USA) and stored in an amber vial glass in the freezer until hydrolysis. An 
aliquot of 150 µl sample extract (non-hydrolysed) was used directly for LC/MS 
analysis. 
 
2.2.5.2 Hydrolysis of Esterified Forms of OA, DTX-1, and DTX-2 
 
In order to detect OA, DTX-1 and 2 in their esterified forms the sample 
extracts were hydrolysed. This was carried out on an aliquot of 150 µl sample 
extract mixed with NaOH solution (18.5 ml, 2.5M) and the sample was heated 
in a water bath for 40 min at 76° C. The sample was allowed to cool down 
before the reaction was stopped with HCl (18.5 ml, 2.5M). The sample was 
filtered through a 0.2 µm cellulose acetate filter and collected for analysis. The 
hydrolysed samples were qualitatively detected by comparing if an > 10 % 
increase of the analyte peak (compared to the non-hydrolysed sample) had 
occurred before hydrolysis. 
 
2.2.5.3 Instrumentation for lipophilic toxin analysis using LC/MS 
 
Separations were carried out with an Agilent 1200 series LC system (Agilent 
Technologies, West Lothian, UK) consisting of a binary pump G1312A an 
auto-sampler G1367B, a temperature controlled compartment G1316A and a 
degasser G1379B. The detector was an Applied Biosystems API 150EX 
(Warrington, UK) mass spectrometer with a TurboIonspray® (Applied 
Biosystems) atmospheric pressure ionization interface. To divert the post 
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column flow of the mobile phase to waste a switching valve (Valco, Schenkon, 
Switzerland) was used for the initial 2 min of both the LC/MS multiple toxin 
and LC/MS hydrolysed extract analysis. For the multiple toxin and hydrolysed 
extract analyses the flow rates, injection volumes, and column temperatures 
were 0.25 ml/min, 5 ml, and 25° C. The mass spectrometer was operated in 
both ionization modes (positive and negative) and selected ion monitoring 
(SIM) acquisition modes. The LOD was > 0.006 µg/g and LOQ was > 0.02 
µg/g for both OA and DTX-2. 
 
2.2.6 Health parameters in Harbour seals 
 
2.2.6.1 Total white blood cell counts 
 
For total white blood cells (WBC), 10 µl whole blood was diluted 1:11 with 
Baar’s fluid (mixture of 0.25 g saponin, 3.5 g sodium citrate, and 1 ml formalin, 
0.1 g brilliant creysil blue). The diluted blood was allowed to settle for 10-15 
min to lyse the red blood cells. The diluted blood was then filled into the 
haemocytometer chambers (Double Improved Neubauer, Philip Harris 
Scientific Ltd., Glasgow, UK) where the white blood cells were counted 
manually in duplicate using a light 40x magnification. Total WBC was 
calculated from the mean of the duplicates x 10 x 1000 / 106 = total white cells 
x 106/ml. This value is the cell concentration in the original suspension. 
 
2.2.6.2 Differential white cell count 
 
A thin smear of blood was made onto a glass slide, air dried and stored at 
room temperature for further analysis. The dried blood smears were stained 
with Leishman’s stain (VWR International Ltd., Leicestershire, England, UK) 
first in neat Leishman’s stain containing methanol that will fix the cells for 5 
min then equal quantities of distilled water and Leishman’s stain for 5 min, 
finally the smear was fixed for 2 min in deionised water. Examination of the 
stained smears was performed under a light microscope using 100x 
magnification, oil immersion. WBC differentials, including monocytes, 
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lymphocytes, neutrophils, and eosinophil were identified and 200 cells 
counted manually. The proportion of each cell type was then converted to an 
absolute quantity using the total white blood cell counts. 
 
2.2.6.3 Faecal egg count 
 
Faecal eggs were counted to assess the level of parasite infection by 
calculating the number of internal parasite eggs per gram of faeces. This was 
carried out because a parasite infection is known to increase the eosinophil 
cell count, a blood parameter also affected by exposure to DA. Only fresh 
faeces from live captured harbour seals were used and faeces were weighed 
and diluted at 1:4 with water saturated with sodium chloride. The faeces were 
passed through a sieve and mixed before a sample was taken and transferred 
to a McMaster egg counting slide. The sample was allowed to settle for 30 
sec before being counted under a light microscope at 20x magnification. 
 
2.2.6.4 Cortisol quantification 
 
For the quantification of cortisol in the plasma samples, a commercially 
available solid phase enzyme-linked immunosorbent assay (ELISA) kit was 
used (DRG Cortisol ELISA EIA-1887) by DRG diagnostics (Marburg – 
Germany). The kit is based on the principle of competitive binding and allows 
the measurement of cortisol in unextracted plasma and serum samples. The 
levels were measured according to the ELISA kit instructions with a standard 
curve ranging between 0 and 800 ng/ml. This work was carried out in 
collaboration with a laboratory technician at the Sea Mammal Research Unit. 
 
2.2.7 Faecal DNA extraction and analysis 
 
2.2.7.1 DNA extraction (isolation of DNA from faeces) 
 
DNA was isolated using a kit from QIAamp DNA Stool Mini Kit (Qiagen, 
Hilden, Germany), following the manufacturer’s instructions where DNA binds 
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specifically to the QIAamp silica-gel membrane while contaminants pass 
through. In brief a sample between 180-220 mg is weighed up and lysed in an 
optimized buffer, an inhibitEx tablet is added to absorb inhibitors. The sample 
is then allowed to digest proteins and proteinase K is used to ensure high 
yield of all types of DNA. Alcohol is added then the sample DNA is allowed to 
bind to the QIAamp spin column after it is washed and the DNA is eluted with 
a low salt buffer from the spin column to a 1.5 ml eppendorf tube where the 
pure DNA is ready for quantification. 
 
2.2.7.2 DNA quantification carried out and written by Xelect, St. Andrews, UK 
 
The DNA samples had been previously extracted from seal scats collected 
from field locations and frozen. Attempts were made to quantify the DNA 
content of the samples by spectrophotometry and agarose gel 
electrophoresis. Due to the highly degraded nature and the relatively low 
abundance of DNA from scat samples, quantification results were generally 
less than 2 ng/µl and abundant fragment size was below 100bp. This is 
unsurprising, given the nature of the samples. Trial amplifications revealed 
that despite the state of the DNA it was still possible to amplify all 3 PCR 
targets. Purified DNA was obtained from tissue samples of one female grey 
seal and one male harbour seal for use as positive controls for species and 
sex. Taqman primers and FAM labelled probes were synthesized according to 
Matejusova et al., (2010). One assay targeted the Y chromosome sequence 
‘SRY’ and successful amplification of this sequence was used to indicate a 
male. The harbour seal assay was designed to target a sequence unique to 
harbour seals and the HG assay was unique to the grey seal. Amplification of 
at least one of these species assays was required to confirm that a negative 
male was actually a female, rather than a failed sample or assay. Additionally, 
an Internal Positive Control (IPC) was used to detect PCR inhibition within the 
DNA samples. This involves a DNA template and VIC labelled PCR assay 
being spiked into the samples. A positive reaction would always be expected 
with the IPC assay unless the sample contained PCR inhibitors. A ROX Dye 
was also added to each well to determine and standardise mechanical and 
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optical variation between wells. Each plate also contained 4 No Template 
Control (NTC) reactions. These are full PCR reactions but with distilled water 
in the place of 2 DNA sample. Any PCR amplification on these reactions 
indicates DNA contamination of the PCR reagents. QPCR was performed 
using Agilent Brilliant III Ultrafast qPCR mastermix, following manufacturers 
instructions, samples were sent for analysis to Xelect Ltd, Scottish Oceans 
Institute, St Andrews, UK. Thermal cycling conditions were as follows; 10 
minutes at 95°C followed by 50 cycles of 10 seconds at 95°C and 1 minute at 
60°C. FAM, VIC and ROX fluorescence data was collected at the end of the 1 
minute step. Ct values, the number of cycles required for the recorded 
fluorescence to pass a set threshold, were generated using baseline-
corrected raw fluorescence (dR) threshold set at 1000, using the MX4000 
v3.0 adaptive baseline algorithm. Any reaction that crossed the fluorescence 
threshold before the completion of 50 cycles was considered to be positive. 
ROX data was used to normalise the FAM and VIC values, to correct for 
mechanical variation between wells. 
 
2.2.8 Data analysis 
 
The harbour seals were divided into three different regions, the Northern Isles 
(including the north coast of mainland Scotland), the west coast and the east 
coast (Fig. 2.1, Marked in map with: “North”, “West” and “East”). Investigation 
of regional, annual and sex related variation was carried out in relation to toxin 
exposure. The year 2011 was removed from the analysis as only one sample 
was collected that year. The dataset was analysed as presence/absence in 
regards to the LOQ, as DA measured in urine has been shown to be a difficult 
matrix to analyse with ELISA (Seubert et al., 2014). In addition, bearing in 
mind that time since exposure or uptake is not known, generalized linear 
models were used to select the models that best fitted the data with toxin 
concentration (in urine or faeces) as the dependent variable and sex, region 
and month (categorical) as the independent factors. Only models that had 
enough data are presented. Each toxin was tested in turn before the effect of 
combined exposure of multiple toxins was investigated. To specify the 
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relationship between toxin concentration and the haematological parameters, 
linear models were used. Toxin concentration was used as the dependent 
variable and white cell count, cortisol or faecal egg count as the independent 
variables. The faecal egg counts were treated as a confounding variable in 
relation to the eosinophil count. Because of outliers in the dataset some of the 
data was transformed to a logarithmic scale in the plots and models. Akaike’s 
information criterion (AIC) was used to rank the models. All analyses were 
performed using R software (R Development Core Team 2007). 
 
2.3 Results 
 
2.3.1 Domoic acid in live captured harbour seals 
 
Between 2008 and 2013 162 individual harbour seals were caught and 
samples collected for the analysis of toxins from harmful algae (Table 2.5). 
 
Table 2.5: Percentage positive (>LOQ) for DA among live captured harbour seal samples, 
represented by toxin as well as season where spring = Mar, Apr, May; autumn = Sept, Oct, 
Nov; winter = Dec, Jan, Feb (sample size are in brackets). 
Region Season DA urine DA 
faeces 
PSP 
toxin 
faeces 
OA 
faeces 
DTX-2 
faeces 
East 
coast 
Spring 
Summer 
Autumn 
88.9 (9) 
100.0 (10) 
71.4 (21) 
11.1 (9) 
25.0 (8) 
36.6 (11) 
42.9 (7) 
0.0 (1) 
25.0 (4) 
0.0 (7) 
0.0 (2) 
100.0 (3) 
85.7 (7) 
0.0 (2) 
33.3 (3) 
Northern 
Isles 
Spring 
Summer 
Autumn 
0.0 (1) 
100.0 (21) 
30.0 (20) 
n.a 
45.5 (22) 
0.0 (17) 
n.a 
n.a 
25.0 (8) 
n.a 
n.a 
20.0 (5) 
n.a 
n.a 
0.0 (5) 
West 
coast 
Spring 
Summer 
Autumn 
29.6 (27) 
100.0 (14) 
n.a 
4.8 (21) 
9.1 (11) 
0.0 (1) 
45.0 (20) 
n.a 
n.a 
33.3 (6) 
n.a 
n.a 
16.7 (6) 
n.a 
n.a 
 
2.3.1.1 DA in urine samples 
 
Between 2008-2010 all of the urine samples (n = 50) from the live captured 
harbour seals analysed for DA were found to contain quantifiable levels (ASP 
ELISA LOQ > 0.004 µg/ml) of DA. The year with highest DA concentration 
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measured in urine was 2008 where the mean was 4.57 µg/ml and the 75% 
quantile: 2.53 µg/ml. This year (2008) was significantly different to the other 
years (Fig. 2.4, Table 2.6, model 1, p < 0.01, the figure shows the 
concentration plotted on a log10 scale due to the skewed distribution of the 
data). Between 2012-2013 (n = 71) only 44.29 % was found to contain 
quantifiable levels of DA. 
 
Across all years, the east coast region had a significantly higher average DA 
concentration (Table 2.6, model 2, p = 0.02, mean: 2.99 µg/ml and 75 % 
quantile 1.82 µg/ml) than the Northern Isles (mean: 0.97 µg/ml and 75 % 
quantile 0.65 µg/ml) and the west coast (mean: 0.41 µg/ml, 75 % quantile 
0.36 µg/ml) (Fig. 2.5). Seals showing urinary exposure to DA were more likely 
to be females (Table 2.6, model 3, p = 0.02, mean: 2.40 µg/ml, 75 % quantile: 
1.43 µg/ml) than males (mean: 0.34 µg/ml, 75 % quantile: 0.13 µg/ml). A 
seasonal trend was observed where all urine sampled from June to 
September had concentrations of DA > LOQ (Fig. 2.6), whereas May and 
October had significantly lower concentrations than the rest of the year (Table 
2.6, model 4, p < 0.01). The highest DA measured in harbour seal urine was 
from a female caught on the east coast in September 2008 with 63.17 µg/ml. 
Models including other interaction terms (year and region, sex and month, or 
the four-way interaction with year, region, sex and month) did not improve the 
fit of the model (P > 0.46, AIC > 148.6). 
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Figure 2.4: Concentration of DA in urine (µg/ml) by year, plotted on a logarithmic scale from 
live captured harbour seals. The colours represent the different regions sampled. The width of 
the box is proportional to the square root of the samples sizes and the box goes from the first 
quartile to the third quartile, whiskers represent the lowest and highest values still within 1.5 x 
inter quartile range (IQR) of DA and the black horizontal line indicates the median of the data 
set, separate circles are outliers. (DA range: 0.00 – 63.17 µg/ml). 
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Figure 2.5: Concentration of DA in urine (µg/ml) by regions, plotted on a logarithmic scale 
from live captured harbour seals. The colours represent the different sex’ sampled. The width 
of the box is proportional to the square root of the samples sizes and the box goes from the 
first quartile to the third quartile, whiskers represent the lowest and highest values still within 
1.5 x IQR of DA and the black horizontal line indicates the median of the data set, separate 
circles are outliers (DA range: 0.00 – 63.17 µg/ml). 
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Figure 2.6: Concentration of DA in urine (µg/ml) by month, plotted on a logarithmic scale from 
live captured harbour seals. The colours represent the different regions sampled. The width of 
the box is proportional to the square root of the samples sizes and the box goes from the first 
quartile to the third quartile, whiskers represent the lowest and highest values still within 1.5 x 
IQR of DA and the black horizontal line indicates the median of the data set, separate circles 
are outliers (DA range: 0.00 – 63.17 µg/ml). 
 
Table 2.6: Regression models for DA concentration in urine samples. 
Model Variable Residual 
deviance 
df fitted df P value AIC 
1. Year 100.5 119 1 <0.01 104.5 
2. Region 146.0 118 2 0.02 152.0 
3. Sex 147.9 119 2 0.02 151.9 
4. Month 77.1 113 7 <0.01 93.1 
The table shows results from live captured harbour seals with separate variables: year, 
region, sex and month of the year. Alternative models were explored using forward-selection 
with the three variables and interaction terms among them. Res deviance, degrees of 
freedom (df), p-value and AIC are shown for each model. Model without explanatory 
variables, res dev = 153.6/120 df. 
 
  
 58 
2.3.1.2 DA in faecal samples 
 
Between 2008-2010, 29.55 % of the faecal samples (n = 44) collected from 
the live captured harbour seals analysed for DA were found to contain levels 
above the LOQ (> 0.020 µg/g, Fig. 2.7). From 2012-2013 (n = 53), only 11.32 
% was documented with quantifiable levels of DA. There was a significant 
difference between the DA concentrations throughout the years, with 2008 
(Table 2.7, model 1, p = 0.04, mean: 1.60 µg/g, 75 % quantile: 1.47 µg/g) 
being the year with the highest proportion of DA positive faecal samples while 
in 2013 all samples (n = 16) were negative. There was a significant spatial 
difference in DA exposure where the east coast (mean: 0.79 µg/g, 75 % 
quantile: 0.03 µg/g) and the Northern Isles (mean 0.90 µg/g, 75 % quantile: 
0.29 µg/g) had a higher proportion of positive faeces samples (> LOQ) than 
the west coast (Table 2.7, model 2, mean; 0.14 µg/g, 75 % quantile: < LOQ). 
There was no difference between the sex and months (Table 2.7, model 3, p 
= 0.54 and model 4, p = 0.51) for DA exposure (Fig. 2.8 and 2.9). The DA 
proportion positive differed throughout the years between the regions and in 
2012 all samples from the Northern Isles (n = 17) were negative for DA (Table 
2.7, model 5, p = 0.01). There was a significant interaction between region 
and sex where on the east coast there was more DA positive males than 
females (Table 2.7, model 6, p < 0.04). Other interaction terms (year and sex, 
year and month, region and month or the four-way interaction with year, 
region, sex and month) did not improve the fit of the model (P > 0.91, AIC > 
103.8). The highest DA concentration in faeces was measured in the Northern 
Isles in 2008 where a harbour seal female had 25.87 µg/g. 
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Figure 2.7: Concentration of DA in faeces (µg/g) by year, plotted on a logarithmic scale from 
live captured harbour seals. The colours represent the different regions sampled. The width of 
the box is proportional to the square root of the samples sizes and the box goes from the first 
quartile to the third quartile, whiskers represent the lowest and highest values still within 1.5 x 
IQR of DA and the black horizontal line indicates the median of the data set, separate circles 
are outliers (DA range: 0.00 – 25.87 µg/g). 
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Figure 2.8: Concentration of DA in faeces (µg/ml) by region, plotted on a logarithmic scale 
from live captured harbour seals. The colours represent the different sex’ sampled. The width 
of the box is proportional to the square root of the samples sizes and the box goes from the 
first quartile to the third quartile, whiskers represent the lowest and highest values still within 
1.5 x IQR of DA and the black horizontal line indicates the median of the data set, separate 
circles are outliers (DA range: 0.00 – 25.87 µg/g). 
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Figure 2.9: Concentration of DA in faeces (µg/g) by month, plotted on a logarithmic scale from 
live captured harbour seals. The colours represent the different regions sampled. The width of 
the box is proportional to the square root of the samples sizes and the box goes from the first 
quartile to the third quartile, whiskers represent the lowest and highest values still within 1.5 x 
IQR of DA and the black horizontal line indicates the median of the data set, separate circles 
are outliers (DA range: 0.00 – 25.87 µg/g). 
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Table 2.7: Regression models for DA concentration in faecal samples. 
Model Variable Residual 
deviance 
df fitted df P value AIC 
1. Year 91.1 95 1 0.04 95.1 
2. Region 89.7 94 2 0.05 95.7 
3. Sex 95.6 95 1 0.54 99.6 
4. Month 81.8 89 7 0.51 97.8 
5. Year x Area 79.4 91 5 0.01 91.4 
6. Region x Sex 84.85 91 5 0.04 96.9 
The table shows results from live captured harbour seals with separate variables and 
interactions between them, these include: year, region, sex and month of the year. Alternative 
models were explored using forward-selection with the three variables and interaction terms 
among them. Res deviance, degrees of freedom (df), p-value and AIC are shown for each 
model. Model without explanatory variables, res dev = 95.96/96 df. 
 
My analysis of DA in urine or faecal samples showed that the harbour seals 
exposed to DA were significantly more likely (p = 0.02) to belong to 
populations from the east coast, where 77.08 % (n = 48) were found to 
contain detectable levels of DA, or from the Northern Isles where 71.67 % (n 
= 60) were > LOQ as compared with the west coast where a total of 53.70 % 
(n = 54) were > LOQ. The results also indicate that females 77.78 % (n = 81) 
were significantly more likely (p < 0.01) to be exposed to DA than males 56.79 
% (n = 81). A positive correlation was found between DA in faecal samples 
and DA in urine (Fig. 2.10, p < 0.05). 
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Figure 2.10: The relationship between DA concentrations in faeces plotted against DA 
concentration in urine plotted on a logarithmic scale, from live captured harbour seals with 
95% confidence interval of the linear regression line. 
 
2.3.2 Domoic acid in anonymous faecal samples 
 
Of the 180 anonymous faecal samples (faeces collected from haul-out sites 
previously frequented by harbour seals) collected 63.33 %, were > LOQ for 
DA (Table 2.8). 
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Table 2.8: Percentage positive (>LOQ) for DA among anonymous haul-out faecal samples, 
represented by toxin as well as season where spring = Mar, Apr, May; autumn = Sept, Oct, 
Nov; winter = Dec, Jan, Feb (sample size are in brackets). 
Region Season DA 
faeces 
PSP toxin 
faeces 
OA faeces DTX-2 faeces 
East coast Spring 
Summer 
Autumn 
75.0 (16) 
43.2 (44) 
78.3 (23) 
0.0 (6) 
75.0 (20) 
73.3 (15) 
57.1 (7) 
40.9 (22) 
6.3 (15) 
14.3 (7) 
4.5 (22) 
31.3 (16) 
Northern 
Isles 
Spring 
Summer 
Autumn 
45.5 (22) 
75.0 (15) 
75.0 (4) 
66.7 (6) 
n.a 
100.0 (2) 
16.7 (6) 
n.a 
0.0 (4) 
0.0 (6) 
n.a 
25.0 (4) 
West 
coast 
Spring 
Summer 
Autumn 
100.0 (17) 
59.0 (39) 
n.a 
n.a 
n.a 
n.a 
n.a 
n.a 
n.a 
n.a 
n.a 
n.a 
 
There was a significant temporal difference with 2010 being a year with the 
highest proportion positive (mean: 7.36 µg/g, 75 % quantile: 0.90 µg/g, Table 
2.9, model 1, p = 0.01, Fig. 2.11). There was no significant spatial difference 
in the proportion positive (Table 2.9, model 2, p = 0.14, Fig. 2.12), but the east 
coast (mean: 6.10 µg/g, 75 % quantile: 0.90 µg/g) and Northern Isles (mean 
3.42 µg/g, 75 % quantile: 2.61 µg/g) had a higher mean DA concentration 
than the west coast (mean: 2.15 µg/g, 75 % quantile: 1.84 µg/g). The highest 
DA concentration measured was on the east coast at 100.46 µg/g DA. There 
was also a significant difference between the months of DA exposure where 
June and May had a lower proportion positive for DA than the rest of the year 
(Table 2.9, model 3, p < 0.01, Fig. 2.13). The best model was achieved when 
the interaction between region and month was fitted to the data (Table 2.9, 
model 5, AIC: 219.3), where the Northern Isles in June were significantly 
different than the other months and regions with a higher proportion of 
samples with DA above the LOQ. Other interaction terms or the three-way 
interaction with year, region and month was not possible to model due to 
insufficient data. 
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Table 2.9: Regression models analysing DA concentration in anonymous faecal samples. 
Model Variable Residual 
deviance 
df fitted df P value AIC 
1. Year 225.1 178 1 <0.01 229.1 
2. Region 234.2 177 2 0.14 240.2 
3. Month 214.9 173 6 <0.01 228.9 
4. Year x Region 227.6 175 4 <0.01 227.6 
5. Region x Month 185.3 163 13 <0.01 219.3 
The table shows results from separate variables and interactions between them, these 
include: year, region and month. Alternative models were explored using forward-selection 
with the three variables and interaction terms among them. Res deviance, degrees of 
freedom (df), p-value and AIC are shown for each model. Model without explanatory 
variables, res dev = 236.6/179 df. 
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Figure 2.11: Concentration of DA anonymous faecal samples (µg/g) by year, plotted on a 
logarithmic scale from live captured harbour seals. The colours represent the different regions 
sampled. The width of the box is proportional to the square root of the samples sizes and the 
box goes from the first quartile to the third quartile, whiskers represent the lowest and highest 
values still within 1.5 x IQR of DA and the black horizontal line indicates the median of the 
data set, separate circles are outliers (DA range: 0.00 – 100.46 µg/g). 
 
 
Figure 2.12: Concentration of DA in anonymous faecal samples (µg/g) by region, plotted on a 
logarithmic scale from live captured harbour seals. The width of the box is proportional to the 
square root of the samples sizes and the box goes from the first quartile to the third quartile, 
whiskers represent the lowest and highest values still within 1.5 x IQR of DA and the black 
horizontal line indicates the median of the data set, separate circles are outliers (DA range: 
0.00 – 100.46 µg/g). 
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Figure 2.13: Concentration of DA in anonymous faecal samples (µg/g) by month, plotted on a 
logarithmic scale from live captured harbour seals. The colours represent the different regions 
sampled. The width of the box is proportional to the square root of the samples sizes and the 
box goes from the first quartile to the third quartile, whiskers represent the lowest and highest 
values still within 1.5 x IQR of DA and the black horizontal line indicates the median of the 
data set, separate circles are outliers (DA range: 0.00 – 100.46 µg/g). 
 
2.3.3 PSP toxins from live captured harbour seals  
 
Results using the HPLC-PCOx method and with confirmation using pre-
column oxidation LC-FLD methods established the presence of PSP toxins in 
16 (39.02 %) faecal samples of the 41 live captured harbour seal tested, 
where 25.00 % (n= 28) were found exposed in 2012 and 69.23 % (n = 13) 
were found exposed in 2013 (Fig. 2.14). Five (38.46 %) out of thirteen live 
captured harbour seals from the east coast were found with PSP toxins in 
their faeces. Two (25.00 %) out of eight seals tested from the Northern Isles 
were found with PSP toxins and nine (45.00 %) out of 20 seals tested from 
the west coast were found exposed to PSP toxins. There was no significant 
difference between the regions (Table 2.10, model 1, p = 0.47). The west 
coast had the highest mean of 30.67 STX µg eq/kg (75 % quantile: 8.00 STX 
µg eq/kg) followed by the east coast with 16.08 STX µg eq/kg (75 % quantile: 
 68 
4.00 STX µg eq/kg) and the Northern Isles 10.88 STX µg eq/kg (75 % 
quantile: 10.50 STX µg eq/kg). Although May (Fig. 2.15) was the month with 
the highest exposure of PSP toxins, this was not significant, but 2013 had the 
highest concentration of the two years (Table 2.10, model 2, p = 0.53, Fig. 
2.15, mean 65.7 STX µg eq/kg, 75 % quantile: 53.00 STX µg eq/kg). None of 
the urine samples had traces of PSP toxins (n = 31). 
 
Table 2.10: Regression models analysing PSP toxins concentration in faecal samples. 
Model Variable Residual 
deviance 
df fitted df P value AIC 
1. Region 49.41 36 2 0.47 55.41 
2. Month 44.42 34 4 0.16 54.42 
The table shows results from live captured harbour seals faecal samples (model 1 and 2) with 
separate variables, these include: region and month of the year. Because of a low sample 
number, interaction models were not available. 
 
 
 
Figure 2.14: Concentration of PSP toxins in faecal samples by year, plotted on a logarithmic 
scale from live captured harbour seals. The colours represent the different regions sampled. 
The width of the box is proportional to the square root of the samples sizes and the box goes 
from the first quartile to the third quartile, whiskers represent the lowest and highest values 
still within 1.5 x IQR of PSP toxins and the black horizontal line indicates the median of the 
data set, separate circles are outliers (PSP toxin range: 0.00 - 282.00 STX µg eq/kg). 
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Figure 2.15: Concentration of PSP toxins in faecal samples by month, plotted on a logarithmic 
scale from live captured harbour seals. The colours represent the different regions sampled. 
The width of the box is proportional to the square root of the samples sizes and the box goes 
from the first quartile to the third quartile, whiskers represent the lowest and highest values 
still within 1.5 x IQR of PSP toxins and the black horizontal line indicates the median of the 
data set, separate circles are outliers (PSP toxin range: 0.00 - 282.00 STX µg eq/kg). 
 
2.3.4 PSP toxins in anonymous harbour seal faecal sample 
 
Two archived faecal samples from 2003 were analysed for this study, and 
faecal samples from 2012 and 2013 were collected from haul-out sites for this 
study of PSP toxins (n = 46). One of the seal faecal samples from 2003 was 
found to contain PSP toxins. For 2012, 54.5 % was found with levels > LOQ 
(mean: 44.89 STX µg eq/kg, 75 % quantile: 44.50 STX µg eq/kg) and for 2013 
76.92 % was > LOQ (mean: 26.15 STX µg eq/kg, 75 % quantile: 19.00 STX 
µg eq/kg) (Fig. 2.16). Anonymous faecal samples were only collected from 
harbour seals on the east coast (n = 42) and in the Northern Isles (n = 7). On 
the east coast 59.52 % were found to be > LOQ for PSP toxins and in the 
Northern Isles 71.43 % were > LOQ. There was no significant difference 
between the two regions sampled (Table 2.11, model 1, p = 0.55) or between 
the months (Table 2.11, model 2, p = 0.99, Fig. 2.17). Unfortunately no 
samples were available for PSP toxins analysis from the west coast of 
Scotland. 
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Table 2.11: Regression models analysing PSP toxins concentration in anonymous faecal 
samples 
Model Variable Residual 
deviance 
df fitted df P value AIC 
1. Region 65.07 47 1 0.55 69.07 
2. Month 45.77 42 5 0.99 57.77 
The table shows results from anonymous harbour seals faecal samples with separate 
variables, these include: region and month of the year. Because of a low sample number, 
interaction models were not available. 
 
 
 
Figure 2.16: Concentration of PSP toxins in anonymous faecal samples by year, plotted on a 
logarithmic scale from live captured harbour seals. The colours represent the different regions 
sampled. The width of the box is proportional to the square root of the samples sizes and the 
box goes from the first quartile to the third quartile, whiskers represent the lowest and highest 
values still within 1.5 x IQR of PSP toxins and the black horizontal line indicates the median of 
the data set, separate circles are outliers (PSP toxin range: 0.00 - 389.00 STX µg eq/kg). 
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Figure 2.17: Concentration of PSP toxins in anonymous faecal samples by month, plotted on 
a logarithmic scale from live captured harbour seals. The colours represent the different 
regions sampled. The width of the box is proportional to the square root of the samples sizes 
and the box goes from the first quartile to the third quartile, whiskers represent the lowest and 
highest values still within 1.5 x IQR of PSP toxins and the black horizontal line indicates the 
median of the data set, separate circles are outliers (PSP toxin range: 0.00 - 389.00 STX µg 
eq/kg). 
 
2.3.5 Lipophilic toxins in live captured harbour seals  
 
Six out of the 23 live-captured harbour seals tested had been exposed to OA 
and eight seals had been exposed to DTX2. Of the seals exposed to OA, 
three were captured on the east coast, one in the Northern Isles and three on 
the west coast (Table 2.5, 2.12, Fig. 2.18). The highest concentration of OA 
was measured on the east coast in a live captured harbour seal with a faecal 
sample at 0.065 µg/g. The sample size was not sufficient for statistical 
inference, but May and October appeared to be important months of OA 
toxicity (Fig. 2.19). 
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Table 2.12: Lipophilic toxins percentage positive (%) in faecal samples from live captured 
harbour seals presented annually from 2003 to 2013 (sample sizes are in brackets). 
OA / DTX-2 in 
faeces 
2008 2012 2013 
All regions OA: 100.0 (1)  
DTX-2: 0.0 (1) 
OA: 33.3 (9)  
DTX-2: 11.1 (9) 
OA: 15.4 (13)  
DTX-2: 53.8 (13) 
East coast OA: 100.0 (1) 
DTX-2: 0.0 (1) 
OA: 50.0 (4) 
DTX-2: 25.0 (4) 
OA: 0.0 (7)  
DTX-2: 85.7 (7) 
Northern Isles OA: n.a 
DTX-2: n.a 
OA: 20.0 (5) 
DTX-2: 0.0 (5) 
OA: n.a 
DTX-2: n.a 
West coast OA: n.a 
DTX-2: n.a 
OA: n.a  
DTX-2: n.a 
OA: 33.3 (6) 
DTX-2: 16.7 (6) 
 
 
Figure 2.18: Concentration of OA in faecal samples by year, plotted on a logarithmic scale 
from live captured harbour seals. The colours represent the different regions sampled. The 
width of the box is proportional to the square root of the samples sizes and the box goes from 
the first quartile to the third quartile, whiskers represent the lowest and highest values still 
within 1.5 x IQR of OA and the black horizontal line indicates the median of the data set, 
separate circles are outliers (OA range: 0.00 – 0.06 µg/g). 
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Figure 2.19: Concentration of OA in faecal samples by month, plotted on a logarithmic scale 
from live captured harbour seals. The colours represent the different regions sampled. The 
width of the box is proportional to the square root of the samples sizes and the box goes from 
the first quartile to the third quartile, whiskers represent the lowest and highest values still 
within 1.5 x IQR of OA and the black horizontal line indicates the median of the data set, 
separate circles are outliers (OA range: 0.00 – 0.06 µg/g). 
 
 
Of the six seals exposed to DTX-2, seven were found on the east coast and 
one on the west coast (Table 2.12, Fig. 2.20). The highest sample measured 
of DTX-2 was found on the east coast with 2.01 µg/g. The sample size was 
not sufficient for statistical inference, but April appeared to be an important 
month of DTX-2 toxicity (Fig. 2.21). Two of the six positive seals exposed to 
DTX-2 had according to the Bristol stool chart (Lewis and Heaton, 1997) a 
type 7 category indicating a loose/runny stool, watery with no solid pieces. 
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Figure 2.20: Concentration of DTX-2 in faecal samples by year, plotted on a logarithmic scale 
from live captured harbour seals. The colours represent the different regions sampled. The 
width of the box is proportional to the square root of the samples sizes and the box goes from 
the first quartile to the third quartile, whiskers represent the lowest and highest values still 
within 1.5 x IQR of DTX-2 and the black horizontal line indicates the median of the data set, 
separate circles are outliers (DTX-2 range: 0.00-2.01 µg/g). 
 
 
Figure 2.21: Concentration of DTX-2 in faecal samples by month, plotted on a logarithmic 
scale from live captured harbour seals. The colours represent the different regions sampled. 
The width of the box is proportional to the square root of the samples sizes and the box goes 
from the first quartile to the third quartile, whiskers represent the lowest and highest values 
still within 1.5 x IQR of DTX-2 and the black horizontal line indicates the median of the data 
set, separate circles are outliers (DTX-2 range: 0.00-2.01 µg/g). 
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2.3.6 Lipophilic toxins in anonymous faecal samples 
 
Of the anonymous harbour seal faecal samples 15 out of 55 (27.3 %) were 
found exposed to OA, 14 of these seals were from the east coast, and one 
from the Northern Isles (Table 2.13). The highest sample was measured from 
the east coast in 2012 with OA levels at 0.029 µg/g (Fig. 2.22). The other 
lipophilic toxin found in the anonymous faecal samples was DTX-2, where 
eight out of 55 samples were exposed to DTX-2. Seven of these samples 
were found on the east coast and one in the Northern Isles (Table 2.13) and 
the highest faecal sample measured was on the east coast in 2012 with 0.014 
µg/g (Fig. 2.24). The sample size for both toxins were not sufficient for 
statistical inference, for OA toxicity (Fig. 2.23) and for DTX-2 (Fig. 2.25). 
 
Table 2.13: Lipophilic toxins percentage positive (%) in anonymous faecal samples presented 
annually from 2003 to 2013 (sample sizes are in brackets). 
OA / DTX-2 
in faeces 
Toxins 2003 2011 2012 2013 
All regions OA 
DTX-2 
0.0 (2) 
0.0 (2) 
0.0 (4) 
25.0 (4) 
31.4 (35) 
20.0 (35) 
28.6 (14) 
0.0 (14) 
East coast OA 
DTX-2 
0.0 (2) 
0.0 (2) 
n.a 
n.a 
34.5 (29) 
24.1 (29) 
28.6 (14) 
0.0 (14) 
Northern 
Isles 
OA 
DTX-2 
0.0 (2) 
0.0 (2) 
0.0 (4) 
25.0 (4) 
16.7 (6) 
0.0 (6) 
n.a 
n.a 
West coast OA 
DTX-2 
n.a 
n.a 
n.a 
n.a 
n.a 
n.a 
n.a 
n.a 
 
 
 76 
 
Figure 2.22: Concentration of OA in anonymous faecal samples by year, plotted on a 
logarithmic scale. The colours represent the different regions sampled. The width of the box is 
proportional to the square root of the samples sizes and the box goes from the first quartile to 
the third quartile, whiskers represent the lowest and highest values still within 1.5 x IQR of OA 
and the black horizontal line indicates the median of the data set, separate circles are outliers 
(OA range: 0.00 – 0.03 µg/g). 
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Figure 2.23: Concentration of OA in anonymous faecal samples by month, plotted on a 
logarithmic scale. The colours represent the different regions sampled. The width of the box is 
proportional to the square root of the samples sizes and the box goes from the first quartile to 
the third quartile, whiskers represent the lowest and highest values still within 1.5 x IQR of OA 
and the black horizontal line indicates the median of the data set, separate circles are outliers 
(OA range: 0.00 – 0.03 µg/g). 
 
Figure 2.24: Concentration of DTX-2 in anonymous faecal samples by year, plotted on a 
logarithmic scale. The colours represent the different regions sampled. The width of the box is 
proportional to the square root of the samples sizes and the box goes from the first quartile to 
the third quartile, whiskers represent the lowest and highest values still within 1.5 x IQR of 
DTX-2 and the black horizontal line indicates the median of the data set, separate circles are 
outliers (DTX-2 range: 0.00 – 0.01 µg/g). 
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Figure 2.25: Concentration of DTX-2 in anonymous faecal samples by month, plotted on a 
logarithmic scale. The colours represent the different regions sampled. The width of the box is 
proportional to the square root of the samples sizes and the box goes from the first quartile to 
the third quartile, whiskers represent the lowest and highest values still within 1.5 x IQR of 
DTX-2 and the black horizontal line indicates the median of the data set, separate circles are 
outliers (DTX-2 range: 0.00 – 0.01 µg/g). 
 
2.3.7 Health parameters 
 
2.3.7.1 Haematological parameters in live captured harbour seals 
 
All live captured harbour seals handled in this study were in good visible 
health with no apparent abnormal neurological signs. However, among 
animals with DA exposure above the LOQ in urine, a significant negative 
relationship was found between blood lymphocyte counts and urinary DA 
concentration (Fig. 2.26, Table 2.14). In addition, a significant positive 
relationship was found between blood monocyte counts and urinary DA 
concentration (Fig. 2.27, Table 2.14). The same trends were seen for harbour 
seals positive for DA exposure in faecal samples (Fig. 2.28 and 2.29, Table 
2.15) as faecal and urinary DA levels were correlated. Although some of the 
other leukocyte counts came out significant in the regression model (Table 
2.15), these were not considered to be biologically important. A full overview 
of mean, median and range for neutrophil, lymphocyte, monocyte and 
eosinophil count can be found in Table 2.16. Faecal parasite egg counts 
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(nematodes) were carried out to control for any eosinophilia associated with 
parasite infection but no relationship was seen. Plasma cortisol concentration 
had no significant relationship with any of the haematological parameters. No 
relationships were found between the any of the haematological parameters 
and PSP toxins exposure. 
 
Table 2.14: Regression models for DA concentration in urine samples and white cell count. 
Model Variable Residual 
deviance 
df fitted df P value AIC 
1. Neutrophils 12.49 57 1 <0.001 81.81 
2. Lymphocytes 166.20 98 1 <0.001 260.48 
3. Eosinophils 31.52 61 1 0.08 141.16 
4. Monocytes 77.82 98 1 <0.001 224.51 
 
 
 80 
 
Figure 2.26: Concentration of DA in urine samples from live captured harbour seals plotted on 
a logarithmic scale compared with lymphocytes cell/μl count in live captured harbour seals 
with 95% confidence interval of the linear regression line. 
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Figure 2.27: Correlation of concentration of DA in urine samples from live captured harbour 
seals plotted on a logarithmic scale and monocyte cell/μl count in live captured harbour seals 
with 95% confidence interval of the linear regression line. 
 
Table 2.15: Regression models for DA concentration in faecal samples and white cell count 
Model Variable Residual 
deviance 
df fitted df P 
value 
AIC 
1. Neutrophils 3.64 11 1 0.4 26.34 
2. Lymphocytes 35.87 47 1 <0.01 113.7 
3. Eosinophils 5.70 13 1 0.9 34.08 
4. Monocytes 5.67 11 1 <0.001 31.87 
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Figure 2.28: Correlation of concentration of DA in faeces samples from live captured harbour 
seals plotted on a logarithmic scale and lymphocytes cell/μl count in live captured harbour 
seals with 95% confidence interval of the linear regression line. 
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Figure 2.29: Correlation of concentration of DA in faeces samples from live captured harbour 
seals plotted on a logarithmic scale and monocyte cell/μl count in live captured harbour seals 
with 95% confidence interval of the linear regression line. 
 
Table 2.16: The table displays the mean, median and range for neutrophil, lymphocyte, 
monocyte and eosinophil count (x 106 cells/ml) and plasma cortisol concentration (ng/ml) for 
live captured harbour seals. Groups were divided into not exposed to DA (DA urine <LOQ 
µg/ml, DA faeces <LOQ µg/g), and exposed to DA (DA urine >LOQ µg/ml, DA faeces >LOQ 
µg/g). *Value differs significantly (p < 0.05) from the other classification group. 
Variable Matrices Mean ± 
SD 
Median 
Range Reference 
range 
lower* 
Reference 
range 
upper** 
 
Neutrophil 
count 
< LOQ DA 
urine 
> LOQ DA 
urine* 
< LOQ DA 
faeces 
> LOQ DA 
faeces 
3080 ± 
1399 
2460 ± 
1290 
2511 ± 
1237 
2151 ± 
1580 
2850 
2148 
2071 
1656 
941-7887 
769-5821 
858-7887 
808-6732 
 
1120-2173 9300-11050 
Lymphocyte 
count 
< LOQ DA 
urine 
1926 ± 
1117 
1655 
720 
557-5534 
0-5501 
440-1458 4794-6000 
 84 
> LOQ DA 
urine* 
< LOQ DA 
faeces 
> LOQ DA 
faeces 
1076 ± 
1140 
1277 ± 
1056 
1163 ± 
1177 
982 
722 
73-4208 
85-3861 
 
Monocyte count < LOQ DA 
urine 
> LOQ DA 
urine* 
< LOQ DA 
faeces 
> LOQ DA 
faeces* 
349 ± 
283 
779 ± 
574 
571 ± 
453 
864 ± 
828 
244 
602 
391 
602 
64-1348 
59-2668 
76-2232 
59-2668 
 
0-96 1170-2397 
Eosinophil 
count 
< LOQ DA 
urine 
> LOQ DA 
urine 
< LOQ DA 
faeces 
> LOQ DA 
faeces 
645 ± 
403 
760 ± 
517 
640 ± 
384 
791 ± 
564 
601 
671 
561 
690 
157-2199 
112-2297 
146-1786 
254-2359 
 
0-464 2875-5157 
Plasma cortisol < LOQ DA 
urine 
> LOQ DA 
urine* 
< LOQ DA 
faeces 
> LOQ DA 
faeces 
454 ± 
247 
248 ± 
170 
326 ± 
232 
172 ± 37 
426 
189 
226 
181 
111-800 
66-800 
66-800 
117-220 
  
* 90% CI on lower threshold ** 90% CI on upper threshold adapted from Greig et al. (2010) 
 
2.3.8 Multiple toxin exposure 
 
2.3.8.1 Exposure to two or more toxins and relationship with white blood cell 
counts in live captured harbour seals 
 
Screening for multiple toxins first started in 2012 for live captured harbour 
seals with only one sample screened for multiple toxins from 2008. This is the 
first reported study where a marine mammal has shown to be exposed to 
more than two toxins from harmful algae at the same time (full overview see 
Table 2.17). There were two samples that indicated exposure to all four toxins 
at once, one was sampled on the east coast and the other was collected on 
the west coast (Table 2.17). There were no indications of any relationship with 
white blood cell counts in the live captured harbour seals exposed to two or 
more different toxins. 
 85 
 
 
Table 2.17: Overview over percentage exposed to different toxins (urine and faeces) from live 
captured harbour seals with respect to toxin(s) and region, sample size in brackets. 
Toxin(s) East cost Northern Isles West coast 
DA 77.1 (48) 71.7 (60) 53.7 (54) 
STX 38.5 (13) 25.0 (8) 45.0 (20) 
OA 25.0 (12) 20.0 (5) 33.3 (6) 
DTX-2 58.3 (12) 0.0 (5) 0.0 (6) 
DA+STX 25.0 (16) 25.0 (8) 25.0 (20) 
DA+OA 16.7 (12) 20.0 (5) 33.3 (6) 
DA+DTX-2 63.6 (11) 0.0 (5) 0.0 (6) 
STX+OA 11.1 (9) 0.0 (5) 25.0 (4) 
STX+DTX-2 37.5 (8) 0.0 (5) 0.0 (4) 
OA+DTX-2 8.3 (12) 0.0 (5) 0.0 (6) 
DA+STX+OA 11.1 (9) 0.0 (5) 25.0 (4) 
DA+STX+DTX-2 33.3 (9) 0.0 (5) 0.0 (4) 
DA+OA+DTX-2 10.0 (10) 0.0 (4) 0.0 (6) 
STX+OA+DTX-2 11.1 (9) 0.0 (5) 0.0 (4) 
DA+STX+OA+DTX-2 11.1 (9) 0.0 (5) 25.0 (4) 
 
 
2.3.8.2 Exposure to two or more toxins and relationship with circulating 
cortisol concentrations in live captured harbour seals 
 
For harbour seals exposed to two toxins at once there was a no clinical 
significant difference in combination with plasma cortisol, nor was there any 
trend in the high or low plasma cortisol for the seals exposed to three toxins. 
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2.3.8.3 Exposure to multiple toxins in anonymous faecal samples 
 
Screening for multiple toxins was carried out in the anonymous faecal 
samples from 2012, the results are displayed in Table 2.18. One faecal 
sample was found to contain 3 toxins (STX, OA and DTX-2) and it was 
sampled on the east coast (Table 2.18). 
 
Table 2.18: Overview of anonymous faecal samples from harbour seals with respect to 
toxin(s) and region, (sample size are shown in brackets). 
Toxin(s) East cost Northern Isles West coast 
DA 89.3 (84) 70.3 (41) 71.4 (56) 
STX 63.4 (41) 75.0 (8) n.a 
OA 31.1 (45) 10.0 (10) n.a 
DTX-2 15.6 (45) 10.0 (10) n.a 
DA+STX 30.8 (26) 66.7 (3) n.a 
DA+OA 31.3 (16) 0.0 (5) n.a 
DA+DTX-2 15.0 (20) 0.0 (5) n.a 
STX+OA 8.3 (24) 0.0 (7) n.a 
STX+DTX-2 29.2 (24) 0.0 (7) n.a 
OA+DTX-2 2.3 (44) 0.0 (9) n.a 
DA+STX+OA 0.0 (11) 0.0 (4) n.a 
DA+STX+DTX-2 0.0 (10) 0.0 (4) n.a 
DA+OA+DTX-2 0.0 (20) 0.0 (4) n.a 
STX+OA+DTX-2 5.9 (17) 0.0 (3) n.a 
DA+STX+OA+DTX-2 0.0 (14) 0.0 (4) n.a 
 
2.3.9 Prey identification 
 
A total of 1986 otoliths were recovered from the 70 samples of faecal material 
collected from both live captured and anonymous harbour seals samples (full 
overview see Table 2.19) and were used for prey species identification. Of the 
total number of faecal samples; 38 faecal samples were from the east coast, 
19 from the Northern Isles and 10 from the west coast. Seventeen species of 
prey were identified while three prey species remained unidentified. Otolith 
identification gives an interesting insight into the seals’ diet, indirectly showing 
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how algal toxins can be transferred to the seals through the food web (see 
Chapter 3 for additional information). 
 
The three highest DA contaminated faecal samples where otoliths were 
recovered came from harbour seals from the east coast sampled between 
July and August 2013. These faecal samples had otoliths from (listed in order 
from percentage frequency of occurrence): Plaice (Pleuronectes), Dab 
(Limanda limanda), Whiting (Merlangius merlangus), Long rough dab 
(Hippoglossoides platessoides), Sandeel (Ammodytes spp) and Cod (Gadus 
morhua). 
  
Of the faecal material collected containing fish otoliths, the three highest PSP 
contaminated faecal samples were from harbour seals from the east coast 
and the west coast. The two east coast faecal samples were collected in June 
and July 2013 while the west coast faecal sample was collected in May 2013. 
On the east coast the harbour seals had been eating (listed in order from 
percentage frequency of occurrence): plaice, dab and unidentified flat fishes, 
while the only otolith identified from the west coast faecal harbour seal sample 
came from a poor cod (Trisopterus minutus). 
 
There were only three faecal samples where OA was measured and from 
which otoliths were recovered, two of these faecal samples were from the 
east coast and the seals had been foraging on plaice, dab, flounder and other 
unidentified flatfish together with whiting and one was from Orkney where the 
seal had been foraging on sandeel and mackerel (Scomber scombrus). 
 
For DTX-2 there was six faecal samples positive for DTX-2 where otoliths 
were recovered, the three highest DTX-2 contaminated faecal samples were 
collected on the east coast and Orkney, where the seals on the east coast 
had been foraging on Goby (Gobiidae) and whiting and the last sample 
collected from Orkney had been foraging on sandeels. 
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Table 2.19: Overview of otoliths collected from live captured and anonymous harbour seal 
faecal samples, total number and by region.  
Species Total East 
coast 
Northern 
Isles 
West 
coast 
Atlantic cod 
(Gadus morhua) 
17 7 10 0 
Dab 
(Limanda limanda) 
668 664 1 3 
Common dragonet 
(Callionymus lyra) 
1 1 0 0 
Eelpout 
(Zoarces viviparous) 
4 1 1 2 
Flounder 
(Platichthys flesus) 
16 16 0 0 
Goby 
(Gobiidae) 
28 27 1 0 
Lemon sole 
(Microstomus kitt) 
3 0 3 0 
Long rough dab 
(Hippoglossoides 
platessoides) 
7 7 0 0 
Mackerel 
(Scomber scombrus) 
1 0 1 0 
Norway pout 
(Trisopterus esmarkii) 
10 0 7 3 
Plaice 
(Pleuronectes) 
642 634 7 3 
Poor cod 
(Trisopterus minutus) 
65 1 4 60 
Rockling 
(none specific) 
1 0 1 0 
Saithe 
(Pollachius virens) 
2 0 1 1 
Sandeel 
(Ammodytes marinus) 
440 285 115 40 
Whiting 
(Merlangius merlangus) 
13 13 0 0 
Wrasse 
(non specific) 
1 0 1 0 
Unidentified flatfish 64 62 2 0 
Unidentified roundfish 2 1 1 0 
Unidentified trisopteran 1 0 1 0 
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2.4 Discussion 
 
2.4.1 Domoic acid 
 
There has been a temporal change in DA exposure in harbour seals before 
and after 2012. All the urine samples between 2008-2010 contained 
quantifiable amounts of DA, while only 43.6% of the harbour seal urine 
samples had DA levels above the LOQ in 2012-2013. This trend, with a high 
proportion of positive samples in 2008-2010 compared to 2012-2013, was 
also seen in faecal samples from both live captured harbour seals and 
anonymous faecal samples for which 2008 and 2010 were years with 
quantifiable levels of DA. These findings can be related to the annual 
variability in Pseudo-nitzschia blooms in Scotland (Fehling et al., 2006). 
Phytoplankton monitoring data from 2006-2013 obtained from the Scottish 
Association for Marine Science (SAMS) revealed three large Pseudo-nitzschia 
blooms (> 100 000 cells per litre) on the east coast in the last 10 years; two in 
2008 and one in 2010 (Stubbs et al., 2013). In Orkney there has been one 
large P. nitzschia spp. bloom during the study period, this occurred in 2010. 
Phytoplankton monitoring data obtained from the west coast of Scotland is 
hard to generalize and is more detailed due to a larger concentration of 
monitoring sites. However, there are large Pseudo-nitzschia blooms every 
year, which vary by location, but there is little information on how widespread 
these blooms are and light microscope identification cannot differentiate 
between toxic and non-toxic species of Pseudo-nitzschia. For example: on the 
Isle of Harris, at Loch Stockinish (Fig. 2.30), P. nitzschia (> 100 000 cells per 
litre) blooms have been detected every year since 2006, except in 2007 and 
2011. Loch Laxford (Fig. 2.34) on the northwest coast reported Pseudo-
nitzschia blooms (> 100 000 cells per litre) in 2006, 2007, 2009 and 2010. 
Further south Loch Torridon, just north of Isle of Skye has had blooms > 100 
000 cells per litre every year since 2006 with the exception of 2012. 
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Figure 2.30: Coastal phytoplankton sampling sites contributing to the Scottish Phytoplankton 
Monitoring Programme, from Swan and Davidson (2011). 
 
These monitoring data indicates the degree of variation on the west coast and 
it is important to stress that these blooms are monitored in sheltered areas 
where shellfish farms are established (Swan and Davidson, 2010), and are 
therefore regions that are not necessarily representative of seal foraging 
areas. Harbour seals have been found to forage up to 100 km from their 
haulout site, although on the west coast the movement usually remains within 
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25 km of the coast (Cunningham et al., 2009). Because of the phytoplankton 
monitoring locations, offshore blooms are often undetected. In addition there 
is a time lag between the phytoplankton blooms and the accumulation of the 
toxin in tissues, and based on the length of the harbour seals foraging trips 
which can last up to two weeks (Sharples et al., 2012), although the duration 
of the trips are usually a couple of days (Sharples et al., 2012). DA, a stable 
amino acid (Johannessen, 2000), can potentially stay in the food chain for 
weeks to months before it is depurated. This means that the harbour seals 
could potentially be exposed to DA contaminated prey for a prolonged time 
period, even weeks after Pseudo-nitzschia blooms die out. In addition DA has 
been shown to be present in the sediment for months and years (Sekula-
Wood et al., 2011). 
 
Goldstein et al., (2008) reported that female CLSs due to their life history 
constraints were five times more likely to experience a rapid absorption of DA 
or an ‘acute’ toxicity. In this study, a sex difference was seen in the Scottish 
harbour seals as more females had a higher concentration of DA in their 
excreta compared to males. This difference in DA could be explained by 
different foraging strategies between females and males, as females have 
been found to forage further out from their haul-out sites than males 
(Cunningham et al., 2009) or differences in prey choice between the sexes. 
 
A study of Pacific harbour seals (Phoca vitulina richardii) found DA was 
detected in 65 % (n = 26) of the urine sampled (DA range 0.4 – 10 ng/ml), and 
in faecal samples (DA range: 0.002 – 2.9 µg/g). Two live-stranded harbour 
seals were found, off the California coast with symptoms indicative of DA 
toxicosis (McHuron et al., 2013). The live captured Scottish harbour seals had 
DA concentrations in urine higher than the levels reported for CLSs suffering 
from ‘acute’ DA toxicity (DA range: 0.01-3.72 µg/ml (Goldstein et al., 2008)) 
and the Pacific harbour seals, although none of the live captured Scottish 
harbour seals were found with seizures upon capture. For faecal samples the 
DA concentration was similar to those reported for CSLs experiencing 
‘chronic’ disease (DA range: 1.6-4.15 µg/g: (Goldstein et al., 2008)). However, 
since we do not know when the seals were exposed to DA we cannot predict 
 92 
how high the DA levels may have been. From the DA results reported here it 
is possible that Scottish harbour seals are experiencing a prolonged or 
‘chronic’ exposure to DA as we are not seeing any stranding of seizing 
harbour seals, an indication of a recent and more ‘acute’ DA toxicity. From the 
literature we know the estimated half-life for DA in serum samples is 
approximately 20 min for rats (Suzuki and Hierlihy, 1993) and 2 hours for 
monkeys (Truelove and Iverson, 1994). DA is usually excreted from urine 
within two days (Bejarano et al., 2007) and it is thought to take a few days up 
to a week for DA to clear in faecal material (Iverson et al., 1989). Based on 
the DA biomarker clearance study (Chapter 6), we have an indication of the 
elimination half-life of the DA biomarker (3 hours) and how quickly DA is 
cleared out of a harbour seals body (within 10 hours). This means that the 
harbour seals that are out foraging for days will be in the risk of being 
continuously exposed to DA. 
 
This study reports potential immunomodulatory effects of DA exposure and 
suggests lymphocytopenia and monocytosis. This has also been suggested in 
other marine mammal species (Gulland et al., 2002; Levin et al., 2010; Pulido, 
2008). DA has shown to have a direct effect on both T-cells and monocytes in 
vitro (Levin et al., 2008) leading to the development of neuroinflammation and 
neurodegeneration. CSLs affected with DA toxicosis have been shown to 
develop eosinophilia (Gulland et al., 2012), an outcome also recorded in 
bottlenose dolphins from the northern Gulf of Mexico (Schwacke et al., 2010). 
This was not seen in the live captured Scottish harbour seals. Interestingly, 
the study revealed a negative relationship between increased DA 
concentration in urine and faeces and lymphocyte counts while a positive 
relationship between increased DA concentration in faeces and urine and 
monocyte counts. Abnormalities in leukocyte counts have been associated 
with exposure to DA. For example, neutrophilia has been associated with DA 
exposure, where a human patient was admitted to hospital (Perl et al., 1990) 
showing neurological signs associated with DA such as confusion and 
disorientation. Although eosinophilia was not seen in this study, different 
species might react differently to toxin exposure. The precise 
immunomodulatory effects of DA in this species are unclear, and the 
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consequences of these low lymphocyte counts may be an increased risk of 
infection while an increased monocyte count can be an indicator of an on-
going infection. 
 
Otoliths recovered in the faeces are used to determine the diet of harbour 
seals (Sharples et al., 2012; Tollit and Thompson, 1996), indicating what the 
seals have been feeding on and in this study, these fish prey species 
represent potential vectors for the trophic transfer of DA. Otolith identification 
does not give a complete description of the harbour seal diet, as some fish 
might be underrepresented because of complete digestion in the gut or fragile 
otoliths (e.g. mackerel) (Silva and Neilson, 1985). However, the highest levels 
of DA measured in fish (see Chapter 3 for details about the results) matched 
the otoliths that were identified in harbour seals exposed to DA from the east 
coast where the greatest decline in harbour seal abundance is occurring. 
Species of diet importance to harbour seals includes plaice, dab, long rough 
dab, whiting and sandeels. 
 
2.4.2 PSP toxins 
 
Saxitoxin and other PSP toxins have caused temporary closure of a number 
of shellfish production areas on the Scottish east coast and in Orkney 
(Howard, 1995-1998) during HAB episodes. PSP toxins are known to 
accumulate in marine fish can be the cause of sea birds and marine mammal 
deaths (Landsberg, 2002; Shumway, 1990). Lethal doses of PSP toxins vary 
with species (Levin, 1992; Meyer, 1953; Schantz et al., 1975). 
 
Only four of the 30 recognised species belonging to the genus Alexandrium 
have been reported to occur in Scottish coastal waters (Swan and Davidson, 
2011). Data from the Scottish phytoplankton monitoring program indicated 
that large Alexandrium blooms (> 500 cells per litre) occurred on the east 
coast of Scotland in 2008, 2009, 2012 and 2013 (Stubbs et al., 2013; Swan 
and Davidson, 2010, 2011). In Orkney there have been numerous 
Alexandrium blooms, where in 2006, 2007 2009 and 2011 water samples 
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contained >2000 cells per litre. On the west coast there were several larger 
Alexandrium blooms in 2013 (> 500 cells per litre). Interestingly, over half of 
the live captured harbour seals found exposed to PSP toxins (55.6 %) were 
captured on the west coast in May 2013. Although active screening of PSP 
toxins in the live captured harbour seals first started in 2012, both 2012 and 
2013 were years in which harbour seals were found exposed to PSP toxins, 
suggesting PSP toxins should continue to be monitored in harbour seals. 
Blooms of Alexandrium occur on the east coast every year and although not 
all of them produce toxins, if PSP toxins are found in shellfish harvesting is 
suspended until the PSP toxins have fallen below maximum permitted levels. 
Although only acute effects of PSP toxins have been reported in mammals 
such as seals, prior exposure to non-lethal doses of saxitoxin may in fact 
make animals less susceptible to lethal doses as humans who eat low level of 
PSP toxins appear to be less susceptible to develop PSP (Prakash et al., 
1972). In a study by Kvitek et al. (1991) captive sea otters (Enhydra lutris) 
were shown to display selective feeding when given the choice of low-dose 
and high-dose of toxic prey. If harbour seals are exposed to PSP toxins on a 
regular basis they may too potentially become less susceptible to the toxin, 
but not enough information is known about the harbour seal acute and chronic 
PSP toxin exposure in Scotland to make any assumptions on how this would 
potentially affect the population. 
 
Similar to the uptake of DA by harbour seals, plaice, dab and other flat fish 
species, are likely to be of particular importance as vectors for PSP toxins 
(see Chapter 3 for PSP toxin information in fish). These fish are benthic 
feeders and are most likely exposed to PSP toxins through their diet of 
zooplankton (White, 1981b) and other invertebrates (Landsberg, 2002). 
Finding of exposure of PSP toxins in Scottish harbour seals raise questions 
about monthly and annual exposure and because of the devastating effect 
these toxins have shown to have (e.g. respiration, peripheral heat 
conservation) (Geraci et al., 1989) exposure could potentially lead to affect 
feeding, behaviour and recuse fitness. 
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2.4.3 Lipophilic toxins 
 
This study is the first to document exposure to OA and DTX-2 in harbour 
seals. The finding of two harbour seals exposed to DTX-2 with loose/runny 
faeces is the first anecdotal evidence that DTX-2 could cause gastrointestinal 
problems in a marine mammal.  
 
Shellfish (primarily bivalve filter-feeding molluscs) consumption of lipophilic 
toxins is severe in northern Europe. Monitoring programs are trying to 
minimize the effect of these toxins, mostly to protect public health and 
although there are no known human mortalities recorded of exposure to 
lipophilic toxins, monitoring has increased because it is becoming a health 
threat in Scottish waters. Dinophysis spp. appear throughout Scottish coastal 
waters in relatively low numbers and are indigenous to offshore waters and 
sea lochs. Data from 2006-2013 from the phytoplankton monitoring program 
reveals the biggest bloom of Dinophysis spp. occurred on the east coast in 
2007 (> 50 000 cells per litre) and although Orkney and the west coast 
experience Dinophysis spp. blooms over the trigger limit (> 100 cells per litre) 
usually every spring and autumn, the largest bloom in Scotland was the one 
recorded in 2007. OA and DTX-2 are toxins that cause DSP with symptoms 
like fatigue, weakness, cramps, vomiting, abdominal pain and diarrhoea 
(Larsen and Moestrup, 1992; Yasumoto et al., 1984). According to the 
scientific panel on contaminants in the food chain (Panel, 2008) they found 
that OA, DTX-1 and DTX-2 were among the most toxic compounds in the 
Okadaic acid toxin group (Panel, 2008). 
 
The effect the lipophilic toxins have on marine organisms is poorly understood 
and there are only two records of marine mammals exposed to these toxins.  
Firstly in a study by Fire et al., (2010b) where they found 3 out of 8 bottlenose 
dolphins exposed to OA, with levels ranging between 0.003-0.010 µg/g. 
Secondly in a study by Capper et al., (2013) who found OA in the lower 
gastrointestinal tract of a manatee (0.016 µg/g). In the same study they found 
one turtle to have traces of OA (0.009 µg/g). 
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The otoliths recovered from the faecal samples positive for OA and DTX-2 
also gives an indication of the potential vectors. On the east coast flatfish 
together with whiting and goby seem to be of importance while in Orkney 
sandeel otoliths were found in the OA positive samples. On the west coast 
Norway eel pout and eelpout appear to be important vectors for OA and DTX-
2 exposure. 
 
2.4.4 Multiple toxin exposure 
 
The current study does not document any clinically important effects of 
multiple toxin exposure. This could be due to a low sample size that was 
analysed for multiple toxins. To date there is little knowledge about the effect 
of multiple toxin exposure, but it is thought that	  several toxicants together can 
enhance the effects of individual substances (H.T. Hogberg pers. comm.). 
 
There were four faecal samples indicating animals were exposed to DA and 
STX, one from the east coast, one from Orkney and two from the west coast 
where the one from the east coast had been foraging on plaice and founder. 
The otoliths recovered from the faecal sample collected in Orkney revealed 
that sandeel had been the choice of prey while the two faecal samples 
collected from the west coast had otoliths from poor cod. There were three 
faecal samples indicating animals were exposed to DA and DTX-2, two of the 
samples were collected on the east coast where the seals had been foraging 
on goby and whiting and one was collected on the west coast where the seals 
had been foraging on eelpout. There was only one sample where otoliths 
were recovered with DA, STX, OA and DTX-2 contamination, this sample was 
collected on the east coast and the seal had been foraging on dab, whiting, 
plaice, founder and unidentified flatfish which is the dominated group of fish 
harbour seals are known to forage on in this region (Wilson, 2014). 
 
A few studies have reported multiple toxin exposure in marine mammals, such 
as the co-occurrence of OA and brevetoxin in bottlenose dolphins that was 
found stranded along the Texas coast (Fire et al., 2010b), co-occurrence of 
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brevetoxin and DA was reported in bottlenose dolphins from Sarasota Bay, 
Florida over a ten-year period from 1999-2009 (Twiner et al., 2011; Twiner et 
al., 2012). A study by Capper et al., (2013) reported multiple toxin exposure 
(brevetoxins, OA, STX and Lyngbya toxins) in stranded manatees. The 
western North Atlantic population of right whale population was found 
exposed to DA and PSP toxins between 2001 and 2006 in the Bay of Fundy, 
Great South Channel, Roseway Basin, and Cape Cod Bay although no 
associated effects was reported (Doucette et al., 2012). 
 
2.4.5 Dose estimation 
 
Oral dose estimations can be carried out by calculating how much toxin the 
seals are likely to ingest on a daily basis. For example, in a study by 
Härkönen and Heide-Jørgensen (1991) they estimated an average of 4 680 
kcal per seal as their daily energy requirement which corresponds to ingestion 
of ca. 3.7-4.2 kg fish per seal per day. Since the toxins occur in the viscera of 
the fish and from the samples in this study, based on available literature, I 
estimated the viscera to be approximately 20% of the fish total mass (Horn et 
al., 2005), a seal would ingest about 0.8 kg viscera per day. An adult harbour 
seal weighs about 80 kg (total body mass) and is approximately 60 kg (lean 
body mass) (Reilly and Fedak, 1991) and if it consumed fish with the highest 
DA detected in the viscera (plaice; 117.4 µg/g) an adult harbour seal would 
ingest ~1.6 mg DA/kg (lean body mass)/day (lethal oral dose 2.71 mg DA kg-1 
adapted from Bejarano et al. (2007)). Similarly, for PSP toxins if a harbour 
seal ingested the highest PSP toxins detected in the fish identified from the 
faecal material (dab: 1021 µg STX eq/kg), it would ingest ~13.6 µg STX eq 
per kg of lean body mass/day. Some PSP analouges might be more toxic 
than others, and it has been reported that an oral dose between 180-200 
µg/kg b.w would kill a dog (Mons et al., 1998). Whilst these levels are well 
below the lethal levels reported for various mammalian species and laboratory 
animal models, seals feed in bouts, with a mean foraging trip duration of 
between 1 to 5 days (Sharples et al., 2012). Therefore there may be days 
when this estimated mean daily oral dose is greatly exceeded. Further 
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detailed pharmacokinetic modelling incorporating oral dose estimates, the 
half-life of the toxins in seals and their feeding behaviour is required to 
estimate the true impact of these levels on the health and survivorship of 
harbour seals. 
 
Estimating exposure and inferring potential lethal effects from the urine and 
faecal concentrations of toxins in live captured animals could be biased. Sick 
seals may not haul-out and if they do they may haul-out alone and therefore 
not be accessible for capture due to the impacts of the toxins. Therefore 
spatial exposure was investigated by collecting anonymous faecal samples at 
a wider range of harbour seal haul-out sites. This provides a better indication 
of the temporal and spatial variation in exposure although it will not provide 
information about the health of the animals. As mentioned above, harbour 
seals forage at sea for an average of between 1-5 days at a time (Sharples et 
al., 2012), and will therefore also defecate at sea. This means that the 
anonymous/random faecal samples, may only come from seals that had 
foraged closer to the shore but those feeding farther offshore may have 
depurated the toxins by the time they return to haul out, so their levels might 
go undetected. Although there is little knowledge about the assimilation 
efficiency of DA in harbour seals, there is data on the clearance rate of DA in 
monkeys and rats (Suzuki and Hierlihy, 1993; Truelove and Iverson, 1994) 
where DA, which is primarily excreted in urine, remains in the tissues and 
urine for a few hours after ingestion of toxins, whilst excretion rates through 
faeces may take much longer (clearance in harbour seals is estimated in 
Chapter 6). 
 
2.4.6 Scottish harbour seal decline and the link with algal toxins 
 
This study demonstrates the link between exposure and prey consumption, 
with evidence that the harbour seals are exposed to DA on an annual basis 
and that there are regional differences with the east coast being a potential 
hot spot as higher DA levels are found in this region. By contrast, harbour 
seals sampled on the west coast had significantly lower DA levels. However, 
 99 
the west coast regions sampled in this study were limited so further locations 
need to be included in future studies to determine whether this pattern 
persists. Results from Chapter 3 documents toxin levels in the Scottish 
harbour seal fish prey on the east coast of Scotland where the biggest decline 
is occurring. PSP toxin uptake was first studied in Scottish harbour seals in 
2012 and the data from 2012 and 2013 seem to suggest an absence of 
regional differences. There is a lack of information regarding harbour seals 
exposure prior to 2012 and in addition, the lack of seal carcasses from the 
west coast in particular makes regional comparisons difficult. 
 
The decline in Scottish harbour seals was first detected in the counts of seals 
hauled out during their annual moult in August around 2000. In Orkney and 
the North Coast (mainland) the population has declined at an annual rate of 
~13 %, while the Shetland harbour seal population has declined less rapidly 
(30 % since 2000) (SCOS, 2013). The west coast and the Western Isles 
harbour seal populations appear to be stable over the same period. The 
Moray Firth population on the east coast had declined, but more recent 
population counts suggest that it may now be stable (SCOS, 2013). The 
greatest decline has been seen in the Firth of Tay population on the east 
coast where the average rate of the annual decline is ~18 % and the 
population size has decreased by 85 % since 2000 (SCOS, 2013). Although 
several factors have been considered responsible for the sharp harbour seal 
population decrease, there is not a clear single factor, which would explain the 
decline. The most likely explanation probably includes a combination of 
factors, such as shooting and trauma (Bexton et al., 2012; Matthiopoulos et 
al., 2014). Toxins from harmful algae were first monitored in harbour seals by 
Hall and Frame (2010) who found the Scottish harbour seals to be exposed to 
DA. Seeing that DA has caused increased mortality or reduced reproductive 
success in CSLs (Goldstein et al., 2008) the hypothesis was to further 
investigate if this is occurring in Scottish harbour seals. 
 
Although there is little information about the occurrence of toxin-producing 
algal blooms in offshore areas where the seals are foraging, this study clearly 
demonstrates that the toxins are taken up by the prey species consumed by 
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the seals at levels that have the potential to cause harmful and lethal effects 
that would perturb the population dynamics of these species. 
 
2.5 Conclusions 
 
Here I show that the exposure of Scottish harbour seals to DA, PSP toxins 
and the lipophilic toxins OA and DTX-2 is likely to occur through their 
consumption of contaminated fish prey such as plaice, dab, long rough dab, 
whiting, and cod rather than through the secondary ingestion of toxins in the 
water column or sediment. Harbour seals on the east coast of Scotland had 
over three times higher DA concentrations in their urine compared to those 
from the Northern Isles and the west coast and although there is a lack of 
anonymous faecal samples from the west coast there is an indication that 
there are higher DA concentration values on the east coast. Of some note is 
the fact that the east coast is the region with the greatest population decline. 
Although the DA levels in urine reported in this study are similar to those 
measured in the urine of acutely poisoned CSLs, urinary levels do not appear 
to be representative of acute toxicity as the live captured harbour seals all 
appeared healthy upon capture. This is because neither study was able to 
determine exactly when the toxins had been consumed, making any direct 
comparisons unreliable. The results in this study highlight a likely chronic 
rather than acute exposure of Scottish harbour seals to DA and PSP toxins, 
where long-term effects are not yet fully understood. Although no overt health 
effects were observed in the live captured animals as assessment was only 
possible for a few minutes around capture and adrenaline and other stress 
responses let alone sedation from the process of capture may obliterate 
subtle neurological signs. This study suggests immunomodulatory effects of 
DA exposure including lymphocytopenia and monocytosis, which may 
suggest risks for the health and survival of exposed harbour seals. 
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Chapter 3 
 
3. Potential fish vectors for toxins from harmful algae 
in SE Scotland 
 
3.1 Introduction 
 
3.1.1 Harmful algal blooms and marine organisms 
 
The term “harmful algal bloom” or HAB is often used to describe visible 
blooms of certain types of marine algae that produce toxins. There is a 
growing interest in measuring the progression of toxins from the producing 
organism (phytoplankton) throughout the food chain as both HABs and their 
toxic products are known to cause fish deaths, render shellfish poisonous and 
cause detrimental health effects and mortality in humans, birds and marine 
mammals through trophic and predator-prey interactions (Anderson and 
White, 1992; Coulson et al., 1968; Landsberg, 2002; Lefebvre et al., 1999; 
Scholin et al., 2000; Sierra-Beltràn et al., 1997). HABs can also cause 
important economic losses, especially for aquaculture and fisheries (Hoagland 
et al., 2002; Perl et al., 1990; Scholin et al., 2000; Sierra-Beltràn et al., 1997; 
White, 1981b) thus understanding the key drivers of toxin distribution and 
uptake through coastal ecosystems is of interest to conservation managers. 
 
3.1.2 Direct exposure to algal toxins 
 
Direct exposure to toxins from harmful algae occurs if organisms ingest or 
inhale (e.g. filter-feeding, predation) the algae and its associated toxin 
(Landsberg, 2002). Key vectors such as zooplankton, sponges and shellfish 
together with planktivorous fish that directly feed on algae, filter the water and 
absorb algae and toxins into their somatic tissues or viscera (Landsberg, 
2002; Lefebvre et al., 1999; Teegarden et al., 2001). Of the marine mammals 
that are exposed to HAB toxins, manatees are directly exposed through their 
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main food sources, turtle grass and eelgrass where the toxin is found in the 
epiphytes on the seagrass, but also in the seagrass blades and rhizomes 
(Capper et al., 2013). Benthic organisms can be exposed through 
consumption of toxic cells or absorption of toxins that sink to the bottom as 
some toxic algae have sedimentary cysts or resting stages as part of their 
lifecycle (Anderson et al., 1996; Landsberg, 2002). Cysts from Alexandrium 
have shown to be 1000 times more toxic in their cyst stage than in their 
vegetative cell stage (Dale et al., 1978). 
 
3.1.3 Indirect exposure to algal toxins 
 
Trophic transfer of toxins from harmful algae occurs when an organism 
consumes another organism lower down the food chain that has been 
exposed directly to the toxic algae. Such indirect exposure thus occurs 
following the consumption of contaminated prey from planktivorous fish and 
squid, carnivorous molluscs and crustaceans (Deeds et al., 2008; Landsberg, 
2002; Lefebvre et al., 1999; Turner and Tester, 1997). This is the mechanism 
by which toxins are then transferred from lower organisms to top predators 
such as marine mammals. In addition there is also an indication that some 
toxins can persist in the food chain long after the toxin produced 
phytoplankton bloom has ended (Sekula-Wood et al., 2009). These are the 
pathways that can move algal toxins from the bottom to the top of the food 
chain where the entry point can be through zooplankton that feed directly on 
toxic algae. Although top predators may be exposed to toxins directly, trophic 
transfer of toxins is probably the most important pathway for higher trophic 
levels to be affected by toxins from harmful algae. 
 
3.1.4 Domoic acid in marine organisms 
 
Pseudo-nitzschia is a widespread marine diatom that exhibits a range of 
physiological tolerances. Diatoms often dominate spring blooms, and due to 
their immobility they require turbulence to keep them in a well-mixed water 
column. There are several factors that have been shown to trigger the 
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production of domoic acid (DA) in Pseudo-nitzschia. Under certain 
environmental conditions, when the blooms have reached their peak and 
nutrients become limited, the diatoms can become stressed and this can be a 
factor to trigger toxin production (Bates et al., 1998; Takagi, 1993). Pseudo-
nitzschia is a common diatom in the phytoplankton community in Scotland 
(Stobo et al., 2008) and they can out-compete other algae in conditions when 
silica is available or the temperature is falling, while other algae need warmer 
temperatures, low salinities and calmer seas to bloom (Bates et al., 1998; 
Mos, 2001). Not all species of P. nitzschia produce toxin, but those that do, 
produce the neurotoxin domoic acid (DA). In addition DA is an amino acid and 
a glutamate agonist that interferes with neurotransmission in the brain and 
causes damage to the hippocampal area by interfering with the ions and 
depolarizing the neurons. This causes neuronal swelling and the nerve cells 
can go through an apoptosis. These nerve cells are important for memory 
storage and learning and there have been several reports of humans and 
animals exposed to DA where P. nitzschia was involved (Bates et al., 1989; 
Costa et al., 2005b; Fire et al., 2009; Gulland et al., 1998; Hall and Frame, 
2010). DA is one of the biggest health threats to CSLs, and the effect it has 
depends on the amount of toxic prey the sea lions ingest through their diet. 
Vectors such as krill, crab, shellfish and finfish are known to filter or ingest 
and accumulate the algae (Landsberg, 2002; Lefebvre et al., 1999). North 
Atlantic right whales have been found to be exposed to DA throughout the 
spring, summer and autumn months in 2005-2006, most likely through 
ingestion of a contaminated copepod vector (Leandro et al., 2010). A study in 
Western Greenland discovered that three Calanus species can retain DA after 
10 hrs of depuration in filtered sea water and act as potential vectors of DA 
(Tammilehto et al., 2012). In Scotland, data from Marine Scotland Science 
revealed the presence of DA in copepods at the Stonehaven coastal 
monitoring site on the northeast coast of Scotland. A maximum of 0.02 ng DA 
per copepod was detected which coincided with cell densities of P. nitzschia 
spp. of approximately 150,000 cells/L (K. Cook pers. comm.). There are 
several reports of fish as vectors for DA, such as the northern anchovy 
(Engraulis mordax) and Mackerel (Altwein et al.; Lefebvre et al., 1999; 
McGinness et al., 1995; Sierra-Beltràn et al., 1997; Work et al., 1993) where 
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toxicity in fish is restricted to the gut content although brain and muscles in 
anchovies have shown low DA uptake (Lefebvre et al., 2001). This shows that 
foraging strategy can influence whether or not a top predator is exposed to 
DA. No data currently exists on toxins in fish from Scottish waters. 
 
3.1.5 PSP toxins in marine organisms 
 
The microscopic marine dinoflagellate genus Alexandrium poses the greatest 
concern for top predators, due to its toxicity and it is the only genus with toxic 
dinoflagellate known to produce PSP toxins and other members of its family. 
PSP toxins can cause the human illness PSP which has largely been 
associated with the consumption of contaminated mussels (Shumway, 1990). 
A regular bloom from this genus has been known to occur for several decades 
on the southeast coast of Scotland, but PSP events are rare and after an 
outbreak in 1968 where 80 % of the Shags on the Farne Islands on the 
northeast coast of England, were killed after eating contaminated sandeels 
(Clark, 1968; Coulson et al., 1968), the Scottish coast has been monitored for 
Alexandrium and PSP toxins. Most research studies have been focused on 
species that are of economical value such as shellfish and PSP toxins have 
been documented in both bivalves and gastropods (Shumway, 1990). 
Zooplankton has been identified as a vector for higher trophic levels as they 
transport PSP toxins through the food chain (Teegarden et al., 2001; Turner, 
2014; White, 1981b). Archived samples of copepods collected during summer 
2008 in coastal waters near Stonehaven, North-east of Scotland, were 
analysed for PSP using HPLC-FLD (J.P. Lacaze, pers. comm.). Toxicity 
results were found to be negative, which fits with the low cell abundance of 
Alexandrium (below 60 cells/L) present at the time of sampling. 
 
Today there are numerous reports of lethal and sub lethal occurrences 
involving exposure to PSP toxins (Fire et al., 2012; Landsberg, 2002; 
Landsberg et al., 2006) and laboratory experiments confirms similar sensitivity 
of PSP toxins to fish as seen in homeotherms (White, 1981a). In 1976 in the 
Bay of Fundy in Canada, mortality of the Atlantic herring (Clupea harengus 
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harengus) was documented in connection with an Alexandrium tamarense 
bloom and PSP toxin production, the vector was reported to be the planktonic 
herbivore Limacina retroversa (White, 1977). Zooplankton have also been 
documented to bioaccumulate PSP toxins (Teegarden and Cembella, 1996). 
In 1984 fish mortality was reported from the Faroe Islands in connection with 
a bloom of Gonyaulax excavate (Mortensen, 1985). The Mediterranean monk 
seal was exposed to PSP toxins in 1997 likely through contaminated fish and 
STXs were a likely factor in the mass mortality of the population inhabiting the 
Mauritanian coast of Africa (Hernández et al., 1998). Other animals such as 
the endangered North Atlantic right whales population inhabiting the Bay of 
Fundy and adjacent New England waters are exposed to PSP toxins on an 
annual basis and questions were raised after this discovery if PSP toxins are 
compromising their health and reproductive status (Doucette et al., 2012; 
Durbin et al., 2002). 
 
3.1.6 Lipophilic toxins in marine organisms 
 
Some dinoflagellates from the genus Dinophysis produce toxins that can 
cause the human illness DSP (Yasumoto et al., 1984). OA and DTX-2 are two 
structural derivatives in the DSP toxin group (Yasumoto et al., 1984), which 
are the most abundant along European coasts (Aune and Yndestad, 1993). 
Despite OA being considered a more harmless toxin than DA and PSP toxins, 
it presents a potential threat as a tumour promoter (Fujiki et al., 1991). DTXs 
have also shown to induce tumours (Fujiki et al., 1988) on mice skin and is, 
together with OA, a potential threat to health. Shellfish (primarily bivalve filter-
feeding molluscs) consumption is large in northern Europe and DSP illness 
has been recorded from several countries (Dale et al., 1993; Kat, 1983; Krogh 
et al., 1985). Exposure to OA was confirmed in a human after eating razor 
clams (Solen marginatus) and green crabs (Carcinus maenas) where a level 
of 16 µg/100 g was found in the edible parts. There is little information about 
these toxins in fish, to my knowledge the only report of natural OA in fish was 
from a barracuda (Sphyraena barracuda) although the toxin confirmation has 
never been verified (Gamboa et al., 1990; Landsberg, 2002). In a molecular 
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development study by Escoffier et al., (2007) the development of medaka fish 
(Oryzias latipes) embryos was studied where they found that OA disturbs 
embryo development which can impact fish recruitment. However, in general 
very little is known about the natural exposure of these lipophilic toxins and 
their effect on marine organisms. 
 
3.1.7 Trophic transfer of harmful algal toxins 
 
Reports and studies indicate that zooplankton, krill and fish are important 
vectors for transferring harmful algae toxin up the food chain (Bargu et al., 
2002; Landsberg, 2002; Maneiro et al., 2000). In addition to fish and 
zooplankton; uptake has been documented in crabs, lobsters, gastropods 
(sea-snails, sea-slugs and limpets), bivalves (mussels) and echinoderms 
(starfishes and sea-urchins). This provides evidence of toxin exposure to 
edible benthic communities (Landsberg, 2002; Silva et al., 2013). Shellfish is 
the most common vector for transferring toxins to humans, and although fish 
have been shown to accumulate toxins, they do not appear (except from a 
few exceptions) to accumulate in the flesh of the fish, only in the gut (viscera). 
Bretz et al., (2002) suggested using species other than shellfish for toxin 
monitoring such as sand crabs as they have shown to be a comparable 
indicator species to mussels. However, the extent and pace that these toxins 
are transferred through the Scottish food chain is virtually unknown, 
particularly outside the shellfish production regions. 
 
In this thesis I show that Scottish harbour seals are exposed to DA, PSP 
toxins and OA together with DTXs (Chapter 2). The aim of this chapter was 
therefore to investigate the potential routes of trophic transfer to the Scottish 
harbour seals main prey, together with a random selection of by-caught fish 
species collected on the east coast of Scotland by determining the levels of 
DA, PSP toxins and lipophilic toxins (OA and DTXs) in the viscera of the fish. 
This information will enable me to estimate the ingested concentrations of the 
various toxins by the harbour seals from the east coast. 
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3.2 Methods 
 
3.2.1 Fish collection 
 
Fish were opportunistically collected from local fishermen in Pittenweem in the 
summer and autumn of 2012 and throughout the calendar year of 2013 
(except Jan, Feb and Apr 13) from the fishing grounds in the Firth of Forth 
(Fig. 3.1). By caught fish were collected based on availability during the 
seasons and varied in length from 5 cm to 50 cm. Note that not all species 
were caught every month. Of notable importance was that the fish were not 
collected during any HAB blooms in the region. A scientific cruise in the Firth 
of Forth hosted by Marine Scotland Science collected flatfish for toxin analysis 
in the autumn of 2012 (Fig. 3.1). The viscera (fish gut) were removed from 
pools of 2 or more fish (depending on size) to provide a sample of ~50 g 
(stomach prioritized) and stored at -20 °C until further analysis. Out of interest, 
one cod liver was divided up and analysed for all three, toxin groups as 
humans in several countries consume cod liver, particularly in the form of cod 
liver oil. 
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Figure 3.1: This map shows the sampling sites (purple squares) of fish samples collected off 
the southeast coast of Scotland between 2012-2013. 
 
3.2.2 DA extraction and quantification 
 
For extracting DA, no less than 50 g of viscera was blended in a mixer and a 
4 g sub sample removed. DA was extracted following the procedure given in 
Chapter 2, section 2.2.3.1; Sample extraction. Detection and quantification of 
DA in the extracts was done using the same instrumentation as described in 
Chapter 2, section 2.2.3.3; Instrumentation. The limit of detection (LOD) was 
set to 7.00 ng/g and limit of quantification (LOQ) to 25.00 ng/g. 
 
3.2.3 PSP toxin extraction and quantification 
 
For PSP toxin extraction, a 4 g aliquot fish viscera subsample was extracted 
following the same method described in chapter 2 section; 2.2.4.1 Sample 
extraction and protein was precipitated following the method in chapter 2, 
section; 2.2.4.2 Protein precipitation. PSP toxins were measured and 
quantified using the instrumentation described in Chapter 2 section; 2.2.4.4 
Instrumentation for PSP toxin analysis using HPLC. The LOQ for the PSP 
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toxins are described section 2.2.4.4 Instrumentation for PSP toxin analysis 
using HPLC. 
 
3.2.4 OA and DTXs extraction and quantification 
 
To extract the lipophilic toxins the fish viscera were homogenised and 5 g 
subsampled. Lipophilic toxins were extracted following the same method as 
described in chapter 2, section 2.2.5.1 Sample extraction and 2.2.5.2 
Hydrolysis of Esterified Forms of OA, DTX-1, and DTX-2. The extracts were 
measured and quantified using the instrumentation described in chapter 2; 
section 2.2.5.3 Instrumentation. The LOD was put to 6.00 ng/g and LOQ of 
20.00 ng/g for both OA and DTX-2. 
 
3.2.5 Data analysis 
 
The data for this Chapter is presented in ng/g to match the current literature 
and the conversion from ng to µg/g is to divide by 1000. Data exploration 
using boxplots were made for each fish species group. This enabled me to 
compare levels in each fish species to one another. Regression models were 
used to select the models that best fitted the data with toxin concentration of 
the toxin as the dependent variable and month (factor) as the independent 
variable. Akaike’s information criterion (AIC) was used to rank the models. 
The AIC is a useful measure that balances goodness of fit of the model 
against model complexity (Akaike, 1974). All analyses were performed using 
R software (R Development Core Team 2007). 
 
3.3 Results 
 
3.3.1 Domoic acid detection in fish 
 
Over the 2-year study period on the east coast a total of 26 species and 215 
individually pooled samples were analysed for DA. Of the samples analysed 
for DA 41.4 % was found >LOQ (n = 89) which included 18 different species 
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of fish. DA ranged from 50 ng/g to 117 400 ng/g (Table 3.1). The highest 
sample was measured in a plaice (Pleuronectes, Fig. 3.2 and 3.3) suggesting 
these flatfish in particular may be important vectors of DA. Other flatfish 
exposed to DA included species such as dab (Fig. 3.2 and 3.3), lemon sole 
(Microstomus kitt, Fig. 3.2 and 3.3), long rough dab (Fig. 3.2 and 3.3) and brill 
(Scopthalmus rhombus, Fig. 3.2 and 3.3). Of the benthic fish species exposed 
to DA, these included; gurnard (Chelidonichthys, Fig. 3.4), sandeel (Fig. 3.4) 
and sculpin (Cottidae, Fig. 3.4). The pelagic fishes exposed to DA included 
bib (Trisopterus luscus, Fig. 3.5 and 3.6), cod; Fig. 3.5 and 3.6), haddock 
(Melanogrammus aeglefinus, Fig 5 and 6), herring (Clupea harengus, Fig. 3.5 
and 3.6), horse mackerel (Trachurus trachurus, Fig. 3.5 and 3.6), mackerel 
(Fig. 3.5 and 3.6), pollock (Pollachius pollachius, 3.5 and 3.6), saithe 
(Pollachius virens, Fig. 3.5 and 3.6), sprat (Sprattus sprattus, Fig. 3.5 and 
3.6), and whiting (Merlangius merlangus, Fig. 3.5 and 3.6). For a full overview 
of the species and range levels for DA see Table 3.1. The cod liver analysed 
did not contain any detectable DA. With all fish groups (flatfish, benthic and 
pelagic) analysed together, there was a seasonal difference in DA uptake 
where May, June and November had a lower monthly mean than the other 
months (Table 3.2, model 1, p < 0.01 and Table 3.3). There was no seasonal 
difference with the fish group split into flatfish, benthic and pelagic (Table 3.2, 
model 2, 3 and 4). 
 
 
Table 3.1: Overview over the fish sampled and analysed for the different toxins, here 
represented by min and max toxin concentration (sample size in brackets). 
Species DA range ng/g STX range mg 
STX diHCl eq/kg 
 
DTXs 
range ng/g 
OA range: (LOQ 
>20 ng/g) 
Bearded rockling 
(non specific) 
0 (3) 0.2-15.37 (2) 0 (2) 0 (2) 
Bib (Trisopterus 
luscus) 
0 - 70 (2) 0.3 (1) 0 (1) 0 (1) 
Brill (Scopthalmus 
rhombus) 
80 (1) 0.01 (1) 0 (1) 0 (1) 
Cod (Gadus 
morhua) 
0 – 2655 (12) 0 – 0.09 (12) 0 (10) 0 (10) 
Dab (Limanda 
limanda) 
0 – 5075 (31) 0 – 1.02 (29) 4.98 (29) 0 – 31.6 (29) 
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Dogfish 
(Scyliorhinus 
canicula) 
0 (1) 0.01 (1) 0 (1) 0 (1) 
Dover Sole (Solea 
solea) 
0 (1) n.a 0 (1) 0 (1) 
Flounder 
(Platichthys flesus) 
0 (1) n.a n.a n.a 
Gurnard (non 
specific) 
0 – 31 (7) 0 – 23 (4) 0 (5) 0 (5) 
Haddock 
(Melanogrammus 
aeglefinus) 
215 – 811 (2) 0.06 – 0.70 (2) 0 (2) 0 (2) 
Hake (Merluccius 
merluccius) 
0 (4) 0 – 0.65 (4) 0 (4) 0 (4) 
Herring (Clupea 
harengus) 
0 – 114 (5) 0 – 0.05 (3) 0 (2) 0 (2) 
Horse Mackerel 
(Trachurus 
trachurus) 
75 – 680 (2) 0.05 – 0.35 (2) 0 (2) 0 (2) 
Lemon Sole 
(Microstomus kitt) 
0 - 5580 (29) 0 – 21.2 (26) 2.5-7.45 
(21) 
0 – 97.0 (21) 
Long rough dab 
(Hippoglossoides 
platessoides) 
0 – 1800 (24) 0 – 0.75 (20) 0 (14) 0 – 16.0 (14) 
Mackerel 
(Scomber 
scombrus) 
80 – 14265 (9) 0 – 2.2 (8) 0 (10) 0 (10) 
Monk fish 
(Lophius sp.) 
0 (1) 0 (1) 0 (1) 0 (1) 
Plaice 
(Pleuronectes) 
0 – 117400 (34) 0 – 0.76 (33) 1.73-3.13 
(31) 
0 (31) 
Pollack (Pollachius 
pollachius) 
80 (1) 0.03 (1) 0 (1) 0 (1) 
Red mullet (Mullus 
Surmuletus) 
0 (1) 0.07 (1) 0 (1) 0 (1) 
Saithe (Pollachius 
virens) 
0 – 275 (3) 0 – 0.1 (3) 0 (3) 0 (3) 
Sandeel (non 
specific) 
0 – 5 (9) 0 (5) 0 (5) 0 (5) 
Sculpin (Cottidae) 0 – 135 (10) 0 – 0.39 (8) 0 (8) 0 (8) 
Sprat (Sprattus 
sprattus) 
17 (1) 0 (1) 0 (1) 0 (1) 
Tusk (Brosme 
brosme) 
0 (2) 0 (1) 0 (1) 0 (1) 
Whiting 
(Merlangius 
merlangus) 
0 – 270 (18) 0 – 0.36 (15) 0 (16) 0 – 35.5 (16) 
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Figure 3.2: DA concentrations in flatfish species sampled in 2012 and 2013, circle size (small 
to large) represents concentration (low to high), the concentration level can be found in the 
legend. The small grey dots represent sample effort with no toxin found. 
 
 
Figure 3.3: Concentration of DA in flatfish (ng/g), by species, plotted on a logarithmic scale. 
The width of the box is proportional to the square root of the samples sizes and the box goes 
from the first quartile to the third quartile, whiskers represent the lowest and highest values 
still within 1.5 x IQR of DA and the black horizontal line indicates the median of the data set, 
separate circles are outliers (DA range: 0 – 117400 ng/g). 
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Figure 3.4: DA concentration in benthic species sampled in 2012 and 2013, circle size (small 
to large) represents concentration (low to high), the concentration level can be found in the 
legend. The small grey dots represent sample effort with no toxin found. DA range: 0 – 135 
ng/g. 
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Figure 3.5: DA concentration in pelagic fish species sampled in 2013, circle size (small to big) 
represents concentration (low to high), and the concentration level can be found in the 
legend. The small grey dots represent sample effort with no toxin found. Range: 0 – 14265 
ng/g. 
 
Figure 3.6: Concentration of DA in pelagic fish (ng/g) by species, plotted on a logarithmic 
scale. The width of the box is proportional to the square root of the samples sizes and the box 
goes from the first quartile to the third quartile, whiskers represent the lowest and highest 
values still within 1.5 x IQR of DA and the black horizontal line indicates the median of the 
data set, separate circles are outliers (DA range: 0 – 14265 ng/g). 
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Table 3.2: Regression models for DA concentration measured in fish. 
Model Variable Residual 
deviance 
df fitted df P value AIC 
1. Month (all groups) 269.36 7 21
4 
<0.01 285.36 
2. Month (flatfish) 156.52 7 12
2 
>0.11 172.52 
3. Month (benthic) 5.41 4 32 >0.99 15.41 
4. Month (pelagic) 67.47 6 62 >0.06 81.47 
 
 
Table 3.3: Toxin concentrations in all fish species that were positive (> LOQ) are represented 
(sample sizes are in brackets). 
Month DA ng/g STX mg 
eq/kg 
OA (ng/g) DTX-2 (ng/g) 
Feb 0.00 (4) 0 (3) 0 (3) 0 (3) 
May 26.19 (42) 27.7 (18) 5.88 (17) 0 (17) 
Jun 27.78 (18) 15.38 (13) 0 (9) 0 (9) 
Jul 48.72 (34) 47.5 (40) 8.11 (37) 0 (37) 
Aug 61.90 (63) 43.08 (65) 12.5 (56) 0 (56) 
Sep 48.65 (37) 81.82 (33) 8.33 (36) 0 (36) 
Oct 80.00 (5) 40.00 (5) 0 (5) 0 (5) 
Nov 14.29 (7) 42.86 (7) 14.29 (7) 0 (7) 
 
 
3.3.2 PSP toxin detection in fish 
 
For the STXs 175 individually pooled samples were selected this included 24 
species of fish. The fish with the highest PSP toxin measured was a lemon 
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sole with 21.2 mg STX eq/kg (Fig. 3.7 and 3.8). Other flatfish exposed to PSP 
toxins included species such as: dab (Fig. 3.7 and 3.8), long rough dab (Fig. 
3.7 and 3.8), plaice (Fig. 3.7 and 3.8) and brill (Fig. 3.7 and 3.8). The benthic 
fish exposed to PSP toxins included fish species such as; bearded rockling 
(Fig. 3.9 and 3.10), dogfish (Scyliorhinus canicula, Fig. 3.9 and 3.10), gurnard 
(Fig. 3.9 and 3.10) and sculpin (Fig. 3.9 and 3.10). The more pelagic fish 
species exposed to PSP toxins included bib (Fig. 3.11 and 3.12), cod (Fig. 
3.11 and 3.12), haddock (Fig. 3.11 and 3.12), hake (Fig. 3.11 and 3.12), 
herring (Fig. 3.11 and 3.12), horse mackerel (Fig. 3.11 and 3.12), mackerel 
(Fig. 3.11 and 3.12), pollock (Fig. 3.11 and 3.12), red mullet (Mullus 
Surmuletus, Fig. 3.11 and 3.12), saithe (Fig. 3.11 and 3.12), and whiting (Fig. 
3.11 and 3.12). For a full overview over the range levels in the different 
species see Table 3.1. The cod liver contained 0.017 mg STX eq/kg 
suggesting PSP toxins do accumulate separately in the liver. There was a 
seasonal difference where September had a higher concentration of PSP 
toxins than the rest of the months (Table 3.3 and Table 3.4, model 1, p < 
0.01). For the flatfish group there was a seasonal difference where September 
was the month with higher concentration than the rest (Table 3.4, model 2, p 
< 0.01), there was no seasonal difference between the benthic or the pelagic 
fish species (Table 3.4, model 3 and 4, p > 0.05). 
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Figure 3.7: PSP toxin concentration in flatfish species sampled in 2012 and 2013 for, circle 
size (small to big) represent concentration (low to high), the concentration level can be found 
in the legend. The small grey dots represent sample effort with no toxin found. 
 
 
Figure 3.8: Concentration of PSP toxins in flatfish (mg STX eq/kg) by species, plotted on a 
logarithmic scale. The width of the box is proportional to the square root of the samples sizes 
and the box goes from the first quartile to the third quartile, whiskers represent the lowest and 
highest values still within 1.5 x IQR of PSP toxins and the black horizontal line indicates the 
median of the data set, separate circles are outliers (STX range: 0 – 21.15 mg STX eq/kg). 
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Figure 3.9: PSP toxin concentration in benthic fish species sampled in 2012 and 2013 for, 
circle size (small to big) represent concentration (low to high), the concentration level can be 
found in the legend. The small grey dots represent sample effort with no toxin found. 
 
 
 
Figure 3.10: Concentration of PSP toxins in benthic fish (mg STX diHCl eq/kg) by species, 
plotted on a logarithmic scale. The width of the box is proportional to the square root of the 
samples sizes and the box goes from the first quartile to the third quartile, whiskers represent 
the lowest and highest values still within 1.5 x IQR of PSP toxins and the black horizontal line 
indicates the median of the data set, separate circles are outliers (STX range: 0 – 15.39 mg 
STX eq/kg). 
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Figure 3.11: PSP toxin concentration in pelagic fish species sampled in 2012 and 2013, 
where circle size (small to big) represent concentration (low to high), the concentration level 
can be found in the legend. The small grey dots represent sample effort with no toxin found. 
 
Figure 3.12: Concentration of PSP toxins in pelagic fish (mg STX eq/kg) by species, plotted 
on a logarithmic scale. The width of the box is proportional to the square root of the samples 
sizes and the box goes from the first quartile to the third quartile, whiskers represent the 
lowest and highest values still within 1.5 x IQR of PSP toxins and the black horizontal line 
indicates the median of the data set, separate circles are outliers (STX range: 0 – 2.18 mg 
STX eq/kg). 
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Table 3.4: Regression models for PSP toxin in fish (all groups and by group). 
Model Variable Residual 
deviance 
df fitted df P value AIC 
1. Month (all groups) 224.23 7 18
3 
<0.01 240.23 
2. Month (flatfish) 124.17 7 10
9 
<0.01 140.17 
3. Month (benthic) 16.29 4 21 >0.05 26.29 
4. Month (pelagic) 52.29 6 42 >0.29 66.29 
 
 
3.3.3 Lipophilic toxin detection in fish 
 
A total of 170 individually pooled samples were analysed for OA and DTXs, 
this included 25 species of fish. There was a significant difference between 
the months of the year (Table 3.5, model 1, p < 0.05), where May had a 
significant lower percentage positive OA concentration than the other months, 
interestingly all of the samples collected in November were > LOQ. When 
investigating if there was a seasonal difference between the fish groups 
(flatfish, benthic and pelagic) there was no seasonal difference for OA 
concentration and between the flatfish and pelagic group (Table 3.5, model 2 
and 3, p > 0.06). All of the benthic fish species were negative for OA. 
 
For DTX-2 there was no seasonal difference (Table 3.5, model 4, p > 0.05) 
and there were not enough data to run models on the individual fish groups. 
Lemon sole was the fish species with the highest OA concentration at 97.0 
ng/g (Fig. 3.13 and 3.14), and the only fish with DTX-2 concentration (> LOD) 
at 7.5 ng/g. Other flatfish exposed to OA included dab, dover sole (Solea 
solea), long rough dab and plaice (Fig. 3.13 and 3.14). For the benthic fish 
exposed to OA, these species included bearded rockling (non specific) and 
gurnard. There was six species of pelagic fish exposed to OA, these included 
cod, haddock, hake (Merluccius merluccius), horse mackerel, mackerel and 
whiting (all Fig. 3.15 and 3.16). Of the flatfish exposed to DTX-2 (but levels 
were < LOQ), the species included were: dab and plaice. Although the levels 
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were not quantified, the results still indicate DTX-2 exposure to these fish 
species. In addition, the cod liver sample did not contain detectable levels of 
OA or DTXs. There was no DTX-1 found in any of the fish samples. 
 
 
 
Figure 3.13: OA concentration in flatfish fish species sampled in 2012 and 2013, where circle 
size (small to large) represent concentration (low to high), the concentration level can be 
found in the legend. 
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Figure 3.14: Concentration of OA in flatfish (ng/g) by species, plotted on a logarithmic scale. 
The width of the box is proportional to the square root of the samples sizes and the box goes 
from the first quartile to the third quartile, whiskers represent the lowest and highest values 
still within 1.5 x IQR of OA and the black horizontal line indicates the median of the data set, 
separate circles are outliers (OA range: 0 – 97 ng/g). 
 
 
 
 
Figure 3.15: OA concentration in pelagic fish species sampled in 2012 and 2013, where circle 
size (small to large) represent concentration (low to high), the concentration level can be 
found in the legend. 
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Figure 3.16: Concentration of OA in pelagic fish (ng/g) by species, plotted on a logarithmic 
scale. The width of the box is proportional to the square root of the samples sizes and the box 
goes from the first quartile to the third quartile, whiskers represent the lowest and highest 
values still within 1.5 x IQR of OA and the black horizontal line indicates the median of the 
data set, separate circles are outliers (OA range: 0 – 36 ng/g). 
 
Table 3.5: Regression model for OA and DTX-2 concentration in fish (all groups and by 
flatfish and pelagic fish). 
Model Variable Residual 
deviance 
df fitted df P value AIC 
1. (OA) Month (all 
groups) 
186.93 7 16
9 
<0.01 202.93 
2. (OA) Month (flatfish) 117.33 7 92 >0.06 133.33 
3. (OA) Month (pelagic) 27.53 6 51 >0.17 41.53 
4. (DTX) Month (all 
groups) 
9.19 7 16
9 
>0.99 25.20 
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3.4 Discussion 
 
3.4.1 Harmful algae toxins in fish from the Firth of Forth, Scotland 
 
The trophic transfer of toxins from harmful algae through the food chain to 
higher predators has been documented in many places around the world (for 
review see (Landsberg, 2002)), but in Scotland there is a lack of information 
on the pervasiveness of these toxins in the food chain. Detection of DA, PSP 
toxins and the lipophilic toxins (OA and DTX-2) confirms that fish on the east 
coast of Scotland are ingesting toxins throughout the year even when the 
HABs responsible for their production are not present. This chapter 
documents the presence of these toxins in pelagic and benthic fish species 
capable of contaminating fish eating predators such as, but not exclusively 
(see Chapter 4), Scottish harbour seals. 
 
3.4.2 Domoic acid in fish 
 
Phytoplankton monitoring data from 2006-2013 reveals that Pseudo-nitzschia 
is present annually on the east coast from April to September, with an 
occasionally occurrence in March and October (Stubbs et al., 2013). Although 
blooms of Pseudo-nitzschia occurs, toxin are not always produced as not all 
strains are toxic (Stubbs et al., 2013; Swan and Davidson, 2011). This study 
documents that the highest DA concentrations were found in benthic fish 
species such as plaice, lemon sole, dab and long rough dab. Of the pelagic 
fishes the highest DA concentration measured was in cod and mackerel. 
Although I lack fish data from January, March, April and December I 
document that DA was detected from the remaining months where fish was 
sampled. This suggests that there is possible a slow depuration rate of DA in 
these fish, or they are exposed to DA across a wide range of seasons and 
thus almost at any time of the year, even if it is not present in sentinel 
shellfish. It has been suggested that the sediment could potentially be a 
reservoir of DA and thus act as a constant source to be taken up the benthic 
feeding organisms. This would not be detected in rope-cultured shellfish from 
toxin monitoring sites (Gallacher et al., 2000). An example of benthic 
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organisms that are exposed to DA is the filter feeding worm (Urechis caupo), 
where the worm was found with DA levels as high as 700 µg/g DA-1 
(Goldberg, 2003). The authors also discovered that the deposit feeding olive 
snail (Olivella biplicata) had DA levels at 2 µg/g-1 DA. Other benthic species 
that have been found exposed to DA are estuarine bivalves that reside in mud 
and sand (Vale and Sampayo (2001). Another example is a study by Kaniou-
Grigoriadou (2005) where they found high concentration of DA in the sand 
and rock burrowing venus clam (Venus verrucosa). Collectively these studies 
provide evidence that benthic invertebrates are probably very important 
initiators in the movement of DA from the benthos to the next level in the 
chain. 
 
Moving up the food chain from benthic invertebrates to fish, limited data exists 
on the natural exposure and toxic effect of DA in fish. Northern anchovy from 
the US west coast have been reported to contain up to 40 mg/g DA in the 
muscle (Lefebvre et al., 2001; Lefebvre et al., 1999; Work et al., 1993). 
Mackerel have also been shown to act as a vector of DA transfer with levels 
up to 142.9 μg/g (Sierra-Beltràn et al., 1997). In a study by Lefebvre et al., 
(2001) they demonstrated that anchovies could experience neuroexcitotoxicity 
after DA exposure, where findings of DA in the brain tissue and flesh raised 
concerns. The authors also suggested that anchovies would act as an easy 
prey target, due to the fact that sinking dead anchovies could be a potential 
pathway of DA transfer to benthic communities. Sardines (Sardina pilchardus) 
and Atlantic horse mackerel were studied by Vale and Sampayo (2001) where 
DA was found in the gut (range: 11.8 – 492.4 μg/g), muscle (range: 0.4 – 3.5 
μg/g) and brain (range: 0.2 – 1.7 μg/g) of sardines. 
 
DA exposure to fish eating predators have been reported in CSLs from the US 
west coast, where morbidity and mortality has occurred as a result of DA 
exposure from contaminated anchovies (Gulland, 2000; Gulland et al., 2002; 
Lefebvre et al., 1999; Scholin et al., 2000). Humpback whales have also been 
found to be exposed to DA through eating contaminated anchovies and 
sardines (Lefebvre et al., 2002b). In Scotland there has been one report of DA 
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in cetaceans, where a dead minke whale (Balaenoptera acutorostrata) was 
found to have taken up DA following a large Pseudo-nitzschia bloom although 
it was not established whether this was the cause of death (Turrell et al., 
2006). 
 
From the results discussed in chapter 2, the most important potential vectors 
of DA transfer to Scottish harbour seals from the identification of otoliths in the 
harbour seals scats were benthic fish such as plaice, dab and sandeels 
together with more pelagic fish such as whiting and cod was found in seals 
exposed to DA. These are specific for the east coast region. Results from a 
PhD study confirms that the diet of the harbour seal on the east coast is 
dominated by flatfish such as plaice but that sandeel together with the pelagic 
fishes such as cod and whiting are also important in the diet (Wilson, 2014). 
 
3.4.3 PSP toxin in fish 
 
Monitoring data from the Scottish phytoplankton monitoring group reveals that 
Alexandrium blooms have been detected from 2006-2013 on the east coast 
annually from April to June, with more sporadic occurrences from July to 
August. Rarely is Alexandrium detected from September to March (Stubbs et 
al., 2013; Swan and Davidson, 2011). PSP toxins were found in all the 
months fish were sampled and analysed. As for the DA results, there is a lack 
of data from January, March, April and December. However, my results do 
suggest that STX can be accumulated throughout the year even when a 
bloom is not present. The life cycle of Alexandrium is important, and consists 
of nine stages, which includes both motile and cyst phases. One aspect that 
increases Alexandrium success in producing blooms is the cyst phase, and its 
ability to remain in the bottom sediment when growth conditions are 
unfavourable. The motile stage of the cells develops by binary fission and 
blooms occur when conditions are favourable. If conditions are poor (e.g. low 
temperature or changes in salinity) the motile species can go into a 
‘’temporary cyst’’ which allows them to avoid unfavourable short-term 
fluctuations in the ocean (Anderson, 1998). 
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In Norway, mortality of farmed salmon has been related to STX during a 
bloom of Alexandrium tamarense (http://www.sintef.no/Fiskeri-og-havbruk-
AS/Marine-ressursteknologi/Barekraftig-produksjon/Algeovervakning/Gift-
algeoppblomstring-i-Nord-Norge/). Oral administration of PSP toxin in both 
flounder, salmon and cod confirms that fish are susceptible to STX (White, 
1981a). Fish feeding directly on PSP toxin producing algae or on 
contaminated zooplankton are in the risk of becoming intoxicated (White, 
1984). In addition, uptake of PSP toxins dissolved in sea water through the 
gills, has also been suggested (Montoya et al., 1996). 
 
Atlantic mackerel is an important vector as it accumulates PSP toxins in the 
liver (Castonguay et al., 1997). Information on the median lethal concentration 
(LC50) of PSP toxins in water is very limited and the oral median lethal dose 
(LD50) for PSP toxins varies among laboratory species such as cats 
(Andrinolo et al., 1999), and in studies with salmon and cod it usually varies 
between 400 and 1000 µg STX eq/kg (White, 1981a). There is a lack of 
precision in lethal oral dose in humans, but an acute reference dose in the 
region of 0.3-0.8 μg/kg bw has been suggested (Anon, 2006). In a study by 
Chen and Chou (2001) extract from toxic algae was tested on milkfish 
(Chanos chanos) where they discovered the LC50 to be 870 µg STX eq/L. In a 
study of fish larval stages Levfebvre et al., (2004) discovered that exposure to 
dissolved PSP toxins can cause morphological abnormalities and short term 
exposure can negatively impact the larval survival. However, accumulation of 
PSP toxins in the edible muscle of fish is not likely to occur (Bakke and 
Horsberg, 2010). Other studies on the effect of PSP toxins in marine 
organisms was carried out by Lenz et al. (2014) where they discovered 
voltage-gated sodium channel genes in marine copepods, where they 
concluded that ingested toxic Alexandrium could potentially affect the 
organism (Lenz et al., 2014). As mentioned earlier in this chapter PSP toxins 
have been suggested to be a factor in the population failure of the 
endangered North Atlantic right whale population where the primary prey C. 
finmarchicus is likely to act as the vector. Levels as high as 0.95 µg STX eq./g 
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in faeces samples were documented (Doucette et al., 2006; Doucette et al., 
2012). 
3.4.4 Lipophilic toxins in fish 
 
Data from the Scottish phytoplankton monitoring program reveals annual 
occurrences of Dinophysis sp. on the east coast (Stubbs et al., 2013; Swan 
and Davidson, 2010, 2011), where on average there are about two months of 
the year when cell counts are above the trigger level (> 100 cells/l). These are 
usually in the summer months of June and July. Detection of Dinophysis cells 
generally starts in April and ends usually at the end of the summer 
(August/September). Fish analysed for OA and DTXs occurred throughout the 
year except in January, March, April and December. OA occurred every 
month sampled except February whilst DTX-2 occurred only in the spring, 
summer and autumn months from May to August. These results suggest both 
OA and DTX-2 are taken up by several species of fish and can be found in the 
viscera of the fish from early spring to late autumn. There are no specific 
studies of lipophilic toxins in fish but OA has been studied in zooplankton 
where it had a potential lethal effect on the larvae (Artemia franciscana) 
(Demaret et al., 1995). Tintinnids, which are small planktonic ciliates 
(microzooplankton) have been suggested to play an important role in the 
transfer of OA to higher trophic levels (Maneiro et al., 2000). 
 
3.5 Conclusion 
 
I have found that a wide variety of fish species caught on the in the Firth of 
Forth on the east coast of Scotland from the area around Firth of Forth 
contain measureable levels of all three toxins of interest; DA, PSP toxins and 
the lipophilic toxins OA and DTX-2. The toxins were not necessarily only 
found during the seasons of peak phytoplankton blooms, in the spring and 
autumn but were found throughout the year. This study therefore documents 
that several species of fish are potential vectors for these algal toxins to 
higher trophic levels, which suggests that a wide variety of susceptible top 
predators could be affected, particularly those that forage in the coastal zone. 
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Linking these findings to the recent diet studies in the Scottish harbour seals 
shows that flatfish are the most important group of fish on the east coast. The 
fact that flatfish dominated the diet of the seals in the Tay and Eden estuaries 
(Wilson, 2014) fits well with my findings and leads to the conclusion that this 
population could be at particular risk of exposure to all three groups of toxins. 
Interestingly, this is the area where the biggest decline of harbour seals is 
occurring (Lonergan et al., 2007) and is clearly of particular importance as the 
decline in this region could indeed be explained by ingestion of these toxins 
through fish, although no regional comparison is possible in this study. Taken 
in conjunction with the evidence presented in Chapter 2, where the proportion 
of positive samples and concentrations in the urine and faeces were, in 
general, highest in the harbour seals from the east coast, these findings 
suggest toxin exposure cannot be ruled out as a cause of the decline in this 
region (although there is a lack of comparable faecal samples from the west 
coast where the populations are stable). 
 
Given the impact that these toxins could cause they could pose a serious 
threat not only to the harbour seals, but also other fish eating predators as 
several cetaceans are also exposed, particularly to DA, as seen in Chapter 4. 
These results are key for future risk assessment models in order to estimate 
and model the individual and population level effects of toxin exposure 
through reconstructing the different diets, foraging strategies and uptake of 
these in the various top predators. 
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Chapter 4 
 
4. Toxins from harmful algae in stranded marine 
mammals in Scotland 
 
4.1 Introduction 
 
4.1.1 Marine mammal strandings 
 
Stranding of a marine mammal means that an animal, for various reasons, 
has washed ashore, and been left helpless if it is still alive but often the 
stranding is of a dead animal (Geraci, 2005). In addition to single strandings, 
mass stranding events can occur and these are defined as beaching of more 
than two marine mammals (usually alive) (Geraci et al., 1999). Mass 
strandings can draw lots of attention from the public. Mass strandings can 
occur in species that for some reason come into unfamiliar areas, such as 
shallow or in-shore regions (Geraci, 2005), but may also be due to a 
widespread infection or toxic event such as a large HAB event. There are 
several factors that are thought to cause marine mammals to strand, such as 
oceanographic events, tidal movements, extreme weather, prey or illness or 
injury of an animal. Many cetaceans come inshore perhaps through curiosity 
or to feed, but few strand. Those that do strand alive often become trapped 
and ground due to the tides (Smith et al., 1985). Other cetaceans may strand 
due to noises in the ocean, and some whalers use this phenomenon, using 
sharp sounds to drive dolphins ashore (Kuiken and Hartmann, 1991). Direct 
effects of human activity (e.g. navy exercises using sonar) has increased the 
attention towards stranding of marine mammals such as beaked whales 
(Fernandez et al., 2004). Generally the reason for the stranding of a mammal 
is hard to identify and all unusual mortality events are referred to as Unusual 
Mortality Events (UMEs). 
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In Europe UMEs or major die offs have occurred in harbour seal populations 
where two epidemics caused by phocine distemper virus (PDV) (Osterhaus 
and Vedder, 1988) have been reported. The first occurred in 1988 where 60 
% of the North Sea harbour seal population was killed (Härkönen et al., 2006) 
and the second outbreak was in the summer of 2002 where thousands of 
dead seals were found (Härkönen et al., 2006; Jensen et al., 2002). Outside 
of these mass events, seals that strand in Scotland are mainly harbour seals 
and grey seals both of which are indigenous to Scottish waters although 
occasional vagrant species, particularly from the Arctic are also reported. In 
2012 grey seals were the most common seal species to be reported stranded, 
representing 26.2 % of the total strandings reported to the Scottish Marine 
Animal Stranding Scheme (n = 126) whereas harbour seals represented only 
8.3 % (n = 39) of the total stranding in 2012 (Brownlow and Davison, 2012). 
This possibly represents a difference due to the difference in population size 
and many of the grey seals reported are pups of the year in which high natural 
mortality occurs. Between 1992 and 1995 there was a peak in grey seal 
strandings in the UK which may have been due to increased shooting 
(Brownlow and Davison, 2012). However, one of the most common cause of 
death for harbour seals in Scotland in particular have in the last couple of 
years been trauma due to spiral lesions (Bexton et al., 2012; Brownlow and 
Davison, 2012). These traumatic deaths are probably due to interactions 
between seals and vessels operating ducted propellers, research into this 
cause of mortality is continuing. 
 
Of the cetaceans, the most commonly stranded species in 2012 and indeed in 
previous years has been the harbour porpoise (Phocoena phocoena) 
representing 14 % (n = 68) of the total stranding in 2012. Two harbour 
porpoises were found the same year with spiral lesions (Brownlow and 
Davison, 2012). In addition to these single dead strandings, two live mass 
strandings of the Long-finned pilot whales (Globicephala melas) have 
occurred recently in Scotland, the first occurred in 2011 in Kyle of Durness on 
the north coast of Scotland and the other in 2012 on the east coast near 
Pittenweem. These are rare occurrences, but are events that bring a great 
deal of public interest. 
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The causes of many marine mammal strandings cannot be explained, but 
toxins from harmful algae can be linked to some of them. Mass strandings 
due to toxic uptake have been suggested as a cause of death in 
Mediterranean monk seals, manatees and CSL (Capper et al., 2013; Gulland, 
2000; Gulland et al., 1998; Hernández et al., 1998; Scholin et al., 2000). 
 
4.1.2 Domoic acid and potential vectors in stranded marine mammals 
 
Among marine mammals, domoic acid (DA), a neurotoxin produced by the 
diatom Pseudo-nitzschia, has caused mortality events since 1998 particularly 
in CSL from the consumption of contaminated planktivorous fish (Lefebvre et 
al., 1999; Scholin et al., 2000). Pacific harbour seals have been found with 
clinical signs indicative of acute DA toxicosis (McHuron et al., 2013). DA has 
also been considered to have a potentially fatal outcome in the North Atlantic 
right whale population (Leandro et al., 2010). DA was detected in the 
intestinal content and faeces during an UME of bottlenose dolphins (Fire et 
al., 2010b) although it was unclear what role the toxin had in the stranding 
event. Interestingly, in a study by Fire et al., (2009) they discovered that the 
offshore feeders; the pygmy sperm whales (Kogia breviceps) and the dwarf 
sperm whales (Kogia sima) stranded along the U.S. Atlantic coast from 1997 
to 2008 were exposed to DA, highlighting the importance of toxin investigation 
in the cetacean food web. Cetacean mortality, especially long-beaked 
common dolphins (Delphinus capensis) have been associated with DA 
producing Pseudo-nitzschia blooms in southern California (De La Riva et al., 
2009)  
 
In Scotland there is a lack of information on how widespread DA is among 
marine mammals, but the toxic diatoms are regularly found in Scottish water 
and harbour and grey seals are exposed ((Hall and Frame, 2010), Chapter 2, 
S. Tarrant unpublished data). From Chapter 3 I found DA is accumulated in 
several groups of fish from SE Scotland, particularly DA seems to accumulate 
in flatfish. This vector may clearly not be restricted to just the SE coast that I 
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have focused on in this study, but may also be important in other areas, as 
evidenced from the widespread finding of toxins in harbour seals throughout 
Scotland (see Chapter 2). Other species such as crustaceans and 
cephalopods can act as vectors (Lefebvre et al., 2002a) of trophic toxin 
transfer to marine mammals (Fire et al., 2009; Lefebvre et al., 2002b; Scholin 
et al., 2000), but none of these species has been investigated in Scottish 
waters. Long-finned pilot whales together with dwarf sperm whales are known 
to feed on cephalopods (Santos et al., 2006) and DA levels have been 
reported in the cephalopods digestive glands (Costa et al., 2005a). Other 
cetaceans such as the white-beaked dolphin (Lagenorhynchus albirostris) and 
the Atlantic white-sided dolphin (Lagenorhynchus acutus) feed on clupeids 
(e.g. herring), small mackerel, gadids (e.g. Atlantic cod and haddock and 
oceanic cephalopods (Das et al., 2000; Kinze et al., 1997)) which are all prey 
species in which toxins have been detected (see Chapter 3). 
 
4.1.3 Other toxins in stranded marine mammals 
 
From July to May 1997 around 117 Mediterranean monk seals died and 
neurotoxins from the PSP toxins group were found in the water and in some 
of the seals (Hernández et al., 1998). Okadaic acid (OA) was detected in 
stomach and intestinal contents of bottlenose dolphin (Fire et al., 2010b), a 
toxin known to cause gastrointestinal problems. In the same study DA and 
brevetoxin was detected in faecal material from a bottlenose dolphin, the 
study raises the question of the effect multiple toxin exposure can have in 
stranding events (Fire et al., 2010b). In a study by Capper et al. (2013) they 
discovered low concentrations of multiple toxins (OA and PSP toxins) in 
stranded manatees on Florida’s shoreline between December 2003 and 
February 2006. 
 
The overall aim of this chapter was therefore to investigate toxins from 
harmful algae in dead stranded fish eating top predators from around the 
Scottish coast. I focus mainly on DA to compare the results to the levels found 
in live captured harbour seals. Samples from dead stranded animals may give 
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a unique opportunity to investigate exposure in a wide variety of different 
species and to potentially assess any health effects, although the carcasses 
are often too decomposed for full necropsies to be carried out and cause of 
death to be established. 
 
4.2 Methods 
 
4.2.1 Sample collection from stranded marine mammals 
 
In collaboration with the Scottish Marine Mammal Stranding Scheme 
(SMASS), Scottish Rural University College, Inverness, faeces, urine and 
other body fluids (such as amniotic fluid) was collected from a variety of 
stranded marine mammal species (Fig. 4.1). Between 2008-2013 a total of 
166 samples from 136 individuals (includes 15 species) were analysed for 
toxins from harmful algae (Table 4.1). Phocids included in this study were 
harbour seals and grey seals. Cetaceans investigated in this study (hereafter 
referred to as “other cetacean”) included: long-finned pilot whales, Atlantic 
white-sided dolphin, bottlenose dolphin, common dolphin (Delphinus delphis), 
harbour porpoise, dwarf sperm whale, minke whale (Balaenoptera 
acutorostrata), sei whale (Balaenoptera borealis), Sowerby’s beaked whale 
(Mesoplodon bidens), sperm whale (Physeter macrocephalus), striped dolphin 
(Stenella coeruleoalba), white-beaked dolphin and unidentified pelagic 
delphinid (this includes one of the following: common dolphin, striped dolphin, 
white-beaked dolphin, Atlantic white-sided dolphin, Risso’s dolphin (Grampus 
griseus), long finned pilot whale or killer whale (Orcinus orca)). 
 
The samples represented 87 urine and 43 faecal samples together with: 15 
liver tissues, seven pericardial fluids, three stomach contents, three thoracic 
fluids, three amniotic fluids, two gastric fluids, two kidney tissues and one 
unidentified body fluid. Based on the amount of material available DA was 
prioritized to be extracted and then the other toxins of interest in this study, 
the PSP and lipophilic toxins (only faecal material). 
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Figure 4.1: Stranding locations of cetaceans and phocids in Scotland between 2008-2013, 
from which samples were obtained for biotoxin analyses. 
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4.2.2 DA extraction and quantification 
 
For extracting DA, 2-4 g of faecal material was homogenized and DA was 
extracted following the procedure in Chapter 2, section; 2.2.3.1 “Sample 
extraction”. Urine samples together with body fluids such as amniotic fluid, 
pericardial fluid and thoracic fluid were used directly in the assay. The 
samples were analysed using the same ASP Enzyme Linked Immunosorbent 
Assay (ELISA) method described in Chapter 2, section 2.2.3.2. The DA assay 
has been widely used to detect DA in various matrices including shellfish 
tissue and urine and faeces from marine mammals (Kleivdal et al., 2007b; 
Lefebvre et al., 1999). The LOQ is described in Chapter 2, section 2.2.3.2. 
 
4.2.3 STX extraction and quantification 
 
For STX extraction 2-4 g faecal material was extracted following the same 
method described in Chapter 2 section; 2.2.4.1 “Sample extraction” and 
protein was precipitated following the method in Chapter 2, section; 2.2.4.2 
“Protein precipitation”. STX was measured and quantified using the 
instrumentation described in Chapter 2 section; 2.2.3.5 “Instrumentation”. The 
LOQ is described in Chapter 2, section 2.2.3.5. 
 
4.2.4 OA and DTXs extraction and quantification 
 
To extract the lipophilic toxins faecal material were homogenised and 2 g 
subsampled, lipophilic toxins were extracted following the same method as 
described in chapter 2, section 2.2.5.1 “Sample extraction” and 2.2.5.2 
“Hydrolysis of Esterified Forms of OA, DTX-1, and DTX-2”. The extracts were 
measured and quantified using the instrumentation described in Chapter 2; 
section 2.2.5.3 “Instrumentation”. The LOQ is described in Chapter 2, section 
2.2.5.3. 
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4.3 Results 
 
4.3.1 Toxin exposure in stranded harbour seals 
 
A total of 17 stranded harbour seals were tested for DA in urine where ten 
(58.82 %) were above the LOQ. Eight of these samples stranded along the 
east coast of Scotland where six (75.0 %) were above LOQ. Four samples 
were collected around the Northern Isles where two (50 %) were above the 
LOQ. For the west coast, five harbour seal urine samples were analysed and 
20 % was above LOQ. The mean for the urine samples tested 0.0834 µg/ml 
(75 % quantile: 0.0352 µg/ml) and the highest urine sample measured for DA 
was from the Highlands with levels of 0.627 µg/ml (Fig. 4.2). 
 
 
Figure 4.2: Concentration of DA in urine (µg/ml) by species plotted on a logarithmic scale. 
The width of the box is proportional to the square root of the samples sizes and the box goes 
from the first quartile to the third quartile, whiskers represent the lowest and highest values 
still within 1.5 x IQR of DA and the black horizontal line indicates the median of the data set, 
separate circles are outliers 
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For the faecal samples fifteen samples were analysed for DA, where 13 of 
these came from the east coast, one from the Northern Isles and one from the 
west coast. Eleven samples were > LOQ (73.3 %). From the east coast 76.9 
% (n = 13) were above the LOQ. One of the faecal samples collected on the 
Northern Isles was > LOQ, and none from the west coast were above the 
LOQ. The mean for the faecal samples measured was 0.169 µg/g (75% 
quantile: 0.232 µg/g) and the highest faecal sample was collected from the 
east coast with 0.519 µg/g (Fig. 4.3). However, in a general linear model, with 
concentration as the dependent variable and area as a factor, there was no 
significant relationship between DA concentration in urine (Table 4.1, model 
1) and the region sampled. It was not possible to run any statistical models on 
the other matrices for harbour seals due to lack of data. Three females were 
found on the east coast dead with a foetus and neonatal exposure (measured 
in the thoracic, gastric or amniotic fluid together with faeces) occurred in all 
three cases. DA was detected in the mother and foetus with levels from 0.006 
to 0.164 µg/g DA in the faecal samples and in thoracic fluid (< LOD, 0.004 
µg/ml) and amniotic fluid (0.022 – 0.023 µg/ml) and gastric fluid (< LOD 
0.0004 µg/ml). DA was detected at low levels < LOD in pericardial fluid in a 
harbour seal from the east coast. 
 
Table 4.1: Regression model for dead stranded harbour seals seen by area for urine 
samples. 
Model Variable Residual 
deviance 
df fitted df P value AIC 
1. Area (urine) 19.55 2 16 0.4 25.55 
 
 
PSP toxin was detected in 2/4 of the harbour seal faecal samples tested, 
three of the samples were collected on the east coast and one was collected 
on the west coast. The two samples with PSP toxin were collected from the 
east coast with levels > LOQ at 12.00 – 18.00 µg STX eq/kg. Two harbour 
seal faecal samples was analysed for OA and DTX-2, one from the east coast 
and the other from the west coast. None of these faecal samples had any 
traces of OA or DTX-2. 
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Figure 4.3: Concentration of DA in faeces (µg/g) by species plotted on a logarithmic scale. 
The width of the box is proportional to the square root of the samples sizes and the box goes 
from the first quartile to the third quartile, whiskers represent the lowest and highest values 
still within 1.5 x IQR of DA and the black horizontal line indicates the median of the data set, 
separate circles are outliers. 
 
4.3.2 Toxin exposure in stranded grey seals 
 
DA was detected, but below the LOQ in three of the nine (33.3 %) faecal 
samples tested from grey seals (Fig. 4.3). Only two urine samples were 
available for analysis for DA where the level found was again below the LOQ 
(Fig. 4.2). Three pericardial fluid samples were available for DA analysis and 
two of the samples (66.7 %) were positive for DA concentration with levels 
above the LOQ at 0.030 µg/ml (Table 4.2). 
 
Two faecal samples from grey seals were analysed for PSP toxins and both 
were collected on the east coast. PSP toxins were detected in one of the two 
faecal samples analysed for the toxin with levels of 40 µg STX eq/kg. The 
same two faecal samples from the east coast were analysed for lipophilic 
toxins, where the one was found with DTX-2 levels of 0.002 µg/g. 
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4.3.3 Toxin exposure in stranded cetaceans 
 
There was one urine sample from an Atlantic white-sided dolphin with DA 
concentration of 0.031 µg/g (Fig. 4.2). One bottlenose dolphin urine sample 
was analysed for DA from the west coast, but the result was < LOQ. One 
striped dolphin urine sample was found < LOQ with DA levels at 0.003 µg/g 
and two samples from white beaked dolphins were analysed for DA where 
both were < LOQ (Table 4.2, Fig. 4.2). The fourth dolphin species analysed 
for DA in both urine and faeces from the east coast, was the common dolphin 
again with levels < LOQ (Table 4.2, Fig. 4.2). 
 
Thirty-one harbour porpoises was analysed for DA where fourteen urine 
samples were > LOQ for DA (DA range: 0.002 – 2.487 µg/ml, Table 4.2, Fig. 
4.2) and 13 of these 14 were found on the east coast and one was collected 
from the Northern Isles. Among the faecal samples 4/6 porpoises were found 
> LOQ (range: 0.006 – 0.120 µg/g, Table 4.2, Fig. 4.3), all of the samples 
were collected from the east coast. 
 
There was one whale from the family Kogia spp. where a urine sample was > 
LOQ with levels at 0.113 µg/ml DA (Table 4.2, Fig. 4.2), this whale was 
sampled on the west coast. Two minke whales were sampled and analysed 
for DA where two urine samples were < LOQ (DA: 0.0008-0.002 µg/ml), but 
one faecal sample was > LOQ with a concentration of 0.0099 µg/g (Table 4.2, 
Fig. 4.2). The faecal sample was also analysed for OA and PSP toxins where 
OA levels at 0.04 µg/g was found and no PSP toxins were found in the minke 
whale, this positive whale was sampled on the Northern Isles. Seven pelagic 
delphinids were sampled for DA, where urine samples revealed 
concentrations > LOQ for DA from three of the samples (DA range: 0.190 – 
0.275 µg/ml, Fig. 4.2), two of these samples were collected on the west coast 
and the third was collected from the Northern Isles. 
 
Of the 17 samples from the mass stranding of long-finned pilot whale in Kyle 
of Durness, two out of seven urine samples was > LOQ for DA (DA range: 
0.004 – 0.031 µg/g, Table 4.2, Fig. 4.2). Fourteen liver samples were tested 
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for DA and one was found with levels of 0.164 µg/g. Two stomach samples 
were analysed for DA where DA was detected with levels of between 0.017 – 
0.046 µg//g. One kidney samples was tested for DA where levels were < 
LOQ. Of the 21 long-finned pilot whales stranded in Pittenweem, thirteen 
urine samples were tested for DA where 5 (38.5 %) was found above the LOQ 
(DA range: 0.004 – 0.041 µg/ml, Table 4.2, Fig. 4.2). Three out of eight faecal 
samples from the Pittenweem stranding were > LOQ (37.5 %, Table 4.2, Fig. 
4.3), DA ranges: 0.013 – 0.080 µg/g. 
 
One pericardial fluid sample from a Sei whale was tested for DA and was 
found < LOQ, the whale was sampled at the east coast (Table 4.2). One urine 
sample from a Sowerby’s beaked whale sampled on the west coast was 
analysed for DA and was < LOQ, as was a urine sample from a sperm whale 
collected on the east coast (Table 4.2). 
 
 
Table 4.2: DA concentrations in stranded marine mammal species by matrix: urine, faeces, 
tissue (liver or kidney), stomach contents and other. Concentrations mean and (range) are 
expressed in µg/g or µg/ml. LOQ: limit of quantification, na: no sample available 
Species  n n 
(>LOQ) 
Urine 
(µg/ml) 
Faeces 
(µg/g) 
Liver/kid
ney 
(µg/g) 
Stomach 
(µg/g) 
Other* 
(µg/ml) 
Atlantic white-
sided dolphin 
1 1 0.031 na na na na 
Bottlenose 
dolphin 
1 1 0.001 na na na na 
Common 
dolphin 
1 0 <LOQ <LOQ na na na 
Grey seal 9 2 <LOQ <LOQ na na 0.020 
(0.030) 
Harbour 
porpoise 
41 15 0.097 
(0.0002-
2.488) 
0.015 
(0.002-
0.120) 
na na 0.030 
Harbour seal 28 14 0.083 
(0.003-
0.627) 
0.105 
(0.005-
0.519)  
na na 0.0156 
(0.004-
0.020) 
Dwarf sperm 
whale 
1 1 na 0.113 na na na 
Minke whale 2 1 <LOQ 0.010 na na na 
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*Including: pericardial fluid, gastric fluid, thoracic fluid and amniotic fluid 
 
4.4 Discussion 
 
DA has a rapid renal clearance and poor fat solubility, which makes DA 
exposure estimation very difficult and the concentrations in the various 
matrices difficult to interpret beyond identifying that animals have taken up the 
toxin. DA only remains in the tissues and urine for a few hours after ingestion 
of toxic prey and studies in monkey and rats shows that DA is primarily 
excreted in urine (Suzuki and Hierlihy, 1993; Tryphonas et al., 1990). DA 
clearance rate through a rats kidney is approximately 9 ml/min/kg body weight 
and it has a half-life of only 20 min (Suzuki and Hierlihy, 1993; Truelove and 
Iverson, 1994). Clearly the time lapse between exposure and stranding was 
not known nor is how much urine or faeces was voided before the individual 
seals or whales died. Some of the samples were also collected days after the 
stranding so natural degradation of DA might have occurred (Bouillon et al., 
2006). 
 
Pelagic 
delphinid 
7 3 0.011 
(0.002-
0.027) 
na na na na 
Long-finned 
pilot whale 
33 8 0.019 
(0.00004-
0.041) 
0.005 
(0.003-
0.080) 
0.012 
(0.00005-
0.164) 
(liver) 
0.0002 
(kidney) 
0.032 
(0.018-
0.046) 
na 
Sei whale 1 0 na na na na na 
Sowerby’s 
beaked whale 
1 0 na 0.6 na na na 
Sperm whale 1 0 na <LOQ na na na 
Striped 
dolphin 
1 0 na nd na na na 
White-beaked 
dolphin 
2 0 <LOQ nd na na na 
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4.4.1 DA in stranded harbour and grey seals 
 
The finding of DA in harbour seals and grey seals were not surprising as 
these are species that have been documented to be exposed to DA in 
Scotland (Chapter 2, S. Tarrant unpublished results). DA was found in low 
levels in both harbour and grey seals and the toxin is not thought to be the 
cause of their deaths as no lesions consistent with either acute of chronic DA 
toxicity in any of the seal brains submitted for histopathology between 2011-
2014 was found (J. Baily pers. comm). However only a very few brains were 
available for histopathology, given that most carcasses, particularly harbour 
seals were too decomposed for complete histology. 
 
The mean levels in the dead stranded harbour seal faecal samples collected 
(mean: 0.077 µg/g, 75 % quantile: 0.093 µg/g, Fig. 4.4) compared with those 
found in the live captured animals were much lower (mean: 0.591 ng/g, 95 % 
quantile: 0.016 µg/g, Fig. 4.4) and were significantly lower than in the 
anonymous faecal samples from the harbour seal haul out sites (mean: 4.238 
µg/g, 75 % quantile: 1.520 µg/g, Fig. 4.4). 
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Figure 4.4: Concentration of DA in faeces (µg/g) by live captured, stranded and anonymous 
faecal samples from harbour seals, plotted on a logarithmic scale. The width of the box is 
proportional to the square root of the samples sizes and the box goes from the first quartile to 
the third quartile, whiskers represent the lowest and highest values still within 1.5 x IQR of DA 
and the black horizontal line indicates the median of the data set, separate circles are 
outliers. 
 
Three pericardial fluid samples were analysed in grey seals where two were 
found with DA > LOQ and to my knowledge this is the first evidence that DA is 
detected in pericardial fluid. DA has been shown to be cardiotoxic as the heart 
is also one of the most affected organs in sea lions that died following DA 
intoxication (Gulland et al., 2002). In southern sea otters (Enhydra lutris 
nereis), DA has been looked upon as a risk factor in association with 
myocarditis and dilated cardiomyopathy (Kreuder et al., 2005). 
 
Neonatal exposure occurred in three cases where three dead female harbour 
seals were found on the east coast with a foetus and in all three cases DA 
was detected in the thoracic, gastric or amniotic fluid together with faecal 
samples from the foetus. Neonatal animals have been shown to be more 
susceptible to DA than adults (Brodie et al., 2006; Goldstein et al., 2009), 
possibly from insufficient renal clearance (Xi et al., 1997). Amniotic fluid has 
been shown to have a poor elimination of DA, where 8 days after stranding 
DA was still detectable in the amniotic fluid of a CSL (Brodie et al., 2006). In 
addition, studies suggest that DA also recirculates as pregnant rats takes 
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longer to eliminate DA, exposing the foetus to DA for a prolonged period 
(Maucher et al., 2012; Maucher and Ramsdell, 2005). In a study by McHuron 
et al., (2013) they found DA both in the stomach contents of stranded harbour 
seals (1.4 ng/g = 0.001 µg/g) and in the milk (2.2 ng/ml = 0.002 µg/g). This 
study together with McHuron et al., (2013) shows that DA can be detected in 
several fluids and matrices in phocids and although little is known about the 
metabolism of DA in phocids (see Chapter 6 for more information about DA 
clearance rate) it is likely that it, like other mammals, is rapidly excreted in the 
urine and faeces and is not metabolised given it is detectable as the parent 
molecule in these matrices (Chapter 2). The DA levels measured in urine and 
faecal samples collected from grey seals were < LOQ except in two cases 
where grey seals were shot in June and levels measured in the pericardial 
fluid were quantifiable. 
 
4.4.2 DA in stranded cetaceans 
 
This study provides evidence of DA exposure in several top predators, not 
only the harbour seals that are the focus of this thesis. Out of the 12 
cetaceans studied six species had DA levels > LOQ, although there was a low 
sample size for most cetaceans in this study. DA was detected in another five 
species indicating exposure although the levels were < LOQ. DA has been 
detected in cetaceans in several places around the world, such as during an 
UME in gray whales (Eschrichtius robustus) that occurred between 1999 and 
2000 (Gulland et al., 2005). During the UME grey whales stranded on the 
west coast of North America and DA was detected in serum, urine and faecal 
samples in a juvenile whale with levels in the urine and faeces of 1.6 and 0.52 
µg DA/ml substrate, respectively (Gulland et al., 2005). Conclusions from this 
study was that the juvenile grey whale probably died from DA intoxication 
although toxic doses for cetaceans have not been established (Truelove and 
Iverson, 1994). 
 
Toxins from harmful algae in stranded marine mammals were also reported 
by Fire et al., (2009), where they analysed several species of cetacean which 
included: the fin whale (Balaenoptera physalus), common dolphin, northern 
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right whale, pygmy killer whale (Feresa attenuata), Atlantic white-sided 
dolphin, humpback whale (Megaptera novaeangliae), Blainville’s beaked 
whale (Mesoplodon densirostris), melon-headed whale (Peponocephala 
electra), harbour porpoise, Stenella sp., bottlenose dolphin and Cuvier’s 
beaked whale (Ziphius cavirostris). None of these cetaceans were found 
exposed to DA or OA. In the same study stranded whales from the family 
Kogia spp., were documented with DA exposure (Fire et al., 2009). The whale 
from the family Kogia spp. in this study (dwarf sperm whale) was found 
exposed to DA with comparable levels to the study by Fire et al., (2009). In 
addition, a stranded minke whale was found after a severe harmful algal 
bloom in southern California where DA was detected in gastric fluid and 
faeces (DA: 258 µg/g) of the whale and otoliths from northern anchovy were 
recovered from the whales stomach (Fire et al., 2010a). 
 
The finding of DA in offshore feeders such as the dwarf sperm whale, sperm 
whales and long-finned pilot whale may be indicative of offshore blooms that 
are not currently being monitored, as all monitoring is inshore in Scotland. 
Although the majority of these samples were negative this is the first time DA 
has been detected in such a wide range of cetaceans in Scotland and 
questions, which prey are responsible for transferring the toxins to offshore 
species and how their foraging patterns and strategies may make them 
vulnerable to exposure. Thus, the lack of toxin analysis from potential offshore 
vectors is an obstacle to definitively explaining how the offshore feeders are 
exposed, but from Chapter 3 I demonstrate that inshore both pelagic and 
benthic fish species take up all three groups of toxins examined in this study. 
 
This study examines a range of different matrixes for the presence of DA, 
such as stomach contents, kidney, liver and different bodily fluids in which DA 
was detected (> LOQ) and these include amniotic, thoracic and pericardial 
fluid as well as liver and stomach contents. In a study by Gulland et al., (2000) 
they analysed for DA in stranded CSLs kidney, stomach washings, 
cerebrospinal fluid and brain samples and no DA was found in these samples. 
Interestingly, stranded bottlenose dolphins have been found exposed to DA 
with levels in the stomach content of 10 ng/g (0.010 µg/g), intestinal content 
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39 ng/g (0.039 µg/g) and faecal material 9 ng/g (0.009 µg/g) (Fire et al., 
2010b). This study shows that DA can be detected in various bodily fluids, 
many of which are worth investigating during a stranding event. 
The cause of death for the cetaceans were varied (pneumonia, physical 
trauma, starvation, live stranding or an bacterial infection), these were 
discussed and ruled out as an indirect cause of death correlated with the toxin 
exposure. In general although some of the seal and cetaceans samples were 
found > LOQ, the levels were so low that acute high level DA toxicosis could 
probably be ruled out as a cause of the stranding. 
 
4.4.3 Other toxins in marine mammals 
 
PSP toxins were detected in two harbour seal faecal samples, one harbour 
porpoise and one grey seal sample. The levels were low and are not thought 
to be the cause of their stranding. However, this is the first evidence that PSP 
toxins can be detected in grey seals and harbour porpoise. PSP toxins have 
been found in harbour seals from Scotland (see chapter 2). 
 
OA was detected in bottlenose dolphins in a study by Fire et al., (2010b) with 
levels in intestinal contents reaching 10 ng/g (0.010 µg/g). With only two 
samples analysed for OA, this toxin was detected in faecal samples > LOQ 
from a minke whale. This is the first evidence of OA in cetaceans in Scottish 
waters. DTX-2 was analysed for in two harbour seal faecal samples and two 
grey seal faecal samples, where one of the grey seal samples was collected 
at Tentsmuir on the east coast. This shows that not only harbour seals are 
exposed to multiple toxins, but also the larger grey seal.  
 
4.5 Conclusions 
 
Due to the fact that toxic doses for cetaceans have not been established, as 
well as the condition of the samples collected from animals stranded for an 
unspecified length of time, it is difficult to interpret what the DA levels in the 
samples represent for the health or cause of death of the animal. Sick animals 
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could feed in new areas and on species that they don’t normally consume, 
exposing them to novel agents such as these toxins. Malnourished animals 
may not have been feeding and this is likely to affect the results. 
 
Understanding the role and distribution of DA and other harmful algal toxins in 
the inshore and offshore food chain is important in order to understand the 
risk that these pose but it is clear that the range and distribution of toxins 
merits further investigation in future. Results from this study seem to suggest 
that there is a difference in the exposure to DA from the inshore feeders such 
as the harbour seal and the harbour porpoise with higher levels of DA, while 
the offshore feeders such as the sperm whale and the long-finned pilot whale 
have lower concentrations of DA.  
 
Future research should focus on offshore monitoring of phytoplankton species 
and their abundance and the DA exposure of vector prey items consumed by 
offshore feeders. Information about potential vectors can be analysed from 
otoliths and other hard parts collected in faecal samples and stomach 
contents. Potential synergistic effects of multiple toxins exposure are thought 
to lead to reduced fitness so studies on the effect of these toxins, especially in 
cetaceans are required. 
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Chapter 5 
 
5. Evidence for a biomarker of domoic acid exposure 
in phocid seals is equivocal 
 
 
5.1 Introduction 
 
5.1.1 Overview of the immune system in marine mammals 
 
Immunology in marine mammals is still a developing discipline and an 
understanding of the functioning of the immune system at the species level is 
important for studying and determining the general health of both individuals 
and populations. The immune system is highly complex and can be affected 
by many different extrinsic factors, such as stress, toxins and pollutants and 
intrinsic factors such as age and life history stage. It can also be used as a 
“biomarker system” for studying the impact of these effects and factors at 
various levels from individuals to populations (Vos et al., 2003), but this 
requires knowledge of what is ‘normal’ for a given species. The immune 
system is composed of two major parts: the innate (non-specific) immune 
system and the acquired (specific) immune system. When an organism is 
exposed to a foreign substance (known as an antigen), such as a microbe or 
a protein, the innate immune system is the first line of defence, where cells 
and proteins are ready to mobilize and fight antigens at the place of infection 
such as by phagocytosis. If an antigen is able to overcome the innate immune 
defence the acquired immune system starts working by proliferating, 
activating and creating mechanisms for eliminating antigens. 
 
Immunoglobulins (Ig or antibodies) and lymphocytes comprise the major part 
of the acquired immune system and are responsible for long-term protection 
in case of re-exposure to the same or a similar antigen. In mammalian serum 
there are five immunoglobulin classes of antibody molecules: IgG, IgM, IgA 
and of less importance IgE and IgD. Lymphocytes play an important role and 
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are divided into B and T-lymphocytes. B-lymphocytes (humoral immunity) 
produce antibodies and each B-lymphocyte is programmed to make one 
specific antibody. When a B-lymphocyte comes across an antigen it gives rise 
to larger plasma cells where each plasma cell produces antibodies. When an 
antibody and an antigen interlink, the B-lymphocytes are incapable of entering 
the cell so destruction of these target cells is left to the T-lymphocytes (cell-
mediated immunity) (Vos et al., 2003). T-lymphocytes are programmed to 
remember, recognize and respond to antigens. T-lymphocytes have two roles 
in the immune defence: the first involves direction and regulation of other 
immune response pathways, and the second is to directly attack antigens 
(Paul, 1993). Of particular interest to this study are the antibodies and many 
have been partly purified and described in several marine mammal species 
(Boyden and Gemeroy, 1950; Cavagnolo, 1979; King et al., 1993; Travis and 
Sanders, 1972). Antibodies are made up of two important components, light 
chain and heavy chain proteins, these form the base of the antibody which 
form a Y-shaped structure. The tip of the Y shaped form is unique for each 
antibody structure (Nash and Mach, 1971). 
 
5.1.2 Immunoglobulin Classes in Pinnipeds 
 
As early as the 1970’s attempts were made to classify and characterize 
pinniped immunoglobulins from sera (Nash and Mach, 1971) where they 
concluded that proteins in pinnipeds were homologous to human 
immunoglobulins IgG, IgA and IgM. IgG are the smallest and most common 
antibodies found. In general IgG is produced in a delayed response to an 
infection and can be detected in the body for a longer period with a half life of 
25.8 days (Mankarious et al., 1988) and interestingly the amount of IgG in 
pinnipeds seem to be significantly higher compared to terrestrial carnivores. 
IgA is a neutralizing antibody, which prevents invading pathogens and act as 
a first line defence against antigens, it is the second most common 
immunoglobulin in serum. IgM forms a large part of the antibodies and is the 
first class of antibodies produced by foetuses and when an antibody response 
occurs (King et al., 1994; Paul, 1993). 
 151 
5.1.3 Low level (chronic) domoic acid exposure in pinnipeds 
 
Domoic acid is a naturally occurring neurotoxic amino acid produced by 
microscopic marine algae such as the diatom Pseudo-nitzschia. High-level 
exposure through contaminated fish has had a significant impact on marine 
mammals (Lefebvre et al., 1999). Although much less is known about low-
level or chronic exposure to DA, CSLs seem to experience heart disease, 
chronic epilepsy and reproductive failure that could be a result of longer-term 
exposure to the algal toxin (Gulland et al., 2002; Lefebvre et al., 1999; Scholin 
et al., 2000; Silvagni et al., 2005). A study by Hiolski et al., (2014) discovered 
that low-level repeated exposure to DA can alter gene transcription in 
zebrafish (Danio rerio, AB strain), and impair the mitochondrial function in the 
brain. Pacific harbour seals were found to be exposed to DA and had brain 
lesions consistent with DA toxicosis (McHuron et al., 2013), however it was 
unclear whether the seals in the study were experiencing acute or chronic 
exposure to DA. 
 
Thus distinguishing between acute and chronic exposure is important but is 
not possible from concentrations in excreta alone. Urine and faecal samples 
dated back to 2008 indicate that Scottish harbour seals are probably now 
exposed to DA on an annual basis (Chapter 2 and (Hall and Frame, 2010)). 
The levels found in both the urine and faecal samples are in the lower range 
of those found in the chronically exposed CSLs, but higher than 
concentrations found in Pacific harbour seals. It is unclear how exposure 
levels relate to acute or chronic DA toxicosis in Scottish harbour seals, but it 
seems likely that populations are experiencing a chronic low-level, repeated 
exposure to DA (see Chapter 2). It is therefore important to have an efficient 
and rapid diagnostic test to assess toxin exposure, particularly for predicting 
what effects might be seen at the population level as the frequency and 
intensity of HABs seem to be increasing world-wide (Hallegraeff, 1993). 
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5.1.4 Domoic acid specific natural antibody 
 
Lefebvre et al., (2012) recently published a study where they reported a 
method to detect chronic, low-level exposure to DA. They found that a novel 
DA-specific immunoglobulin G (IgG, here referred to as DA-specific antibody) 
response could be used as an indicator for this category of exposure. This 
DA-specific antibody was first discovered in zebrafish that was used as a 
vertebrate model in the experiment. The fish were exposed to DA via 
intracoelomic (IC) injection two to four times every month (over a nine month 
period). After 18 weeks an immune response occurred in the fish, after the 
DA-specific antibody was seen to increase although the zebrafish seemed 
healthy. Since the finding of the DA-specific antibody, samples from naturally 
DA exposed wild CSLs were examined and the DA specific antibody was 
found in their serum samples. The results of the zebrafish experiment 
indicated that chronic low-level exposure to DA does not build resistance to 
the effects of DA, as would be expected if the antibodies were functioning as 
perhaps expected and as they do in response to pathogen exposure. Instead 
chronic exposure increased neurologic sensitivity to DA as the chronically 
exposed zebrafish (i.e. those that developed DA specific antibodies) were 
found to be three times more sensitive to DA than the naively exposed zebra 
fish (Lefebvre et al., 2012). If this effect is consistent across taxa, it has very 
important implications for determining, understanding and predicting the effect 
of low-level chronic DA exposure in harbour seals and indeed other 
piscivorous marine mammals.  It was therefore important for me to replicate 
this method using samples from Scottish harbour seals that have been 
collected and archived at SMRU since before the start of the observed decline 
in abundance. 
 
5.1.5 Enzyme linked immunosorbent assays (ELISA) 
 
Enzyme linked immunosorbent assays (ELISA) are highly sensitive 
immunoassays that can be used to detect antibodies and other proteins in 
blood samples (Butler, 2000).  They can be designed to detect and quantify 
peptides, proteins, bacterial antigens, hormones and antibodies. In the assay 
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an antigen must be immobilized to a solid surface and then exposed to a 
specific monoclonal or polyclonal antibody conjugated with an enzyme. 
Enzyme-labelled antibodies have been used for many years for detecting 
antigens (Butler, 2000) and the assay quantifies the amount of antigen in a 
sample by assessing the conjugated enzyme activity through incubation with 
a substrate that produces a measurable product, such as optical density 
(Butler, 2000). There are generally three main methods that form the types of 
ELISAs, indirect ELISA, direct ELISA and sandwich ELISA. Indirect ELISAs 
(or iELISA) involve two binding processes where the primary antibody is 
incubated with the antigen involved, followed by incubation of a labelled 
secondary antibody (Crowther, 1995; Crowther and Walker, 2009). A direct 
ELISA assay involves adsorption of an antigen to a plastic plate where a 
protein (normally bovine serum albumin) is added to the plate to block out 
additional binding sites on the plate. There is no secondary antibody and the 
primary antibody is linked to the detection enzyme (Crowther and Walker, 
2009). The most sensitive ELISA method is the sandwich ELISA and has the 
name because the method quantifies the antigens, which is captured between 
two layers of antibodies (the capture antibody and the detection antibody) 
(Crowther and Walker, 2009). 
 
5.1.6 Aims of study 
 
The objective of this study was therefore to use the iELISA assay modified 
and suggested by Lefebvre et al., (2012) to investigate if Scottish harbour 
seals had been historically exposed to DA by using archived serum samples. I 
wanted to determine if there is a pattern of antibody development around the 
same time as the harbour seal decline was detected (around year 2000). The 
results would provide further information on the potential link between the 
decline and the uptake of DA, both temporally and spatially.  The main aims of 
this study were therefore to firstly verify and replicate the published method by 
using sera from some of the same individuals as in the Lefebvre et al., (2012) 
study and secondly apply the approach to phocid seals, particularly focusing 
on harbour seals with the aim of determining whether exposure rates 
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(estimated from the prevalence of these DA antibodies in the samples) have 
increased over the same time frame as the decline in abundance. Samples 
were also available from the other phocid species found in UK waters, the 
grey seal. Investigation of the presence of these DA specific antibodies in 
grey seals will also be examined, as current evidence suggest they are less 
exposed to DA (S. Tarrant unpublished data). Finally, commercially available 
dog serum from laboratory animals was included as additional quality control 
samples. 
 
5.2 Method 
 
5.2.1 CSL and dog serum samples 
 
Three California sea lion serum samples were sent from the Marine Mammal 
Centre, Sausalito, CA, US to the SMRU, UK laboratory. These three samples 
were identical to the samples in the study published by Lefebvre et al., (2012) 
and would be used to replicate and verify the method. 
 
Unfortunately, I did not obtain the identical control samples (sea lion serum 
from healthy sea lions born and raised in captivity at Sealife Park Hawaii) 
used in the Lefebvre et al., (2012) study for method validation control. 
Therefore, other negative controls were substituted such as commercially 
available dog reference serum (from the Laboratory of Cellular Physiology, 
National Heart Institute, National Institutes of Health, United States Public 
Health Service, Bethesda, Maryland) stored at -20 °C was used as a quality 
control as this serum is collected from pathogen free laboratory animals that 
would not have been exposed to DA. 
 
5.2.2 Phocid serum samples 
 
Serum samples from harbour and grey seals collected by the Sea Mammal 
Research Unit under the UK Animal (Scientific Procedures) Act 1986, Project 
and Personal Licenses were available for evaluation. 
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5.2.3 Negative controls - IgG removal and dilution curve 
 
In the Lefebvre et al., (2012) study they detected a DA specific antibody of 
subclass IgG, so in order to validate the method and provide important 
negative controls, both serum albumin and IgG were removed from the 
respective serum samples from the different species in the study. This was 
also carried out to test for matrix effects to see if there was anything (except 
antibodies), in the serum samples that could interfere with the modified assay. 
Removal was carried out using the Thermo Scientific Pierce® Albumin/IgG 
Removal Kit (product nr. 89875) following the manufacturer’s instructions. The 
kit contains a resin mixture of immobilized cibacron blue that binds to the 
serum albumin and protein A that binds to many species and subclasses of 
IgG including harbour seals (Swart et al., 1995). The filtrate, containing 
sample with albumin and IgG removed was used for immediate iELISA 
analysis, this providing a useful negative control. In addition to the IgG 
removal samples, an antibody serum dilution curve was carried out with a 
heavy chain secondary antibody in order to quantify the magnitude of any 
change in absorbance ratio for the different species tested. This would also 
assist in assessing whether serum dilution would indicate a change in the 
assay response. Dilution curves was not reported in the Lefebvre et al., 
(2012) study. 
 
5.2.4 Indirect ELISAs for Domoic acid-Specific Antibody Detection in serum 
 
This method had been modified using the ASP ELISA assay from Biosense, 
(ASP ELISA assay kits, Biosense, Bergen, Norway), where detection of DA-
specific sea lion IgG was investigated by using the DA conjugated 96-wells 
plate (Fig. 5.1). Serum is added to the well and any DA-specific antibodies 
present in the serum are allowed to bind to the DA conjugated to the plate 
well. After washing, a 1:5 000 and a 1:10 000 dilution of two different 
horseradish peroxidase (HRP) labelled anti-canine IgG’s (heavy chain and 
light chain: Bethyl Laboratories Inc., Montgomery, Texas, USA) which are 
known to cross-react with (Capers, 2006; Colvocoresses, 2004) were tested 
to determine whether there was any difference in binding between these two 
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detecting antibodies. The HRP labelled anti-canine IgG was incubated for 90 
min to allow it to bind to the DA specific antibody in the serum. The plate was 
washed for a second time to remove any unbound HRP labelled anti-canine 
IgG. Tetramethylbenzidine (TMB) was added which acts as a visualizing 
reagent designed to react to the bound HRP labelled anti-canine IgG (Fig. 
5.2). The plate was left to incubate in the dark for 30 min and the optical 
density was measured in an automatic microplate reader at 450 nm (OD450) 
(Lefebvre et al., 2012). Absorbance ratios were calculated to compare the 
results with the Lefebvre et al., (2012) publication, this was carried out 
following the published method where the absorbance of the serum sample 
(X) was divided by the mean control serum absorbance plus three times its 
standard deviation (SD). 
 
 
Figure 5.1: Assay summary for the original ASP ELISA DA (Biosense) detection method. 
Adapted and modified from the Biosense protocol. 
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Figure 5.2: Summary of the modified assay which is an Indirect ELISAs (iELISA) for Domoic 
acid-Specific Antibody detection in pinniped serum, modified from the ASP ELISA as shown 
in Figure 5.1. 
 
5.2.5 Blockage of nonspecific binding sites 
 
A separate trial was carried out to remove any interfering binding proteins that 
might be present in the serum sample by using a bovine serum albumin buffer 
(BSA) (Sigma-Aldrich, Lot #41K1645). BSA is known for its stability and lack 
of interference with biological reactions and are thought to prevent nonspecific 
antibody binding by hindering hydrophobic interaction between proteins and 
ionic interactions (Renshaw, 2007). 
 
5.3 Results 
 
5.3.1 Validation of iELISA assay (CSL and reference dog serum) 
 
For the validation of the published method a trial was carried out according to 
the publication by Lefebvre et. al., (2012) using CSL serum samples. The first 
trial revealed a nineteen times higher absorbance ratio in all the three 
replicates provided by The Marine Mammal Center than published by 
Lefevbre et al., (2012) (mean of duplicates, Table 5.1). Thus, some 
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modification was made to the method in an effort to reduce these ratios. To 
block out any interfering proteins, a BSA buffer was added. The buffer 
reduced the optical density and the absorbance ratio decreased –by up to 
92.6 % to 1.44 which is a comparable ratio to those that had been published 
(see all in Table 5.1). Then the total IgG and albumin were removed to 
provide a negative sample.  Removing the IgG decreased the absorbance 
ratio by another 11.1 % (Table 5.1), however according to Lefebvre et al., 
(2012) if the absorbance ratio is >1 the sample is still positive for DA. 
 
To rule out binding or interference with the HRP labelled anti-canine 
antibodies I first ran the assay with the anti-canine antibodies at 1:5 000 and 
1:10 000 alone with no serum added. These secondary antibodies had no 
interference with the modified assay as the absorbance ratio was close to 
zero (Table 5.2). 
 
BSA buffer was also tested in the modified assay, alone and together with the 
HRP labelled anti-canine antibody. It did not interfere with the modified assay, 
as the absorbance ratio was very low and similar to the results obtained from 
the blanks 0.21 ± 0.2 (Table 5.2). The anti-canine IgG or the BSA buffer did 
not bind to the plate-well and can both be ruled out as potential interference 
factors, in terms of falsely increasing the absorbance ratio. 
 
The reference dog serum had the highest absorbance ratio of all the serum 
tested > 18.29 (Table 5.1). From the results it appears that when the HRP 
labelled anti-canine IgG was diluted to 1:10 000 the absorbance decreased 
slightly and when the IgG was removed completely the absorbance 
decreased nineteen times (Table 5.1). 
 
5.3.2 Trial of DA-specific antibody detection in phocid serum samples 
 
To further investigate true DA-specific antibody presence in the samples of 
interest to this research, serum from harbour seal pups and harbour seal 
adults together with grey seal pups was assayed following the same method 
as published by Lefebvre et al., (2012) at a 1:5 000 and 1:10 000 dilutions of 
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the HRP labelled anti-canine IgGs. The harbour seal pup serum revealed a 
high absorbance ratio > 5.45 (Table 5.3), where Lefebvre stated that values 
>1 indicate presence of DA-specific antibodies. The grey seals had a lower 
absorbance ratio than the harbour seals < 2.53 (Table 5.3), but according to 
Lefebvre criteria, with detection of DA-specific antibodies. 
 
5.3.3 Negative control trial 
 
Mean absorbance ratio among the CSLs control samples (all serum tested 
stripped of IgG and albumin) was 0.18 ± 0.2 (SD). These samples were used 
as a control to see if any additional proteins in the serum or the buffer were 
interacting with the ASP ELISA kit components or binding to the plate-well. 
Additional blanks (n = 9) were treated with all the kits components, but had no 
added serum and revealed a mean absorbance ratio of 0.23 ± 3 (SD) (Table 
5.2). Both the control sample and the blanks did not bind or interfere with the 
plate-well or assay. Hyperbolic serum dilution curves measuring levels from 
high to low was expected and documented in the CSL and harbour seal 
serum (Table 5.4, Fig 5.3), although the grey seal serum had a flatter curve 
which was unexpected. 
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Table 5.1: Absorbance ratio of serum samples of California Sea Lion (CSL) tested for DA 
specific antibodies using an indirect enzyme-linked immunosorbent assay (iELISA) at 1:5 000 
and 1:10 000 dilution of the secondary antibody. Absorbance Ratio = sample serum 
absorbance - (mean control serum absorbance+3SD); Values >1 indicate presence of DA-
specific antibody. 
CSL - ID # 1:5 000 
*with BSA **IgG removed 
1:10 000 
*with BSA 
10046 (Lefebvre) 1.23 n.a 
10046 (replicate) 19.44 / 1.44* / 1.16** 12.65 / 0.39* 
10047 (Lefebvre) 1.72 n.a 
10047 (replicate) 19.12 / 1.38* / 1.14** 17.30 / 0.33* 
9759 (Lefebvre) 9.88 n.a 
9759 (replicate) 19.72 / 1.27** n.a 
Reference dog 19.94 / 1.80** 18.29 
 
 
Table 5.2: Absorbance ratio bovine serum albumin (BSA), HRP labelled anti-canine IgG and 
blanks tested for DA specific antibodies via an indirect enzyme-linked immunosorbent assay 
(iELISA) at 1:5 000 and 1:10 000 dilution. Absorbance Ratio = sample serum absorbance - 
(mean control serum absorbance+3SD); Values >1 indicate presence of DA-specific antibody. 
Other 1:5 000 
**IgG removed 
1:10 000 Blank 1 / 2 / 3 
HRP anti-canine IgG 
light chain 
0.21 0.22  
HRP anti-canine IgG 
heavy chain 
0.21 0.21  
BSA buffer 0.22 n.a  
BSA buffer + HRP anti-
canine IgG 
0.33 n.a  
Blank 1 / 2 / 3 
4 / 5 / 6  
7 / 8 / 9 
  0.23 / 0.22 / 0.21 
0.21 / 0.21 / 0.23 
0.21 / 0.21 / 0.23 
BSA 0.23 n.a  
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Table 5.3: Absorbance ratio of serum samples of harbour seals (PV) and Grey seals (Hg) and 
reference dog serum tested for DA specific antibodies via an indirect enzyme-linked 
immunosorbent assay (iELISA) at 1:5 000 and 1:10 000 dilutions. Absorbance Ratio = sample 
serum absorbance - (mean control serum absorbance+3SD); Values >1 indicate presence of 
DA-specific antibody 
Harbour seal (Pv) 
Grey seal (Hg) - ID # 
1:5 000 
*with BSA **IgG removed 
1:10 000 
*with BSA 
 
Pv  
  
11718 11.82 5.74 / 2.10* 
60266 11.17 1.20 / 0.90* 
76481 5.45 / 2.30* / 1.89** n.a 
 
Hg 
  
58737/2 2.61 / 1.56* / 0.72** 1.77 
58753/4 2.53 / 1.45* / 0.57** 1.72 
 
 
Table 5.4: Absorbance ratio of serum samples diluted from 1:1 to 1:16 from CSL, PV and Hg 
 
Sample 
Dilution curve 
1:1 1:2 1:4 1:8 1:16 
Grey seal 0.68 0.54 0.50 0.69 0.73 
Harbour seal 2.20 1.62 1.23 0.92 0.83 
California sea lion 1.60 1.14 0.98 0.77 0.64 
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Figure 5.3: Dilution curve from 1:1 to 1:16 of the selected species tested for the magnitude of 
change in absorbance ratios. 
 
 
5.4 Discussion 
 
5.4.1 Failure to replicate iELISA results using CSL and dog reference serum 
 
From the results of this study we were unable to replicate and validate the 
findings of Lefebvre et al., (2012) using the same serum samples. This could 
be for a number of reasons: 
 
1) The samples sent from TMMC were contaminated or serum proteins 
and binding sites were damaged due to defrosting during the 
transportation process 
2) The BSA might have blocked out some the specific binding sites when 
testing the CSL serum which would give another absorbance ratio 
3) After removing all the IgG from the sample, the absorbance ratio was 
almost the same as when adding the BSA to the assay, indicating there 
was no binding of IgG (or other proteins) when adding BSA which lead 
to the conclusion that the assay is not detecting IgG 
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Although these reasons could interfere with the assay, evidence from this 
study suggests that the modified assay is not detecting DA specific 
antibodies. 
 
The study by Lefebvre et al., (2012) found evidence, through whole-genome 
microarray profiling and up regulation of immune-relevant genes, that zebra 
fish undergo an immune response to the sub-acute repetitive DA dose regime 
carried out in the study. Domoic acid is a small water-soluble amino acid and 
a neurotoxin. It is doubtful that a small amino acid such as DA alone could 
trigger the humoral immune system to produce antibodies (Lefebvre et al., 
2012) and it has been suggested that DA could be binding to a larger protein 
and thus has the potential to be antigenic. It has been shown that specific 
humoral immune responses do occur against small haptens (small molecules 
that can elicit an immune response when attached to a larger carrier protein) 
that are similar in size to DA when linked to a serum protein, or a larger carrier 
protein for immunogenicity (Yoshida et al., 1970). Haptens have the property 
of antigenicity but not immunogenicity. 
 
The ASP Biosense assay is designed to detect free DA in a sample, and free 
DA is known to occur in serum (Truelove and Iverson, 1994). Free DA in 
serum could potentially interfere with the modified assay and interact with the 
DA specific antibodies (if indeed they have been generated). In the Lefebvre 
et al., (2012) study they had three CSLs with no clinical signs of DA-induced 
excitotoxicity (e.g. seizures), this is the only evidence used to suggest that 
these CSLs were experiencing a low level chronic DA exposure. It has been 
suggested that most of the free DA in monkeys is cleared out of their serum 
after 30 min (Truelove and Iverson, 1994), but no studies have been carried 
out in CSL to measure this. From the results presented in Chapter 6 DA is 
cleared by harbour seals after 10 hours. If this were the case for CSLs there is 
a possibility that free DA is present in some of the serum samples, as there is 
no evidence from the published study that excludes any potential free DA in 
the CSL serum samples. There is a possibility that if the DA specific 
antibodies were binding to the DA conjugate on the ASP ELISA plate well 
then the DA specific antibodies would compete with any free DA in the serum 
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and bind to either of them. If a binding of free DA in the serum and DA specific 
antibodies occurred, these would go undetected, as they would be washed 
out in the washing step and thus free DA could potentially interfere with the 
modified assay. Although this doesn’t explain why I didn’t get the same result 
by using the same samples, and although I continued to test this assay with 
other samples I were sceptical about this reliability. The reference dog serum 
had the highest optical density measured of all samples in this study. 
Reasons why will be discussed further in the discussion. 
 
5.4.2 DA specific antibodies in phocid seals 
 
One of the harbour seal serum samples was collected from an animal in 
Rødsand in Denmark, an area where toxic phytoplankton blooms are 
uncommon (Anderson et al., 2001). This serum sample was selected as a 
possible harbour seal ‘control’ due to the low toxic activity in the region and 
therefore the expectation that it would be negative. In addition, harbour seal 
pup serum samples from Lismore on the west coast of Scotland were tested.  
These animals might also be expected to be naïve as they were all neonates. 
According to Lefebvre et al., (2012), an immune response towards DA starts 
after  approximately 18 weeks of exposure and DA specific antibody 
production increases after 24 weeks. Harbour seal females give birth and 
nurse their pups on land and fast during the beginning of the lactation period 
(Thompson et al., 1994) and although maternal transfer of DA is known to 
occur (Maucher and Ramsdell, 2005; Rust et al., 2014), the west coast is an 
area where the seals are unlikely to be chronically exposed to DA (See 
Chapter 2). It would be very unlikely for these pups to have developed DA 
specific antibodies as they are weaned after four weeks and would be 
sampled within this time period when they only get milk from their mother. 
Studies of antibodies transfer from mother to milk has been carried out in 
several marine mammals for example: northern fur seal and harbour seal 
pups, where they found a slow increase of IgG during the first four months of 
the pups life (Cavagnolo, 1979; Ross et al., 1993). We can therefore assume 
that potential DA specific antibodies would be unlikely transferred from mother 
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to pup in a high volume. Grey seal serum samples were chosen as another 
phocid control sample as they have shown to have low levels of DA (Tarrant 
et al. 2014 unpublished results) and would again be unlikely to have 
developed DA specific antibodies. However, these assumptions are based on 
limited knowledge of actual exposure and if the CSL samples were validated 
and the dog serum had been negative then I would have concluded that these 
samples also contained DA-specific antibodies. The serum dilution curve 
confirms some antibody binding, as the binding decreased with the dilution 
concentration. 
 
5.4.3 Validation of iELISA assay 
 
The ASP ELISA assay from Biosense is not designed to detect DA specific 
antibodies, the assay is designed to detect free DA in shellfish samples 
(Kleivdal et al., 2007a), and has been used to detect free DA in urine and 
faecal samples from marine mammals although urine samples have shown to 
be a difficult matrix to analyse with high coefficient of variation probably due to 
the salt content (Seubert et al., 2014). The ASP ELISA plate-well contains 
conjugated DA, proteins and blocker (C. Miles, ASP ELISA developer pers. 
comm.). 
 
Since all our serum samples had a higher absorbance ratio than was 
measured in CSLs, it is more likely that a non-specific IgG is binding to the 
conjugated DA, the protein or the blocker coated on the plate-well. There is no 
evidence in the Lefebvre et al., (2012) study that they removed any non-
specific IgG antibodies from the samples they analysed. 
 
The HRP labelled anti-canine IgG is designed to bind to dog IgG, but it is 
known to bind to IgG from other species (Capers, 2006; Colvocoresses, 2004) 
and this study confirmed there was no interference in terms of higher 
absorbance ratio from this detecting antibody for both the heavy and light 
chain variants. The HRP labelled anti-canine IgG has an enzyme label, where 
a colour is produced after incubation with a substrate. The optical density is 
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measured using a spectrophotometer, and a reaction is only possible if the 
HRP labelled anti-canine IgG has bound to an antibody on the plate-well. If 
these antibodies were DA specific a reaction would not occur in the reference 
dog serum. The reason for the high absorbance in the reference dog serum is 
likely due to the fact that the HRP labelled anti-canine IgG has a higher affinity 
to the dog than any other species since it is the homologous species. 
 
5.4.4 Evidence of method failure 
 
1) The reference dog serum would not have been exposed to DA, therefore 
finding a high absorbance ratio measured in the serum indicates binding of 
non-specific IgG to the DA conjugate coated on the plate-well. This was 
confirmed when all the IgG was removed from the dog sera and the 
absorbance ratio decreased nineteen times to ~1.8. 
 
2) The BSA buffer is designed to block any non-specific protein binding sites 
and although it decreased the absorbance ratio (for example in the CSL sera 
from 19.44 to a comparable level of 1.44, where Lefebvre et al., (2012) 
reported the same sample to have an absorbance ratio of 1.16) it does not 
confirm that DA-specific antibodies are the antibodies binding. This 
highlighted the need to include critical controls to ensure the true binding of 
any naturally occurring DA-specific antibodies. 
 
3) As mentioned in the Methods section, the blanks were treated with all the 
ASP ELISA kit components and the steps of the assay followed as for the 
other samples but the blank wells did not include any serum. The blanks 
would indicate if anything was interfering from the kit.  Since the absorbance 
ratio was low between 0.23 and 0.21, this implied no interference from the kit 
components. 
 
4) The HRP-labelled anti-canine IgG was tested alone and with the BSA 
buffer to rule out any binding to the DA conjugate coated on the plate-well. 
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Both these tests revealed a low absorbance ratio also around 0.2, which 
would indicate no binding. 
 
5.5 Conclusions 
 
Results from this study reveal that if DA specific antibodies are present the 
modified assay method published by Lefebvre et al., (2012) is either difficult to 
replicate and validate or it is detecting an unrelated protein (or proteins) 
present in canids and phocids. One interpretation of the findings reported here 
is that they indicate binding to a non-specific IgG. There seem to be some 
fundamental issues with the assay design. At this stage it would not be 
recommended that this modified method be used without further research to 
analyse serum samples for DA-specific antibodies in pinnipeds. It could be the 
case that DA specific antibodies are only possible (at this stage) to measure 
in serum of zebrafish, which was the model used for the Lefebvre et al., 
(2012) study. Future studies should concentrate on using purified IgG from 
known exposed animals and develop a method that specifically can detect 
any DA specific antibodies. 
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Chapter 6 
 
6. Biomarker for domoic acid clearance in harbour 
seals 
 
 
6.1 Domoic acid clearance rate in harbour seals  
 
6.1.1 Introduction 
 
Pharmco- or toxicokinetics (PK or TK) is the study of the absorption, 
distribution and metabolism of substances (drugs or toxins) in the body. This 
discipline therefore involves studying the time course of a drug or toxin in 
various body compartments (Hedaya, 2012). Pharmacokinetics generally 
models the doses of therapeutic drugs so they will be efficient and produce 
the desired response and not be given at doses high enough to cause toxicity. 
Understanding the movement of drugs or toxins and how they are 
metabolised by the body involves two aspects a) empirical data from time-
course dosing studies and b) mathematical models, which estimate various 
kinetic parameters, allowing researchers to determine the pathways and 
physiological impacts the drugs or toxins may have. In the first stage, the 
dosing studies, most PK studies use intravenous dosing (either with the drug 
itself or a surrogate marker compound), although oral dosing and other routes 
can also be used. Often the route of exposure for the drug or toxin of interest 
is chosen but for oral dosing some information about the bioavailability (i.e. 
the fraction of the drug or toxin that is absorbed or stored by the body and 
how much is just eliminated unchanged) of the compound is required. The 
metabolism and elimination rates can then be estimated by collecting blood or 
urine samples at timed intervals from when the compound was administered 
and measuring the amount of the compound present in those samples. Using 
plasma or serum samples in dosing studies is the most common way of 
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investigating a drug in PK models, because whole blood with the different 
cellular elements becomes too complex (Hedaya, 2012). 
 
6.1.2 Pharmacokinetic parameters 
 
There are several key parameters that are required in the second stage of the 
process, the PK models, and these are: 
• Maximum drug or toxin concentration (Cmax)  
• Time of maximum concentration (Tmax)  
• Elimination rate constant (ke)  
• Systemic clearance (Cl)  
• Elimination half-life (T1/2)  
• Area under the drug/toxin concentration versus time curve (AUC)  
• Volume of distribution (Vd) 
• Bioavailability (F) 
 
After the administration of a drug or marker compound, a maximum 
concentration (Cmax) is reached in the circulation, the time the compound 
takes for the concentration to be reached is referred to as Tmax. The 
elimination rate constant (ke) is a description of a compound that follows first-
order kinetics (elimination of the compound is directly proportional its 
concentration) (per unit of time). The elimination rate constant is related to two 
other parameters, clearance (Cl) which measures the time it takes for the drug 
or compound to be excreted from the body (per unit time) and the half-life 
(T1/2) describes the time it takes for a drug to decrease by 50 % of the current 
concentration, most drugs have several half-lives. Pharmacokinetic modelling 
is performed by either non-compartmental or compartmental methods. A non-
compartmental model requires fewer assumptions and calculates the 
exposure to a drug by estimating the area under the drug concentration 
versus time curve (AUC), the AUC (Fig. 6.1) is used to calculate the overall 
clearance of a drug or compound (Buxton, 2006). Bioavailability (F) describes 
the rate and extent to which a drug enters the body and becomes available at 
the site of action. Bioavailability ranges in value from 0 – 100 % which 
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corresponds to the proportion that has reached the systemic circulation 
(Hacker et al., 2009). Drugs that are given intravenously (iv) are the most 
efficient and have a bioavailability of 100 %, while other administrated doses 
weather it is orally, subcutaneous, intramuscular, nasal, inhaled, sublingual or 
transdermal the bioavailability ranges between 0 – 100 %. 
 
 
Figure 6.1: Determination of bioavailability of a drug, adapted from Hedaya (2012). 
 
To calculate the bioavailability parameter following an oral administration of a 
drug, the rate of drug concentration (AUC) after an oral dose is compared with 
an intravenously (iv) dose (Equation 1). 
 Equation  1:  𝐹 = !"#(!"#$)!"#  (!")   
 
When an animal is exposed to a drug or a toxin before the previous exposure 
(dose) is completely removed, accumulation occurs. This means that the 
resulting concentration will be higher. Steady state (Fig. 6.2) is an important 
parameter and can be defined as when the rate of drug or toxin input is equal 
to the rate of drug elimination, this depends on the half-life of the drug or toxin 
and the longer the half-life the longer it takes to reach steady state (Hedaya, 
2012). 
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Figure 6.2: Illustration of an example of how long it takes for a drug to reach steady state, 
adapted from Hedaya (2012). 
 
 
6.1.3 Domoic acid toxic mechanisms and clearance rates 
 
Domoic acid (DA) is an amino acid and a glutamate agonist that interferes 
with neurotransmission in the brain by binding to receptors in the central 
nervous system and causing damage or cell death in the hippocampal area. 
Thus because the neurons affected by DA are located in the hippocampus, 
affected people experience short-term memory loss, which is one of the most 
noticeable symptoms of DA poisoning (Perl et al., 1990). Interestingly in the 
study by Perl et al., (1990) no DA was detected in the blood of the people 
affected by the 1987 Canadian DA toxin event which raised questions 
regarding the clearance rate of DA. Normal kidney function plays an important 
role in the clearance of DA and it was documented in a study by Preston and 
Hynie (1991) that after a nephrectomy in rats, DA serum and brain levels were 
elevated compared to rats with intact kidneys. Studies of rats and monkeys 
indicate that DA has a rapid renal clearance (approximately 9 ml/min/kg body 
weight) and has a half-life of 20 min (Suzuki and Hierlihy, 1993; Truelove and 
Iverson, 1994). Inulin has been used to measure the clearance rate of DA, 
because it is not metabolized, secreted or reabsorbed in the body (Stitzer and 
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Martinez-Maldonado, 1978; Suzuki and Hierlihy, 1993). Iohexol, a 
nonradioactive contrast medium used as a marker for renal and plasma 
clearance, has been shown to be comparable to inulin as it is excreted intact 
by the kidneys (Brown and O'reilly, 1991; Gaspari et al., 1995). Iohexol has 
had an increasing interest in the scientific community and is now commonly 
used and has been validated in cats and dogs as a measure of glomerular 
filtration rate (GFR) (Brown et al., 1996; Gleadhill and Michell, 1996; Goy-
Thollot et al., 2006). Because iohexol has a low affinity for serum proteins and 
iodinated compounds are stable in plasma samples there is no major 
metabolism, deiodination or biotransformation. This means it can be 
substituted for inulin in both kidney function tests and to understand the 
pharmacokinetics of similar compounds, such as DA and potentially other 
hydrophilic toxins. Iohexol is also excreted though the urine unchanged with 
an average half life (in rats and dogs) of 74 min (Mützel and Speck, 1980). 
 
Numerous outbreaks of toxicity worldwide, and results of this study (chapters 
2 and 3) indicate that DA moves up the marine food chain (Landsberg, 2002). 
The effect DA has depends on the amount of toxic prey and therefore the 
dose of DA consumed by predators (Gulland, 2000; Lefebvre et al., 1999). 
Because no information exists on comparative pharmacokinetic parameters 
for marine mammals, the present study was the first step in investigating how 
quickly the DA biomarker iohexol is metabolised, cleared and excreted by 
healthy harbour seals. By collecting serial plasma samples from captive 
animals and measuring how long iohexol is detectable in the serum following 
an oral exposure I can determine basic pharmacokinetic parameters, 
particularly AUC and elimination half-life. This is of importance in the 
interpretation of the DA concentration levels measured in the urine of live 
captured and dead stranded harbour seals (Chapter 2), and to model the 
individual and population level risks and consequences of DA uptake to 
harbour seals in future. 
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6.2 Method 
 
6.2.1 Harbour seals 
 
Five male captive harbour seals were housed at the Sea Mammal Research 
Unit individually in continuous flowing salt-water tanks. These seals were 
captured in the Eden estuary on the east coast of Scotland, using hand held 
nets under the SMRU Home Office Animal (Scientific Procedures), Act 1986 
Project Licence. Four harbour seals were adult males and one was a sub-
adult male. The four adult males had a body weights from approximately 80 – 
100 kg while the sub-adult male weighed 50 kg (Table 6.1). The harbour seals 
were clinically healthy and were feeding daily before the study started. The 
seals were not given food 8 hours prior to the start of the experiment. 
 
Table 6.1: Harbour seals used in this study by name, sex (male or female), developmental 
stage (pup, sub-adult, adult) and mass (kg). 
Harbour seal 
individual 
Sex Developmental 
stage 
Mass (kg) 
Mac M Adult 80.6 
Xav M Adult 82.8 
Vern M Adult 86.4 
Uri M Adult 101.4 
Tim M Sub-adult 49.6 
 
6.2.2 Immobilization 
 
Harbour seals were immobilized using a combination of midazolam 
(Hypnovel; Roche, Welwyn Garden City, UK) 10mg/2ml solution, 0.3ml/10kg 
IM as a premed and 0.1ml/10kg IV (to control tremors) and ketamine (Ketaset 
100mg/ml solution, 0.1ml/10kg IV). While anesthetized, an Instech Solomon 
CBAS C70 7Fr heparin coated PU round tip catheter was inserted using a 
Dispomedica 8Fr peel away sheath introducer into the extradural vein. The 
catheter was kept from coagulating at the luer with heparinized saline (10 U 
heparin/ml 0.9% NaCI) at each sampling. 
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6.2.3 Trial 1 
 
The first procedure involved one harbour seal (Mac). After the seal was 
immobilized, iohexol (OmnipaqueTM 350, 350 mg/mL, Amersham Health, 
Cork, Ireland) was administered through a feeding tube at a dose rate of 2 
ml/kg (lean body mass, total dose: 140.0 ml). The feeding tube was flushed 
with 150ml water before removal. Time zero was set at the end of the 
administered Iohexol. Two heparinized blood samples (10 ml) were obtained 
from the catheter at 0, 30, 120, 600 and 1440 min after injection. The animal 
was observed during and after the procedure for any adverse reactions to 
iohexol. Urine samples were collected at 0 and 1440 min by urinary 
catheterisation. Blood samples were centrifuged at 2700 g for 12 min and 
plasma was removed and stored at -20 °C until analysis. Because of the 
analytical problems that occurred, only plasma samples were analysed in this 
study. 
 
6.2.4 Trial 2a 
 
Based on the results from trial 1, a decision was made to increase the blood 
sampling intervals to 10, 20, 30, 60, 120, 600 and 1440 min after 
administration of iohexol (total dose; 130 ml), and this was carried out with the 
second harbour seal (Xav). This trial was carried out twice on the same seal, 
leaving the seal to recover for a week in between the trials. 
 
6.2.5 Trial 2b 
 
After encountering some problems with the method for analysing iohexol 
using UV spectrophotometry (see section 6.2.6), the samples from the second 
set of trials were analysed using LC/MS/MS.  Thus based on the results from 
the UHPLC-MS/MS analysis (see 6.2.5 Analysis of iohexol using the UHPLC-
MS/MS method) a further trial was planned, this time involving three individual 
harbour seals (Verne, Uri and Tim). After immobilization (as above) iohexol 
was administered again orally (total doses as follow; Verne: 172.8 ml, Uri: 
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202.8 ml, Tim: 161.2 ml) and blood was collected in the same way as 
described in section 6.2.3 Trial 1. Collection time for blood samples was more 
frequent being every hour from 1 to 10 h. 
 
6.2.6 Analysis of iohexol as iodine using a UV spectrophotometric method 
 
6.2.6.1 Sample preparation and analysis method trial 1 and 2 
 
Initially, for the first trial, the blood samples were analysed following a 
colorimetric method published by Bäck et al. (1988) where iohexol is 
deiodinated by hydrolysis of alkaline and iodine release by the ceric arsenite 
reaction. Before the analysis a standard (50 µl serum from a non-trial exposed 
seal) + 50 µl iohexol) and a blank (50 µl serum) is prepared. The samples 
were added to polystyrene tubes where 5 ml of 1 mol/l NAOH is added. The 
sample were vortexed and incubated for 2 hrs in 90 °C. After incubation 50 µl 
were transferred into a micro centrifuge tube where 1 ml of the working 
solution (5 parts 1 mol/l sulphuric acid with 1 part bromide/bromate solution 
and 4 parts arsenite solution) are added to each sample. Then at timed 
intervals 50 µl ceric ammonium sulphate were added to the sample mixed and 
left to incubate for 20 min. The mix was then transferred into micro cuvettes 
and read using a UV-Visible spectrophotometer at 410 nm. The iodine 
concentrations were calculated using the equation in the publication by Bäck 
et al. (1988). 
 C   =   Cstand  x  log(Ablank  /  Asample)/log(Ablank  /  Astand).  
 
Where: Cstand = concentration of the standard 
Ablank = absorbance blank 
Asample = absorbance sample 
Astand = absorbance standard 
 
A standard curve was made to validate the assay and allow determination of 
the quantity of iodine in the samples. This iodine detection method is based 
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on a method first described by Sandell and Kolthoff (1934) and relies on the 
iodine as a reducing agent for cerium. The production of iodine in the reaction 
is reduced by trivalent arsenic (Bäck et al., 1988). 
6.2.7 Analysis of iohexol using the UHPLC-MS/MS 
 
6.2.7.1 Sample preparation for trial 1, 2 and 3 
 
Because of the failure of the analytical method (section 6.2.4 Analysis of 
iohexol as iodine using a UV spectrophotometric method) it was decided to 
use an alternative method to directly analyse the iohexhol in the plasma 
samples.   This method could not be carried out at SMRU so the plasma 
samples were stored at -20oC following collection for transfer to the Marine 
Science Scotland laboratory for analysis. 
 
The sample preparation was based on a method published by Lee et al. 
(2006). Before the analysis 100 µl of sample aliquot + 100 µL of acetonitrile in 
2 mL Eppendorf was vortexed twice for 5 sec. The sample was then 
centrifuged for 4 min at 14 000 rpm. The sample supernatant was then filtered 
through a 0.2 µm centrifugal filter. The filtered sample was then centrifuged 
for 2 min at 14 000 rpm and again filtered using a 0.2 µm centrifugal filter. 
Filtered samples were transferred into 350 µL amber vials for UHPLC-MS/MS 
analysis. 
 
6.2.7.2 Analytical method UHPLC-MS/MS 
 
For the calibration a spiking solution (SS): 26.5 µL of iohexol 350 
(Omnipaque) + 9970 µL of distilled water was used (Fig 6.3). Plasma samples 
were analysed following the method published by Lee et al. (2006) with some 
modifications and was performed at the Marine Scotland Science Laboratory 
in Aberdeen. 
 
The method involving the use of ultra high performance liquid 
chromatography-tandem mass spectrometry (UHPLC-MS/MS) was modified 
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and optimised for the specific detection of iohexol. A 3200 QTRAP mass 
spectrometer (ABSciex) was coupled with a 1290 Infinity UHPLC system 
(Agilent), comprising a 1290 Infinity binary pump, a 1290 Infinity 
Thermostated column compartment and a 1290 Infinity auto-sampler. 
Separation of the substrate was achieved using an XBridge column (C18 – 
3.5 µm – 150 * 3 mm) using an isocratic elution (30% B). Mobile phase A was 
100% aqueous and mobile phase B was 95% acetonitrile, both containing 
2mM ammonium formate and 50 mM formic acid.  With a flow rate was set up 
at 0.4 ml/min and a column oven maintained at 25 ºC throughout the analysis, 
the analysis run time was eight minutes. The injection volume for both 
standards and sample extracts was 5 µL. The mass spectrometer was used in 
multiple reaction-monitoring (MRM) mode and three specific transitions, one 
for quantitation and the other two for confirmation, were monitored for iohexol. 
The monitored transitions and source parameters are detailed in Tables 6.2 
and 6.3. 
 
 
Table 6.2: Mass spectrometer optimised parameters for the considered iohexol transition 
 
Transition 
Q1 
(m/z) 
Q3 
(m/z) 
DP 
(V) 
EP 
(V) 
CEP 
(V) 
CE 
(V) 
CXP 
(V) 
Iohexol 
T1 822.02 804.1 
176 6 34 
31 8 
T2 822.02 375.2 87 4 
T3 822.02 603 35 6 
DP: declustering potential 
EP: entrance potential  
CEP: collision cell entrance potential 
CE: collision energy potential 
CXP: collision cell exit potential 
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Table 6.3: Source optimised parameters 
 
CUR 
(V) IS (V) TEM (ºC) 
GS1 
(psi) 
GS2 
(psi) 
CAD 
(V) 
Source 
/Gas 10 5200 300 20 15 9 
CUR: curtain gas voltage 
IS: electro spray voltage 
TEM: source temperature 
GS1: nebuliser gas pressure 
GS2: heater gas pressure 
CAD: collisional activated dissociation voltage 
 
 
Figure 6.3: Calibration curve: because linear regression did not give the best fit (R2~0.9800 at 
best), a polynomial regression fit was used. 
 
 
6.2.8 Pharmacokinetic models 
 
Because the seals are orally exposed to toxins this study was designed to 
give an oral dose of the marker compound, iohexol and measure the iodine 
(using UV spectrophotometry) or iohexol (using UHPLC-MS/MS) content in 
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plasma samples collected serially over a 1-12 h time period. To evaluate the 
pharmacokinetics of iohexol there are several models that could be 
considered. The most frequently used are the non-, one- and two 
compartmental models. In a non-compartmental model the elimination of a 
drug follows a first order process and is often used by clinicians to calculate 
half-life (Fig. 6.4). In a one compartmental model it is assumed that the drug is 
being distributed instantaneously throughout the body (Fig 6.4) (Hacker et al., 
2009). In a two compartmental model it is assumed that the drug is distributed 
into two distinct compartments, which represent the central and peripheral 
compartment (Fig. 6.4) (Hacker et al., 2009). 
 
 
Figure 6.4: Models to be considered when designing a drug or toxin clearance study, adapted 
from Hedaya (2012). 
 
For this study a non-compartmental analysis was used where the area under 
the concentration time curve or AUC, Tmax, Cmax, and elimination half-life was 
calculated using the WinNonlin programme (6.3.0.395, Core Version 
04Jun2007, Pharsight, Mountain View, CA). Bioavailability and total clearance 
was not possible to calculate because the lack of an intravenous administered 
dose in addition to the oral dose data. The AUC, which represents the total 
iohexol exposure over time, was calculated from the concentration in the 
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plasma (Cp) versus time of sampling. The most common approach is a 
numerical approximation method called the trapezoidal rule (Equation 2). 
 Equation  2: 𝐴𝑈𝐶   =    !"!!"!!! 𝑡𝑛 − 𝑡𝑛 − 1  
 
The elimination half-life (t1/2) is given by (Equation 3): 
 Equation  3:  𝑡 12   =   0.693 ∗𝑀𝑅𝑇 
 
 
Where 0.693 is the natural logarithm of 2 and MRT is the mean residence 
time, which is calculated by the non-compartmental model using the 
WinNonlin programme (Reed et al., 2009). 
 
6.3 Results 
 
6.3.1 Harbour seal reaction to iohexol 
 
The harbour seals in all studies (Mac, Xav, Verne, Uri and Tim) completed the 
study without any untoward effect of the compound administrated. No 
observed changes in behaviour after the study were completed. 
 
6.3.2 Results using a UV spectrophotometric method 
 
The results from first set of samples were promising (Fig. 6.5, black line) as a 
peak of iodine was measured in the UV spectrophotometer after 30 min since 
the iohexol was administered. However, in a replicate analysis the curve 
flattened out around 30 min and a peak was first detected only after 10 hrs 
since administration of the iohexol (Fig. 6.5, red line). 
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Figure 6.5: The iodine absorbance result from trial 1 by using UV spectrophotometer with the 
iodine absorbance measured in the serum from the harbour seal “Mac” vs the serum sample 
time, black line is the first analysis and the red line is the replicate. 
 
For the second trial the blood-sampling interval was increased to investigate if 
there was a peak between 10 and 60 min. There was no real peak identified 
in the second trial (Fig. 6.6, black and red line). 
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Figure 6.6: The iodine absorbance result from trial 2a by using UV spectrophotometer with 
the iodine absorbance measured in the serum from the harbour seal “Xav” vs the serum 
sample time, black line is the first analysis and the red line is the replicate. 
 
 
In the replicate trial there was a peak at 20 min (Fig. 6.7, black line) but when 
this sample was run as a duplicate, two peaks were identified, the first at 10 
min and the second at 30 min (Fig. 6.7, red line). 
 
 183 
 
Figure 6.7: The iodine absorbance result from trial 2b by using the UV spectophotometric 
method with the iodine absorbance measured in the serum from the harbour seal “Xav” vs the 
serum sample time, black line is the first analysis and the red line is the replicate. 
 
After the first and second trial a standard curve was analysed to examine if 
the method was working optimally and to determine the relationship between 
concentration of iodine and absorbance. Several trials of the standard curve 
were carried out, but unfortunately the results were not consistent or 
successful, so that no increase in absorbance was seen with increasing 
concentration of iohexol (Fig, 6.8). This indicated some fundamental failure of 
the method and invalidated the results obtained above. 
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Figure 6.8: Three trials (blue, red and green line) of a standard dilution curve for iodine 
concentration where the absorbance is measured based on the iodine concentration in the 
iohexol. 
 
6.3.3 Analytical method UHPLC-MS/MS 
 
Due to the inconsistency of the UV-spectrophotometric method, the plasma 
samples were then analysed using an UHPLC-MS/MS. The method was 
successful in measuring iohexol concentrations in the plasma (Fig. 6.9 and 
Fig. 6.10). 
 
6.3.2.4 Pharmacokinetic models 
 
The dose rate chosen was based on studies in dogs (Klenner et al., 2009) 
and because harbour seals have very large fat stores, the dose was 
calculated on a lean body mass basis so as to be comparable.  Omnipaque 
350 contains 755mg/ml of iohexol thus the administered dose was 755mg/mL 
* 2mL/kg (lean body mass) = 1510mg/kg. 
 
The result from the UHPLC-LC/MS/MS method are shown in Table 6.4 and 
6.6 for the five harbour seals (Mac, Xav, Verne, Uri and Tim).  Because the 
sample time points were much fewer for the first three trials, the additional 
pharmacokinetic parameters were only calculated for the last three seals 
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trialled. Thus the Cp by time and AUCs calculated for Verne, Uri and Tim are 
given in Table 6.7. 
 
Table 6.4: Table showing the different pharmacokinetic parameters Cmax and Tmax for both 
harbour seals Mac and Xav in trial 1 and 2 a and b 
Time (min) Cp (Mac) Cp (Xav 2a) Cp (Xav 2b) 
0 0 0 0 
10 - 0.14 0 
20 - 2.07 0 
30 0 2.92 0 
60 - 4.06 0.19 
120 7.65 8.47 5.49 
600 1.07 0 0.44 
1440 0 0 0 
 
 
 
 
Figure 6.9: Graph showing the concentration of iohexol measured in plasma of the two 
different harbour seals, Mac and Xav (2a and b) where Cmax , Tmax is indicated on the graph. 
 
 
Table 6.5: Table showing the different pharmacokinetic parameters Cmax , and Tmax for the two 
different harbour seals Mac and Xav in trial 1 and 2 a and b. 
Seal Cmax Tmax (min) 
Mac 3.5 120 
Xav 2a 3.9 120 
Xav 2b 2.5 120 
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Table 6.6: Table showing the measured iodone concentration (Cp) in plasma (µg/ml) and the 
time the sample was collected for the three harbour seals Verne, Uri and Tim. 
Time (min) Cp (Verne) Cp (Uri) Cp (Tim) 
0 0.00 0.00 0.00 
60 15.51 17.87 26.81 
120 30.28 24.81 38.70 
180 51.44 32.92 34.72 
240 54.44 32.92 30.69 
300 44.91 36.90 23.89 
360 27.45 37.13 18.24 
420 19.91 36.76 17.64 
480 16.67 32.31 20.37 
540 13.10 27.64 26.62 
600 12.50 22.92 16.06 
 
 
Table 6.7: Table showing the AUC for the three harbour seals using the linear rule Verne. Uri 
and Tim.  
Time AUC (Verne) AUC (Uri) AUC (Tim) 
0 0 0 0 
60 16.75 19.3 28.95 
120 66.2 65.4 99.7 
180 154.45 127.75 179 
240 268.8 198.85 249.65 
300 376.1 274.25 308.6 
360 454.25 354.2 354.1 
420 505.4 434 392.85 
480 544.9 508.6 433.9 
540 577.05 573.35 484.65 
600 604.7 627.95 530.75 
 
A single kinetic profile may be well summarized by the peak concentration 
Cmax, the time when the peak occurred Tmax, the elimination half life, t1/2 and 
the AUC. Tmax and Cmax are obtained from the Cp/time plot for each seal as 
shown in Fig. 6.10 and Table 6.8, elimination half-life (t1/2) is shown in Table 
6.8. 
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Figure 6.10: Graph showing the concentration of iohexol measured in plasma of the three 
different harbour seals, Verne, Uri and Tim where Cmax , Tmax is indicated on the graph. 
 
 
Table 6.8: Table showing the different pharmacokinetic parameters Cmax , Tmax and elimination 
half-life (t1/2) for the three different harbour seals, Verne, Uri and Tim. 
Seal Cmax Tmax (min) Elimination half-
life (min, t1/2) 
Verne 117.6 240 191.4 
Uri 80.2 360 197.4 
Tim 83.6 120 226.8 
Average ± SD 93.8 ± 20.68 240 ± 120 205.2 ± 19.2 
 
6.4 Discussion 
 
Exposure to DA has occurred for many years in marine mammals (Fire et al., 
2009; Hall and Frame, 2010; Lefebvre et al., 1999; McHuron et al., 2013; 
Scholin et al., 2000), and continues to pose a threat to their health and 
survival. Therefore there is an increasing interest in understanding how 
quickly DA is cleared out of the body. 
 
In this study, elimination of the DA biomarker iohexol was in part adequately 
described by the equation of a non-compartmental model, although total 
clearance rate and bioavailability could not be calculated in this study. Iohexol 
is biphasic meaning it has a rapid distribution and slower elimination. This 
study documents the maximum drug or toxin concentration (Cmax), the time of 
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maximum concentration (Tmax) and the elimination half-life (t1/2) of iohexol. 
The elimination half-life (measured in min), which is the time period required 
for the concentration of the drug or toxin to be reduced by one-half was in this 
study measured to be on average 205.2 (3.42 h)  ± 19.2. In a study by 
Truelove et al. (1994), rats had a mean half-life (min) of 21.0 (0.35 h) ± 3.2 
and in monkeys a mean (min) of 16.0 (0.27 h). In addition to DA having a 
short half-life in both rats and monkeys (Suzuki and Hierlihy, 1993; Truelove 
and Iverson, 1994), iohexol was measured to be below detection limits after 
four hours of exposure. Iohexol clearance rate have been measured in dogs 
to have a half-life of 173 (2.88 h) ± 53 minutes (Collignon et al., 2012), and 
are physiologically more similar to harbour seals than rat and monkey.  This is 
very similar to the elimination half-life I estimated for the harbour seals. 
 
Establishing a single pharmacokinetic reference value for estimating the 
elimination of DA would be incorrect as there can be several reasons why 
there is a difference between the pharmacokinetic parameters between the 
harbour seals in this study. These differences can be age-related, affected by 
mass and body size and by diet, hydration status and fitness. From the first 
and second (2a and 2b) trials (Mac and Xav 2a and b) no true peak (Cmax) of 
iohexol was identified as it occurred between 120 and 600 min.  
 
In the third trial, which involved the harbour seals Verne, Uri and Tim the peak 
was identified on average at 240 ± 120 min. Both Verne and Uri had a Tmax 
that occurred later than Tim and both of these seals were adult harbour seals 
(> 5 years) while Tim was a sub-adult (2-4 years) as estimated from their 
mass and the mass/age relationships for UK harbour seals (SMRU 
unpublished data). Age could potentially be a factor that could affect the 
elimination of iohexol (Hoek et al., 2007). Since the iohexol is used for 
measuring renal failure, kidney function, hydration status together with body 
size could play a role at slowing down the clearance in harbour seals with a 
lower renal function (Gaspari et al., 1995; Perl et al., 1990; Suzuki and 
Hierlihy, 1993). 
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Blood is a difficult matrix to use for estimating exposure to DA because it is 
quickly eliminated, as demonstrated by the results of this study.  Although we 
were not able to continue to collect blood samples beyond 10 h, to the point of 
complete disappearance of iohexol, the declining Cp suggested that this 
would have occurred within the next 2-3 hours. Because of this rapid removal 
of DA from the blood, samples such as urine and faeces have been collected 
(Chapter 2 and Chapter 4) in order to measure DA exposure in marine 
mammals. DA is primarily eliminated in the urine following absorption (Suzuki 
and Hierlihy, 1993)} which makes this the preferred matrix for determining the 
time course of exposure. Maucher and Ramsdell (2005) measured DA in 3 
body fluids; urine, plasma and milk and after a 1.0 mg/kg intraperitoneal 
exposure in lactating rats they found that most of the DA is excreted through 
the urine and that the 1-hr values were 3 orders of magnitude greater than in 
the plasma and that the plasma had 10 times higher DA concentrations than 
milk.  This clearly indicates that most systemic DA is cleared quickly through 
the kidneys. There have been several models for DA clearance studies in 
mice, rats and cynomolgus monkeys where symptoms such as tremors, 
seizures and scratching have been reported after varying doses of DA 
exposure (Iverson et al., 1989; Tasker et al., 1991; Tryphonas et al., 1990) 
and CSL with DA toxicosis exhibit similar symptoms such as ataxia, head 
weaving, scratching, decreased responsiveness and seizures (Gulland et al., 
2002). 
 
Future studies will therefore need to focus on a) determining how often 
harbour seals urinate (which could be determined from captive experiments) 
b) measuring the clearance of iohexol after an intravenous injection to 
determine bioavailability and c) collection and analysis of urine preferably on 
an hourly basis at the same time as the intravenous experiment. This 
experiment would need to ensure that the bladder is empty at the start. More 
sophisticated models involving a two compartmental model could then be 
used for calculating the total clearance, as well as the urinary excretion rate of 
the DA biomarker iohexol. This knowledge could then be used to back-
calculate DA exposure levels for different harbour seal haulout sites around 
Scotland, where average foraging distances are different (ranging in the UK 
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from < 10 to > 60 km, (Sharples et al., 2012). These data could then be added 
into a risk assessment model to evaluate if DA is indeed a likely factor 
causing the decline in the harbour seal population in Scotland. 
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Chapter 7 
 
7. General discussion 
 
7.1 Thesis aim 
 
This thesis was motivated by questions regarding the cause or causes of the 
harbour seal decline in Scotland, focussing on the role that toxins from 
harmful algae may play. These were:  
 
1. Are the Scottish harbour seals exposed to multiple toxins in Scotland and 
what are the potential health effects of this exposure? 
2. What are the key prey species involved in the trophic transfer of toxins to 
harbour seals?  
3. Are there other fish eating predators exposed to toxins in Scotland, or is it 
only occurring in Scottish phocids? 
4. For how long has harbour seals in Scotland been chronically exposed to 
domoic acid (DA)? Can the recent discovery that CSLs have natural 
antibodies to DA (Lefebvre et al., 2012) be used to investigate historic DA 
exposure in archived blood samples from harbour seals in Scotland? 
5. Following exposure to DA, how quickly are the harbour seals excreting the 
toxin, compared to other model species? 
6. Can exposure to toxins from harmful algae be a factor responsible for the 
harbour seal population decline in some regions of Scotland? 
 
7.2 The exposure of Scottish harbour seals to multiple toxins 
 
DA produced by the diatom Pseudo-nitzschia has become an interesting 
potential factor in the decline in abundance (in some regions) of the Scottish 
harbour seals (Hall and Frame, 2010). Results from this study show that in 
addition to their continued exposure to DA, at least on a relatively annual 
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basis over the last 6 years, Scottish harbour seals are additionally exposed to 
several other toxins that have the potential to cause substantial morbidity and 
mortality. In particular I found they were ingesting PSP toxins, a critical finding 
given their very lethal nature (Garcıá et al., 2004; Hernández et al., 1998; 
Long et al., 1990). 
 
Although the levels measured in the faecal samples collected were low, 
harbour seals are at risk of dying if exposure exceeds a threshold dose (Bates 
et al., 1989). There are many members of the PSP toxin family and it is a 
complicated toxin to study, with extraction methods and toxin quantification 
still under development. PSP toxins could potentially have a devastating effect 
on the harbour seal population and indeed PSP toxins were the cause of the 
mass mortality in the monk seal populations of the western Sahara 
(Hernández et al., 1998). In addition to causing mass mortality, PSP toxins 
can exhibit sub-lethal health effects that are hard to demonstrate in free-living 
animals as they can inhibit critical body processes such as respiration (Mons 
et al., 1998). 
 
Although there is no information on the effect of PSP toxins in harbour seals, 
several reasons exist that could increase the susceptibility of a seal to these 
PSP toxins, than for example for humans; (1) seals have blubber (composed 
of adipocytes), which the water-soluble PSP toxins cannot access/perfuse 
because of their hydrophilic nature, (making the toxin more concentrated in 
the body tissues and organs). (2) The marine mammalian dive reflex which 
optimizes respiration by peripheral vasoconstriction where blood is shunted 
away from non-critical tissues and directed to the vital organs such as the 
heart and brain, which limits access to other organs such as the kidney and 
liver (Geraci et al., 1989). (3) The respiratory systems sensitivity to 
anaesthetic agents in pinnipeds (reports of complications due to anaesthesia 
involve apnoea, bradycardia, extended recovery, hypo- and hyperthermia and 
in worse case death occurs (Gales, 1989; Hammond and Elsner, 1977; 
McDonell, 1972; Sinnett et al., 1981)), due to their physiologic and anatomical 
adaptation (i.e. cardiovascular, respiratory and thermoregulatory) to diving 
(Gales, 1989; McDonell, 1972; Ridgway and Simpson, 1969). 
 193 
 
The third group of toxins investigated in Chapter 2 was the lipophilic toxins 
such as OA and DTXs. These toxins have not been widely studied in marine 
mammals and only a few papers in the literature exist indicating exposure in 
bottlenose dolphins in Texas, USA (Fire et al., 2010b) and in manatees in 
Florida (Capper et al., 2013). Investigation of exposure to both OA and DTX-2 
confirmed that Scottish harbour seals are exposed to not only DA and PSP 
toxins, but to three different toxin groups. I also observed DTX-2 in relation to 
a couple of possible cases of gastroenteritis, which may be indicative of poor 
digestion (Chapter 2). Although these toxins cause the most common shellfish 
illness DSP in humans, knowledge of its presence and location in the food 
chain is sparse, and to my knowledge only one case of natural OA exposed 
fish exists (Gamboa et al., 1990). 
 
There was significant regional and temporal variation, particularly in exposure 
and uptake of DA in harbour seals for which I had most data. Due to the small 
sample size, I was not able to investigate the regional and temporal variation 
in the other toxins I focussed on (PSP toxins, OA and DTXs) so clearly further 
work on this is needed on these toxin groups in the future. It is interesting that 
all the urine samples collected and analysed between 2008 and 2010 for the 
live captured harbour seals contained quantifiable amounts of DA. This trend 
was also seen for faecal samples both for the live captured and anonymous in 
the years from 2008 to 2010. Annual variation in the Pseudo-nitzschia spp. 
blooms in Scotland can explain this observed DA trend (Fehling et al., 2006). 
Another explanatory factor for the DA variability from the west coast to the 
east coast can be explained by the hydrographical conditions as studies have 
shown that DA levels can be higher in areas where the salinity is higher 
compared to less saline areas (Doucette et al., 2008). The ecosystem from 
the west coast is quite similar in many ways to the east coast (Baxter, 2011), 
where for example the coastal waters around the east coast and the west 
coast of Scotland are affected by fresh water from numerous small rivers 
(Baxter, 2011). Although limited detailed knowledge exists on the detailed 
hydrographical parameters (such as temperature and salinity) in the areas 
where the harbour seals are foraging, studies indicate that the west coast 
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shows a lower and more variable salinity content than the east coast (Baxter, 
2011), and this is probably due to the increased flow rate and fresh water 
input from the rivers along the west coast. 
 
Difference in sampling time in relation to excretion rate could also explain the 
lower levels measured on the west coast. It would be interesting to investigate 
offshore hydrographical parameters (such as wind stress, heat fluxes, 
temperature and current) in addition to phytoplankton blooms in the areas 
where the harbour seals are foraging. Regional differences in foraging 
duration and travelling time to the different haul out sites (Sharples et al., 
2012) need to be taken into account when comparing toxin levels in excreta 
from seals inhabiting the different regions. Regionally comparison should 
therefore be made with caution, as I still don’t know what the toxin levels 
represent in the harbour seals given that I don’t know the time of toxin 
ingestion. However, further inferences could be made from modelling 
approaches (see below). Even though the proportion of positive samples was 
higher on the east coast, the significantly lower concentration on the west 
coast is of particular interest in relation to the preferred prey consumed. On 
the west coast the harbour seals prefer to forage on gadoid fish (Wilson, 
2014) compared to seals on the east coast that forage more intensively on 
flatfish and sandeels (Sharples et al., 2009; Wilson, 2014). Flatfish has in this 
study been highlighted as an important vector of toxin transfer and changes in 
harbour seal diet can thus have major consequences for exposure. Although 
caution is taken when interpreting the toxin levels measured in the harbour 
seals throughout this study, I have found a higher toxin concentration levels 
for the majority of samples collected (urine and faeces in live captured 
animals and faecal samples from anonymous animals) in the areas where the 
population is in decline (east coast and Northern Isles). This is important 
information and linking these findings to the preferred prey and potential 
vectors of toxin transfer, I conclude that toxins from harmful algae remain a 
potentially significant factor in the harbour seal population decline. 
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Due to the lack of sample quantity to measure all toxins in all samples and the 
limited resources available for this study, analysis for DA was prioritised. This 
enabled me to investigate the relationship between DA in faecal and urine 
samples and certain basic immune parameters that could be measured in the 
field or on return to the laboratory. Of particular interest were the white blood 
cell levels (Levin et al., 2005) and particularly the eosinophil counts, which are 
significantly elevated in CSL with acute and chronic DA toxicosis (Gulland et 
al., 2012; Schwacke et al., 2010; Twiner et al., 2011). Exposure to DA has 
been reported to have other immunological effects such as increased T-
lymphocyte proliferation and can in turn decrease host resistance (Levin et al., 
2010).  The immunomodulatory effects, possibly as a result of DA exposure 
reported in this study (Chapter 2), were lower lymphocyte cell counts. 
(lymphocytopenia) related to an increase in urinary and faecal DA 
concentrations. In addition effects on the monocyte cell counts (monocytosis) 
were also documented where an increase in urinary or faecal DA 
concentration was related to an increase in cell counts. Lymphocytopenia can 
increase the risk of infection, and interestingly monocytosis often occurs in 
response to a chronic inflammation or infection, indicating these two effects 
could be linked. The yearly reoccurrence of both lymphocytopenia and 
monocytosis may indicate that this effect is related to chronic DA exposure. 
These correlations with white blood cell counts have not been documented in 
other exposed species before so this could be a species-specific effect. 
However, the implication for the health of the individuals and the levels of 
exposure that may elicit this response requires much further investigation. 
Comparing the mean lymphocyte cell counts in this study to wild-caught 
harbour seals from California, US indicated that the mean lies around the 
lower threshold of the normal range (Greig et al., 2010), which confirms 
lymphocytopenia. In addition, when comparing the monocyte cell counts to 
the wild-caught harbour seals from California, the mean lies closer to the 
upper threshold for the normal rage (Greig et al., 2010), indicating a 
monocytosis. Assuming these reference ranges are appropriate for use in UK 
harbour seals, I can conclude that the changes in white cell counts may be 
clinically significant. 
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A reduction in lymphocyte counts can be indicative of chronic stress, (which 
also increases the endogenous production of glucocorticoids (Duncan et al., 
1994)), chronic infection or malignancy. Diseases caused by parasite 
infections (Kelly et al., 2005) or viral infection (Bossart et al., 1990) can often 
be accompanied by lymphocytopenia and immunosuppression, which can 
result in opportunistic infections (Ramaekers et al., 1975). Results of this 
study may indicate an immune suppression associated with DA but I was not 
able to investigate for any bacterial or viral infections. Natural killer (NK) cells 
are one of three types of lymphocytes and play a large role in defending the 
host from virally infected cells and tumours and reduced NK cells were found 
when harbour seals were given fish contaminated with persistent organic 
pollutants (Ross et al., 1996). Given the susceptibility of harbour seals to viral 
infections such as phocine distemper virus (Osterhaus and Vedder, 1988), 
this could be an important lymphocyte sub-set to investigate and identify 
further in relation to DA uptake or the other toxin groups studied in this thesis. 
 
An increase in monocytes can occur if the body is exposed to an acute 
bacterial, protozoal or a viral infection (Duncan et al., 1994) and can also 
occur during chronic inflammatory conditions. Monocytosis was documented 
in bottlenose dolphins recovering from morbillivirus bronchopneumonia 
(Reidarson et al., 1998). To my knowledge there is only one case described in 
the marine mammal literature where lymphocytopenia and monocytosis 
occurred simultaneously, in a CSL suffering from adenovirus (Dierauf et al., 
1981). 
 
I was able to show that harbour seals are exposed to multiple toxins from 
harmful algae but did not have sufficient samples to relate these combined 
levels in individual animals with health parameters. It may be that if the 
occurrences of toxins in prey are positively correlated (so that fish with high 
levels of DA also have high levels of the other toxins) then some of the 
relationship seen could be due to the synergistic or additive effects of these 
additional toxins. Results from Chapter 3 document that of the flatfish species; 
plaice, lemon sole and dab are the three species that accumulate the highest 
levels of all three groups of toxins. Multiple toxin exposure has been 
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documented in bottlenose dolphins from Texas, US where OA and DA was 
detected at low levels in the tissues (Fire et al., 2010b), although no 
associated health effects were reported. In a study by Dragunow et al., (2005) 
they suggested that in vitro toxicity of OA is increasing in the presence of the 
algal toxin gymnodimine (produced by dinoflagellates from the genus 
Karenia). Further investigations into multiple toxins both at lethal and at the 
sub-lethal levels are required. DA bind to glutamate receptors in numerous 
organs suggesting exposure can not only have neurological effects, but other 
perhaps more subtle health effects, which indicates that studies of the 
occurrence and abundance of glutamate receptors in other organs in harbour 
seals (such as the adrenal glands (Gendron and Morley, 2005; Kristensen, 
1993)) should be investigated. 
 
Cortisol levels in the blood were also an important blood parameter in the CSL 
studies, where results documented that levels are significantly lower in CSL 
with DA toxicosis (Gulland et al., 2012). The lack of evidence for lower levels 
of cortisol or higher levels of eosinophils suggests that the Scottish harbour 
seals captured and sampled in this study were not suffering from acute or 
chronic toxicosis. Although the levels measured in the harbour seals urine and 
faecal samples were comparable to the levels reported for the CSL taken into 
rehabilitation at the Marine Mammal Centre in California (Goldstein et al., 
2008), the highest level in the prey collected during the large DA mortality 
events on the US west coast were 223 µg/g compared to the highest level 
measured on the east coast of 117 µg/g which represent a 90.6 % higher 
level than the prey collected on the east coast of Scotland (but see below for 
further discussion on levels in prey). 
 
I would conclude that this indicates that in the surviving seals I was able to 
study in the various regions exposure is perhaps more likely to be low level 
and chronic in nature. I did not observe seals showing neurological signs and 
these have not been reported to SMRU by observers or through the seal 
rehabilitation centres during my PhD time. However in February 2009 there 
were some unusual events where harbour seal pups were found in fields, on 
pavements, golf courses and on roads along the east coast (C. Seddon pers. 
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comm.). The phytoplankton monitoring didn’t start until March that year so it is 
difficult to say if this unusual behaviour event could be linked with exposure to 
HAB. There was also an observation on a seizing grey seal in July 2011 (A. 
and M. Reeve pers. comm.), phytoplankton monitoring document bloom over 
the trigger limit > 50 000 cells per litre. Although these events are rare it is 
quite possible though that those with the most severe symptoms and health 
effects from exposure above the threshold for effects do not make it back to 
the haul out site after foraging. Thus, given that these conclusions were drawn 
from studying the survivors it was important to investigate exposure levels in 
the same matrices and pathological effects in any carcasses that washed 
ashore and were the subject of post mortem examination by the Scottish 
Marine Animal Stranding Scheme (SMASS). 
 
7.3 Domoic acid in dead stranded marine mammals 
 
Dead marine mammals were sampled and the levels compared to those seen 
in the live captured animals. The 28 dead harbour seals that were available 
did not have significantly higher levels than the live animals and the causes of 
death attributed to these individuals, where available were not linked to toxin 
exposure. However, the sample size of seals available for this study was 
small and may not represent the dominant causes of mortality for seals in 
these regions. 
 
Due to the amount of decomposition, detailed pathology and histology was 
not always possible for these animals. Limited conclusions can be drawn 
although the ultimate cause of death was not thought to be toxin related it is 
still possible that toxins could have been involved either as a direct or an 
indirect cause of death. Impacts on organs such as the heart (Goldstein et al., 
2008) and brain (Goldstein et al., 2008) were not investigated and neither 
were sequelae (Teitelbaum et al., 1990) that could be related to toxins other 
than DA, particularly PSP toxins and this aspect should therefore be 
prioritised in future. Intrauterine DA exposed mice showed hippocampal 
damage and neuronal death occurred in the offspring (Dakshinamurti et al., 
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1993), it would be interesting investigate any possible DA effects in pups of 
harbour seals that are exposed to DA in utero. 
  
All freshly dead harbour seals should have brain and heart tissue taken for 
histology. Brains should be serially sectioned and examinations should be 
carried out to investigate for any gross abnormalities. Lungs should be 
checked if they are congested as this was a consistent feature of the Monk 
seals’ mortalities (Harwood). Both lung and brains should be analysed for 
PSP toxins. However, the occurrence of fresh harbour seal carcasses 
washing ashore around the Scottish coast is very limited (Brownlow and 
Davison, 2012). Unless the animals die close to shore they do not appear to 
strand. For example, despite the very high mortality that must have occurred 
on the east coast given the very significant decline in numbers (~90% since 
2000, (SCOS, 2013)), the magnitude and speed of the decline cannot be 
explained only by effects on fecundity but must be due to increased mortality 
as well (N. Hanson, pers. comm.) yet very few dead seals are reported as 
stranded in this region. This is also unlikely to be due to reporting bias as the 
SMASS have good coverage in this area and it is highly populated with many 
dog walkers and other members of the public using most of the coastline for 
recreation. 
 
Samples of faeces and urine from other marine mammals, particularly 
cetaceans, that strand around the UK coast were also analysed to compare 
with the results for the harbour seals and to determine if other coastal species 
particularly harbour porpoises had higher levels or prevalence of exposure 
compared to more offshore species. Results from this investigation document 
exposure of both the coastal and offshore cetaceans where the harbour 
porpoise (inshore species) had a significantly higher level than the offshore 
feeders. The DA levels measured in harbour seals and the harbour porpoise 
were the highest of the stranded marine mammals, but interestingly were 
lower than those that had been measured in the live captured harbour seals. 
Stranding of harbour porpoises was documented in relation to DA in 2002, 
2005, 2007 and 2010 in California, US (Wilkin et al., 2012) with levels ten 
times higher than what is reported in this thesis. The DA levels measured in 
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grey seals (that are known to generally forage further off the coast than 
harbour seals (Thompson et al., 1996) were below the LOQ except in two 
cases where grey seals were shot in June on the east coast and levels 
measured in the pericardial fluid were quantifiable and comparable to fluid 
levels that had been measured in harbour seals. 
 
Interestingly DA levels measured in the faecal samples from the pilot whales 
were the highest of the offshore feeders and although no diet information 
exists on these samples, pilot whales are known to forage on cephalopods 
(Desportes and Mouritsen, 1993). Cephalopods have been found to act as 
vectors of DA (Costa et al., 2005b) although levels in these prey have not 
been investigated around the Scottish coast. 
 
7.4 Previous exposure to domoic acid in harbour seals 
 
 
In order to find out if DA exposure in particular is a recent or historic 
phenomenon and to find out if the appearance of markers of exposure 
appeared in the population at about the same time as the decline in harbour 
seal abundance for the regions of interest (east coast and Northern Isles), an 
aim of this study was to use the recent discovery that acute and chronically 
exposed CSL generate antibodies against DA (Lefebvre et al., 2012). The 
archived set of blood samples collected from harbour seals over the last 20 
years or so available at SMRU provided an exceptional resource for this 
purpose. However, I was unable to replicate or validate the method published 
by Lefebvre et al., (2012) despite the availability of identical samples from 
CSL used in the paper. The reasons for this are unclear but several trials 
were carried out, using different samples from phocid seals and most 
importantly using commercially available dog serum, which would not contain 
antibodies against DA. In addition to the high absorbance ratios found in 
samples that should have been negative, given they were from pups or 
regions without DA suggests some fundamental problem with this approach. 
False positive results were being obtained, as the method may be detecting 
proteins other than anti-DA antibodies. However, the results presented by 
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Lefebvre et al., (2012) were compelling so further investigation are needed 
before this approach is completely dismissed. For example extraction and 
isolation of the specific antibodies from the blood samples could be carried 
out using the DA antibodies produced by Biosense (Norway) using a different 
format such as a dot-blot or Western blot assays (Pryor, 2001). Although most 
commercial manufacturers only supply antibodies as part of a kit format, they 
may be persuaded to supply a small amount for evaluation purposes. 
 
Monoclonal antibodies have been produced to detect DA (Kawatsu et al., 
1999), but designing an antigen where DA is bound to a larger carrier 
molecule would be interesting to carry out and generating monoclonal 
antibodies that are DA specific and would only bind to a specific epitope on 
the designed DA antigen. Conducting laboratory animal experiments where 
an animal is inoculated with the antigen (carrying the specific epitope) and 
investigations to see if production of antibodies occurs. Further development 
an assay that is able to detect these antibodies might refine the approach to 
determine the presence of naturally occurring DA-specific antibodies in the 
serum of exposed animals. 
 
If DA specific antibodies exist they would most likely bind to any free DA in the 
blood and make it more difficult to excrete via the kidney, at it would keep 
circulating in the body. It would be interesting to look for DA conjugates in 
exposed animals where free and covalently bound (to a carrier molecule) 
toxin was investigated. Enzymatic proteolysis or immunohistochemistry of 
tissues in exposed animals could be investigated in order to see if it gives 
ELISA-detectable DA-containing protein fragments. Another experiment would 
be to investigate for the presence of DA-specific antibodies using labelled DA 
(such as a fluorescent tag), which can be detected using a fluorescence 
polarization immunoassay. 
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7.5 Vectors for toxin exposure to harbour seals 
 
 
The vectors for exposure are clearly the seals’ prey but it is important to 
determine which species are the primary vectors, particularly for future risk 
assessment studies. I was able to collect and analyse fish samples 
throughout the spring, summer and autumn, which were discards from 
different fishermen on the east coast of Scotland. I found that all three groups 
of toxins were detected in fish collected on the east coast. DA and PSP toxins 
were detected in all three groups of fish (pelagic, benthic and flatfish), while 
the lipophilic toxins were only detected in one pelagic fish and several 
flatfishes. Interestingly DTX-2 was only detected in flatfish, suggesting this 
might be the major vector group. 
 
Pseudo-nitzschia are not motile and they are relatively heavy due to the silica 
within their cell walls, which can cause the algae to sink to the seabed if the 
water turbulence is low (Swan and Davidson, 2011). Studies have been 
carried out to prove that DA may persist long after a Pseudo-nitzschia spp. 
bloom has ended and that DA can act as an important vector in the deep-
water food chains (Sekula-Wood et al., 2009). Further evidence of DA 
contamination to benthic organisms are proven by Kvitek et al., (2008) where 
they discovered DA in four feeding groups; filter feeders, predator, 
scavengers and deposit feeders. 
 
Harbour seals mainly forage on benthic prey in certain areas, within 20-45km 
of the coast (Thompson et al., 1994; Tollit and Thompson, 1996; Wilson, 
2014). Although toxin exposure in fish was only investigated on the east coast 
using fish discards collected from the North Sea, it appears that benthic 
demersal flatfish accumulate the highest amount of toxin. This was also the 
conclusion of a study of DA in benthic and benthopelagic fish species in 
Monterey Bay, California, where DA were significantly higher in benthic fish 
when there were few toxic cells present in the water surface (Vigilant and 
Silver, 2007). 
 
 203 
The results from Chapter 3 shows that fish on the east coast are exposed to a 
range of toxins and continuing this type of screening/investigation is highly 
recommended and should be conducted throughout the Northern Isles and 
the west coast region. Investigation of benthic organisms would be an 
additional priority to understand the trophic linkages between top predators, 
fish and the benthic invertebrates. 
 
 
This dataset has provided the first comprehensive data on concentrations of 
toxins in fish viscera in from a small area in the UK and has been of interest to 
the UK Food Standards Agency who are responsible for understanding 
potential human health risks. Of some note was that the data were not 
obtained during any HAB event and therefore probably represent the 
minimum exposure. Despite this, the concentrations were log-normally 
distributed where some fish had relatively high levels of toxins. These data will 
therefore be invaluable in a risk assessment model which could be seasonally 
structured so that model simulations could take account of the fact that toxin 
exposure may be higher during the summer than at other times of the year. 
 
Further work on exposure through analysis of whole fish rather than just fish 
viscera as although the viscera contain by far the largest proportion of the 
toxins, some may be found in the brain of fish (Lefebvre et al., 2002a; Vale 
and Sampayo, 2001). This would improve the accuracy of the oral exposure 
levels and dose estimates. In addition to studying fish prey from other regions, 
improving information about levels of toxins in the most important prey such 
as sandeels, which were underrepresented in this study would be a 
importance. Also prey should be collected from the specific harbour seal (and 
grey seal for comparison) foraging regions rather than from the fishermen, 
they should be obtained from all regions, particularly the west coast and 
should be particularly analysed during HAB events. This information would 
help with estimating more accurately how much toxin the harbour seals could 
be exposed to in the different regions in Scotland. 
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7.6 Estimating the elimination of toxins in harbour seals 
 
The data on the concentrations of toxins in fish provide a minimum estimate 
for exposure estimation but in order to determine how likely animals are to 
consume sufficient toxin for it to produce adverse health effects more 
information about how the animals metabolise and excrete the toxins is 
required and particularly the time course for excretion. Harbour seals feed in 
bouts so they may not consume sufficient toxic prey in one bout to exceed the 
effect threshold. However, if the feeding bouts were sufficiently close together, 
the effect of repeated oral exposure in relation to excretion rate and whether 
animals reach steady state would increase. The experiment I carried out in 
captive animals using iohexol as a marker for DA excretion estimation found 
that the elimination half-life is approximately 3.5 hours, and the concentration 
peak occurred at around 4 after ingestion. All the DA is therefore likely to be 
eliminated by 10-12 hours. 
 
However, in order to complete the pharmacokinetic model, further data are 
needed by studying the plasma iohexol time course following an intravenous 
dose and by studying the iohexol concentration in urine samples. Additional 
information about the urination rate and if the bladder empties entirely every 
time urination occurs (in harbour seals) would also improve the accuracy of 
the elimination estimates. This additional data would enable me to complete 
the clearance calculation. This information would be used to construct a more 
realistic two compartmental pharmacokinetic model. It would also be 
interesting to investigate if the same clearance pattern occurs in CSL that 
have very high exposures during large bloom events and are known to 
experience morbidity and mortality from DA exposure. 
 
Investigation of a biomarker for PSP toxins and the lipophilic toxins is also 
required to understand the clearance of these toxins. In addition experiments 
to then understand the clearance rate of multiple toxins combined would be 
important to investigate. It is possible that these toxins interact with each other 
and this could affect the clearance, peak concentration and half-life of each 
one. 
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7.7 Risk assessment studies 
 
 
The studies in this thesis have investigated the exposure, uptake, effect and 
excretion of toxins in harbour seals and compared the results to levels in other 
marine mammals found stranded in UK waters. The results will be critical in 
the development of appropriate risk assessment models. For example, data 
on the levels of toxins in individual harbour seals could be combined with the 
data collected on the individuals’ movements. 
 
Some of the animals studied were also equipped with SMRU GPS/GSM tags 
and when the data are available, it could be used to establish the individual 
animals’ fine scale foraging pattern (assuming its future behaviour is 
comparable to its previous behaviour), region of exposure and the temporal 
and spatial factors that dictate the concentrations found in the excreta when 
the animals were captured at the haulout site. This individual based approach 
could then be combined into a specific individual based population model 
describing the impact that the toxins may have on the population abundance. 
Simulations would take into account the type and amount of prey consumed 
(based on recent investigations into the diet of harbour seals (Wilson, 2014)) 
and the dose of toxin assimilated by a number of individuals in a population, in 
an approach similar to that used for the CSL (Bejarano et al., 2007). 
 
Combined with dose-response data derived from what is known about lethal 
levels for each toxin in turn (and in combination) from the literature on animals 
and humans (Andrinolo et al., 2002; Negri et al., 1995; Schantz et al., 1975), 
the effect that this exposure would have on the probability of survival for each 
individual in the population would be estimated. When the number of 
individuals remaining in the population at the end of each year is combined, 
the effect on the population abundance and growth rate would be assessed 
and compared with the observed population trends. 
 
This study has provided much of the empirical data needed for assessing the 
risks to the harbour seals in Scotland from the potentially lethal effects of 
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toxins from harmful algae. I have shown that DA and PSP toxins in particular 
could be likely factors involved in the decline, where further investigation is 
needed. Combining the results from the individual studies, specifically on 
multiple exposure, concentrations in prey and elimination rates into a risk 
assessment framework will be the next step in determining the true probability 
that they are one of the major drivers.  Nevertheless, I have also shown that 
positive relationships between specific white blood cells and concentrations of 
DA in the urine and faeces may suggest sub-lethal health effects that, 
combined with other factors such as infectious disease or nutritional stress, 
may cause mortality as an indirect effect of toxin uptake. 
 
7.8 Method development 
 
In the recent years there has been discussion on the validity of using urine as 
a monitoring matrix for quantifying DA because of the salt content which is a 
result of the mechanism for regulating salt balance (Seubert et al., 2014), and 
comparisons with different analytical techniques should interpreted with care. 
Further investigations are needed in sample preparation and development of 
a method that can reliably measure DA in urine samples. Similarly, for the 
faecal samples it is difficult to draw conclusions from comparing the results 
from one study to another due to differences in equipment, analytical 
materials, and technical capability. Limit of detection and quantification are 
needed in these types of studies and it is important to communicate this in 
research papers. 
 
A problem with studying multiple toxins is the amount of sample that are 
needed for extracting the toxins. Methods that can reduce the amount of 
sample needed to extract the different toxins are required, this way monitoring 
of multiple toxins could be more readily conducted. Preferably a method that 
does not rely on mass spectrometry as these instruments are usually very 
expensive and the method requires large samples due to the long clean-up 
processes. The ASP ELISA method developed by Biosense is an excellent 
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low cost method that can easily be applied in basic laboratories which was 
well correlated with the results obtained by UHPLC/MS-MS. 
 
7.9 Conclusions 
 
It is not possible at present to conclude that the results of my thesis can for 
certain explain any of the current regional harbour seal declines, as I am 
missing perhaps the most compelling evidence of dead stranded harbour 
seals which died of toxicosis.  However, there are several interesting 
conclusions that can be drawn from the current results. Choice of prey, which 
could be driven by regional or seasonal changes in availability, in the harbour 
seals habitat will play an important role in determining exposure level. When 
comparing the levels across the years DA monitoring there has been a 
general decrease (i.e. since 2008). It could be that the toxin investigations 
began only after a peak in environmental levels and that we are now seeing a 
general decline.  However, continued surveillance of levels in predators and 
prey will indicate if this general pattern continues. 
 
This is the first evidence that harbour seals are exposed to DA, PSP toxins 
and lipophilic toxins and thus the first time harbour seals are reported taking 
up three different toxin groups simultaneously, which in turn makes toxin 
exposure investigation in this population more complex. Lymphocytopenia 
and monocytosis are associated with exposure to DA, but the individual and 
population level effects of these changes are not yet well understood and 
certainly warrant further investigation. 
 
Evidence of trophic transfer of toxins on the east coast largely appear to be 
driven by flatfish, as they accumulate higher concentration of all three groups 
of toxins. Evidence of toxin exposure to other fish eating predators was found 
with DA concentrations being higher among the inshore than the offshore 
feeders. Future close inter-disciplinary collaborations between algologists, 
chemists, ecologists and epidemiologists are needed to achieve a better 
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understanding of the dynamics and distribution of these toxin groups and their 
potential health effects in marine mammals and fish around Scotland. 
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